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ABSTRACT
Goblet cell hyperplasia is found in many hyper¬
secretory disease states. Despite this the origin,
synthetic and secretory control, and population regulation
of goblet cells remain unknown.
The aim of this study was to establish a single-dose
model of goblet cell hyperplasia in the rat lung which was
free from respiratory infection and a superimposed
inflammatory reaction. The agent used was isoprenaline,
multiple injections of which had been shown to induce
goblet cell hyperplasia in the rat lung.
The effects of a single systemic dose of isoprenaline
were investigated. The isoprenaline response was then
studied in order to ascertain the mechanism whereby
isoprenaline induced goblet cell hyperplasia.
It was found that a single 40 mg/kg dose of
isoprenaline induced a reproducible 3-4 fold increase in
goblet cells in the rat lung. The response could be
detected at 12 hours, reached a maximum between 24 - 48
hours and then gradually declined, regaining control values
8-16 days later. The response was dose-dependent and a
shallow dose-response curve was obtained which could be
antagonised by propranolol. Salbutamol and methoxamine
were also shown to induce goblet cell hyperplasia in the
rat lung. Isoprenaline induced goblet cell hyperplasia
ii'i
when applied directly to the respiratory epithelium. The
goblet cell hyperplasia was stereospecific for (-)
isoprenaline at low doses but not at high doses. The
response was the same in male and female rats.
It was concluded that the goblet cell response was due
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SYNOPSIS
The original intentions of this project were as
follows:-
Firstly, to establish a single dose model of
isoprenaline-induced goblet cell hyperplasia in the rat
lung. This model was then to be used to study the goblet,
about which very little is known, in detail. In
particular, it was intended to use the model in conjunction
with cell kinetic studies using tritiated thymidine, to
ascertain the role of mitosis in the origin of the new
goblet cells and also to study the turnover of the goblet
cell population in the lung. It was envisaged that this
work would be carried out using both light and electron
microscopes. In addition, it was proposed to carry out
differential cell counts of the respiratory epithelium,
such that the same area used for the assessment of goblet
cells under the light microscope would be used for the
differential cell counts under the electron microscope. It
was also intended that the model would be used in
conjunction with radioactive labelled mucin precursors to
study the effects of isoprenaline on the pattern of mucin
synthesis and discharge from goblet cells. This work would
also have employed both light and electron microscopes.
To facilitate combined light and electron microscopic
studies it was necessary to develop new histological
techniques for the fixation, processing, cutting and
1
staining of large plastic embedded blocks of lung tissue.
The requirement for the light microscopic quantitation of
goblet cells was for thin sections 1 - 1.5 jam thick
encompassing the entire length of the main airway of the
left lung of the rat along with all of its side branches.
From the remaining block a map was to be made and areas of
interest, i.e. those studied at the light microscope level,
would be sawn out and sections cut for the electron
microscope. It follows that the embedding medium chosen
had to be compatible with both the light and the electron
microscope. One such medium is araldite and when the
project commenced there had just been produced a new design
of microtome which, it was claimed, would cut large thin
sections of araldite embedded material. However,
subsequent experience proved that it was impossible to
achieve adequate quality of sections, using this machine,
for the light microscopic assessment of goblet cells (see
Appendix v). Eventually a compromise solution was reached
whereby the left lungs from experimental rats were embedded
in glycolmethacrylate (GMA) for the light microscopic
assessment of goblet cells and selected right lungs were
post-osmicated and embedded in araldite for future study
under the light and electron microscopes.
The development and rejection of the various
histological techniques tested took up the whole of the
first year of the study. However, by the beginning of the
second year of the study the histological side of the
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project had been decided upon. There was then a further
delay of 6 months caused by an outbreak of Sendei virus at
the I.C.I Alderley Park breeding unit, during which time no
suitable alternative source of animals was found (see
Chapter 3 section 3.1). This incident necessitated the
repeat of at least one experiment and a complete
reassessment of the criteria for the acceptability of lungs
into the study. Thus, it was deemed necessary to examine
every single lung for the presence of disease before they
were used for the quantification of goblet cells. This
required the cutting and staining of additional sections
and thus lengthened the time between dosing the animals and
quantifying goblet cells.
As it was not possible to pursue the development of
new techniques for autoradiography in GMA through lack of
time, and also because GMA is not electron stable and
cannot therefore be used satisfactorily in the electron
microscope, both the proposed cell kinetic and differential
cell count studies had to be abandoned. It was therefore
decided to investigate the isoprenaline response in greater
detail and attempt to ascertain a possible mechanism
whereby isoprenaline induces an increase in goblet cells.
Thus, experiments were designed to establish:
a) the existence or not of a dose-response
relationship
b) the details of the timing of the response
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c) whether there were male/female differences in the
response
d) the stereospecificity of the response using the
optically active isomers of isoprenaline
e) whether any other sympathomimetic or para¬
sympathomimetic drugs were capable of eliciting a
similar response
f) if it was possible to antagonise the isoprenaline
induced goblet cell hyperplasia pharmacologically
with propranolol, a ^-adrenoceptor antagonist
g) if isoprenaline, when applied directly to the
respiratory epithelium either as an aerosol or as
a bolus intratracheal injection, was capable of
inducing the same goblet cell response.
Finally, preliminary studies were made to develop a
novel fast screening technique for the assessment of
tracheal goblet cells. This technique was called the
tracheal dab technique and is described in Appendix i. The
aim was to develop a very fast method for the
quantification of goblet cells which would in turn make
feasible the screening of a wide range of drugs for an
effect on respiratory goblet cells.
This in essence is the project as it was originally





The respiratory epithelium, which forms the lining of
the airway passages, contains many specialised cells. One
of these is the goblet cell which is responsible for the
production of mucus. Mucus production provides a means of
trapping and removal, via the mucocilliary transport
mechanism, of particulate matter, including bacteria, as it
enters the lung.
Very little is known about the factors which control
goblet cell numbers within the lung, their origin within
the respiratory epithelium or about the mechanisms which
control the synthesis and secretion of mucus. In certain
hypersecretory disease states the number of goblet cells is
known to increase. The mechanism causing this increase is
however unknown.
Many attempts have been made to find an animal model
of goblet cell hyperplasia. Most of these models have
involved direct multiple exposures of the respiratory
epithelium to irritant gases. However, a more recent model
has been demonstrated using multiple systemic doses of
\
isoprenaline, a ^-adrenoceptor agonist. This is the first
model of goblet cell hyperplasia in the lung not
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complicated by the superimposed inflammatory reaction
caused by direct damage to the epithelium by an irritant.
The study reported here was undertaken to investigate
the isoprenaline-induced goblet cell hyperplasia in greater
detail. Experiments were designed to establish a model of
respiratory goblet cell hyperplasia using a single intra¬
peritoneal dose of isoprenaline which could be used to
ascertain when the increase in goblet cells occurred and
how long it lasted. A series of studies were undertaken in
order to find out if the response was dose-dependent.
Attempts were made to antagonise the effects of
'isoprenaline using the p-adrenoreceptor antagonist
propranolol. A number of sympathomimetic and parasympatho¬
mimetic drugs were tested for a similar effect on
respiratory goblet cells. Differing routes of admini¬
stration were tried to see if they had any effect on the
isoprenaline-induced goblet cell hyperplasia. Various
novel histological techniques were evaluated in an attempt
to develop an improved procedure to make quantification of
the goblet cells easier and quicker.
The first section of the introduction will contain
descriptions of the lung and the respiratory epithelium
with particular reference to the rat proximal airways.
This is followed by the historical background associated
with the goblet cell, and a detailed description of the
goblet cell structure and function. Next there is a
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section on the factors known to influence respiratory
goblet cells and a brief review of the possible origins of
the goblet cell. At the end of this section there is a
paragraph on the innervation in the lung and its role in
the control of goblet cell synthesis and secretion.
Finally, there is a brief review of the pharmacology of
isoprenaline with details of both its direct pharma¬
cological actions and its indirect metabolic and
biochemical actions.
1:2 STRUCTURE AND FUNCTION OF THE LUNG
Anatomv: The mammalian lung exists primarily to effect
gaseous exchange and to perform this function it possesses
multiple thin-walled distensible air sacs connected by a
series of passages with the external atmosphere. The
detailed pattern of airtubes and aerating tissues varies
from species to species; all are nevertheless constructed
on a similar plan (Spencer, 1977). The nasal passages
communicate directly with the atmosphere; these lead into
the trachea and this in turn divides at the carina to form
the right and left main bronchi.
In the rat the right bronchus further divides outside
the lung parenchyma and each of these branches enters one
of the four separate lobes of the right lung (see Figure
1). The left lung in the rat, on the other hand, is a










Ventral view of the respiratory organs of the rat








branches immediately upon entering the lung. In man there
are normally three lobes on the right and two on the left.
Upon entering the lung the bronchi divide repeatedly,
ultimately ending in terminal bronchioles. In man these
give rise to a further one to three generations of
respiratory bronchioles. In the rat, however, there are
very few respiratory bronchioles (Castleman et al., 1975),
and it is the terminal bronchioles and not the respiratory
bronchioles which end in alveolar ducts. The alveolar
ducts terminate in two or more air sacs and from these
arise the alveoli which increase the surface area and
constitute the aerating surface.
A series of cartilage rings lend support to the
trachea and main bronchi. In man they extend along the
intrapulmonary airways as far as the end of the small
bronchi; in the rat cartilage rings only occur in the
extrapulmonary airways and terminate at the hilum (Jeffrey
ana kudj tin.
The manner in which the airways divide to form a
branching network is not the same in all species - in man
it is a mixture of monopodal, polypodal and dichotomous
branching. In the rat, because the left lung is a single
lobe, the manner in which the airways branch is very
different (see Figure 2). This simple branching pattern
allows division of the lung into set anatomical areas,
zones 1-5, using the side branches leading off from the
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FIGURE 2
Schematic diagram to show the nature of the branching
of the main bronchus in the left lung of the rat.
(The figures 1-5 represent the zones referred to in
the text)
main bronchus (Figure 2). All these branches travel in the
same plane and by careful orientation of the fixed,
inflated lung during embedding and cutting, it is possible
to obtain histological sections showing the main bronchus
and each of its side branches (see Figure 3). This has
important implications for reasons which will be discussed
in section 1:33, as it allows study of the respiratory
epithelium at the same anatomical site in different rats.
Airways and Respiratory Epithelium: In mammals the airways
are lined by a respiratory epithelium which extends from
the nasal pharynx right out to the terminal and respiratory
bronchioles. Since this thesis is concerned with intra-
pulmonary respiratory epithelium, most of the following
will relate to the ciliated epithelium of the lower
respiratory tract.
The basic structure of the airway epithelium was
determined by the late nineteenth century and descriptions
of various cell types were published by the following:
Ciliated and goblet cells (Henle, 1837); goblet, chalice
and beaker cells (Knauff, 1857; Shulze 1871; and Frey,
1874); basal and intermediate cells (Frankenhauser, 1879;
Waller and Bjorkman, 18&2).
With the advent of the electron microscope ultra-
structural details became apparent which had not been seen
at the light microscope level and descriptions of
increasing numbers of different cell types in the
9
FIGURE 3
Low power photomicrograph (xl) showing the left full
main airway and its branches obtained in 1.5 urn GMA
sections (Bullard's haematoxylin/eosin staining).
>
FIGURE 3.
respiratory epithelium were published. There are now
several light microscope and electron microscope studies
giving detailed descriptions of the cell types present in
the rat (Breeze and Wheeldon, 1977; Kuhn, 1976; Jeffrey
and Reid, 1975 and 1973a; Rhodin and Dalhamn, 19 5 6 ;
Rhodin, 1959; Kent, 1966). Currently, ten cell types,
eight epithelial and two mesenchymal, are recognised within
rat airway epithelium (see Table 1).
The number and distribution of each cell type within
the epithelium are not constant throughout the length of
the respiratory tree. Thus a cell may only be found in
proximal airways whilst another will show a mainly peri¬
pheral distribution. In the rat the distribution of epi¬
thelial and migratory cells is as follows:-
Proximal intrapulmonary airways: Ciliated cells,
goblet cells, basal cells, intermediate cells, very rarely
serous cells and K-cells, occasional brush cells and Clara
cells, lymphocytes and globule leukocytes.
Peripheral intrapulmonary airways: Ciliated cells,
Clara cells, brush cells, intermediate cells, very rarely
K-cells, lymphocytes, and globule leukocytes.
Most can only be identified ultrastructurally or using
sophisticated histochemistry. At the light microscope
level in proximal airways the following can be reliably
identified: ciliated cells (haematoxylin and eosin stain),


























The 10 epithelial cell types classified on the basis of
position, presence of cilia, and type of secretory granule,
if any.
(R. Jones, 1976).
histochemistry), lymphocytes, globule leukocytes, non-
ciliated non-secretory cells and non-ciliated secretory
cells. The non-ciliated secretory cells include both
serous and Clara cells whilst the non-ciliated non-
secretory cells include brush cells and intermediate cells.
1:3 THE GOBLET CELL
1:31 The Historical Background to the Goblet Cell
The earliest description of the goblet cell was given
by Henle in 1837. Later, various authors also described a
large cup-shaped cell in the respiratory epithelium. They
were as follows: Bowman, 1847; Knauff, 1857; Schulze,
1871 and Frey, 1847. The term goblet cell was used as a
descriptive term because of the shape of the mature form of
the cell. They have also been called chalice, beaker and
cup-shaped cells.
1:32 The Structure and Function of the Goblet Cell
Structure: Mature goblet cells have an expanded cup-shaped
cytoplasm, called the theca, which is filled with secretory
droplets. The cells are connected to the epithelial base¬
ment membrane by a thin stem into which the cytoplasmic
organelles and nucleus are compressed (see Figure 4).
Thus, it is often difficult to see the structural details
of the organelles even at the ultrastructural level. The
nucleus, which is situated at the base of the cell appears
&KC Be
FIGURE 4
A schematic presentation of the tracheal epithelium of
the rat. C = Ciliated cells; G = Goblet cells in
various stages of secretion; BRC = Brush cell; BC =
Basal cell (after Rhodin and Dalhamn, 1956) .
very densely stained at the light microscope level. It is
irregular in shape and contains a small nucleolus.
Immediately above the nucleus there is a prominent Golgi
apparatus. It is here that the mucin is synthesised. The
supranuclear area also contains extensive profiles of rough
endoplasmic reticulum and a few mitochondria and
tonofilaments.
The cytoplasm of the goblet cell is relatively
electron opaque with many free ribosomes giving it a marked
basophilia. At the apex of the cell the cytoplasm contains
numerous mucin granules, these are of differing size and
are bound by a thin, often discontinuous membrane. The
contents of the granules can be either a fibrillar or a
homogenous low density material, and in the rat they
contain an electron-dense core (Jeffrey, 1975). The
luminal surface of the goblet cell is covered by a number
of short microvilli which project into the airway lumen.
Function; The function of goblet cells is to synthesise
and secrete mucin. The mucin so produced varies from
species to species, from cell to cell, from tissue to
tissue and with disease, and some cells may even produce
two or more types of mucin at the same time. Generally,
goblet cells are capable of producing 4 types of mucin, a
neutral mucin which stains with PAS (Periodic Acid/Schiff)
but not AB (Alcian Blue), and three acid mucins; a
sialidase-sensitive sialomucin, a sialidase-resistant
sialomucin, both of which stain with combined AB/PAS stains
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to give red/blue and blue/red colours, and a highly acid
sulphomucin which reacts with AB, Hales Colloidal Iron and
High Iron Diamine stains. It appears that under normal
conditions a goblet cell population secretes a particular
range of glycoproteins but that in response to irritation
the product may be modified as in the case of respiratory
infection when there is a shift towards a predominance of
acid sulphomucin in the rat (Reid, 1970; Jones and Reid,
1978).
Synthesis; Goblet cell synthesis of glycoproteins occurs
at 3 sub-cellular sites; the peptide backbone is
assembled on membrane-bound ribosomes within the rough
endoplasmic reticulum (RER). A series of glycosyltrans¬
ferases (the so-called multi-glycosyltransferase system),
then add the different carbohydrate moieties to the protein
backbone as the growing glycoprotein transverses from the
RER to the SER (smooth endoplasmic reticulum) and then to
the Golgi apparatus where sulphation takes place.
Glycoproteins destined for secretion are packaged into
secretory vesicles in the Golgi apparatus and these, once
released into the cytoplasm, mature into storage vesicles
which gradually accumulate at the apex of the cell.
Secretion of mucin granules takes place either singly with
the granules remaining intact (reverse pinocytosis) or
occasionally the contents at the apex of the cell may
coalesce and be extruded from the cell as a stream of mucin
(Schachter, 1978).
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1:33 The Quantification of Respiratory Goblet Cells
Problems of Identification: One of the difficulties
encountered when attempting to quantify goblet cells is
that not all goblet cells exhibit the classic 'goblet'
shape. Immature or recently emptied goblet cells appear as
columnar, slender cells often with only a few mucin
granules in the cytoplasm. At the light microscope level
such cells may not be identified as goblet cells,
particularly when mucin specific stains have been used, as
insufficient mucin content of the cells makes them appear
as non-ciliated secretory cells with a few apical granules
- a classification which can include serous, Clara and
possibly intermediate cells.
In order to make this source of error as small as
possible, it is necessary to decide at the outset the
criteria that are to be applied when identifying goblet
cells and to adhere to them rigidly throughout any study.
In this study only frank goblet cells, i.e. those with a
distended mucin-filled theca, were counted as goblet cells.
Problems of Distribution: Another problem which is en¬
countered when counting respiratory goblet cells is their
uneven distribution within the respiratory epithelium.
Their numbers increase toward the caudal part of the
trachea, there is also a greater density of goblet cells in
the cartilagenous wall of the trachea than there is on the
membranous wall. In intrapulmonary airways goblet cells
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occur infrequently either singly or in clusters, with
conspicuous clusters at points of bifurcation. Their
numbers decrease rapidly towards the periphery, and in the
normal, healthy animal there are no goblet cells present on
small bronchi and bronchioles. Nevertheless they can be
induced at these peripheral sites by disease and
irritation.
Because of the wide variation in distribution it is
difficult to quantify goblet cells accurately. In a study
such as this it is essential therefore that when assessing
goblet cells and making a comparison between different
groups of rats that the same anatomical area is studied in
each case. Sections therefore have to be large enough to
make this possible, preferably encompassing the'entire
length of the main airway in the left lung. Lamb et al.
(1969) and Jones (1976) have shown that the distribution of
goblet cells in zones 1 and 2 of the intrapulmonary airway
of the rat (Figure 2) is fairly constant thus making it a
good area for studying changes in the goblet cell
population. The advantageous branching system of the
airways in the left lung is therefore of great help in
defining the area to be counted (Figure 3).
1:34 The Factors Affecting Goblet Cell Function
Introduction: An increase in epithelial goblet cells is a
characteristic feature of chronic inflammatory changes in
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mucosal membranes (Florey, 1970). Thus, respiratory goblet
cells respond to a variety of adverse stimuli by both
increased mucus production and an increase in numbers;
this is a defensive mechanism used to protect the delicate
tissues of the lung.
Amongst the external factors which have been shown to
affect the goblet cell population are irritant gases and
liquids, particulate matter, infections caused by inhaled
bacteria and viruses, and pharmacological agents (Florey,
1932; Reid, 1963; Lamb and Reid, 1968; Mawdesley-Thomas and
Healey, 1969; Mawdesley-Thomas et al.. 1971; Elmes and
Bell, 1963; Freeman, 1964; Freeman et al.. 1972; Mellors,
1958; Lamb and Reid, 1969; Cash et al.. 1979; Jones et al..
1975; Sturgess and Reid, 1973; Baskerville, 1975; Jones and
Reid, 1979a and 1979b; Kleinerman, 1976). The nature of
the internal, i.e. physiological, factors which exert a
controlling influence on the goblet cell population are not
known. Goblet cell secretion does not appear to respond to
either parasympathetic or sympathetic nerve stimulation,
although both types of nerve endings play a role in
controlling submucosal gland secretion. Recently, a
substance P-like material has been shown to be present in
nerves in the lamina propria and basement membrane of the
respiratory epithelium, but its relationship to goblet cell
activity is not known (Wharton et al.. 1979).
16
Experimental Models of Respiratory Goblet Cell Hyperplasia
Using Irritant Liquids and Gases;
FORMALIN LIQUID: Florey (1932) described experiments in
which he studied the effects of daily injections of dilute
formalin on the airway mucosa. The formalin was injected
into the airway via a glass tube passed through the
glottis. Ciliated, columnar epithelial cells were replaced
by cuboidal shaped cells resembling the transitional
epithelium of the bladder; goblet cells were greatly
increased in number and the glands showed evidence of
exhaustion of secretion.
MUSTARD OIL: In 1932, Florey studied the effects of the
direct application of mustard oil on cat respiratory
epithelium. The results on goblet cells were inconclusive
since there was a superimposed desquamation of the
epithelium. However, in areas least affected there was a
suggestion of goblet cell increase.
SULPHUR DIOXIDE: In 1963, Reid reported an increase in rat
respiratory goblet cells following exposure to SO2 gas at
200-300 ppm for 5 hours a day for 6 weeks. The aim of the
study was to produce an animal model of the changes in
chronic bronchitis without a superimposed respiratory
infection.
Lamb and Reid in 1968
greater detail and found that
not directly follow mitosis
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studied the SO2 effect in
the goblet cell increase need
and that newly formed cells
changed their pattern of glycoprotein production to a pre¬
dominance of acid glyco-protein. Reid in 1963, and Lamb
and Reid in 1968, also studied the reversal of the changes
produced within the airway epithelium. They were found to
persist up to 3 months after the cessation of exposure.
Subsequent studies have shown that the response to the
irritant is dose-dependent (Mawdesley-Thomas and Healey,
1969; Mawdesley-Thomas et al.. 1971). In the same studies
they reported a similar change induced by SO2 in the
respiratory airways of the lamb. On the other hand,
studies in the dog have shown different responses to S02.
Proximal segmental airways showed a reduction in goblet
cell numbers whilst distal airways and bronchioli showed an
increase in goblet cells. The trachea and lobar bronchi
exhibited squamous metaplasia with a loss of both ciliated
and goblet cells (Chakrin and Saunders, 1974). In a later
publication they reported that S02 exposure had produced a
decrease in the number of acidic groups within the goblet
cells of the airway surface (Spicer, Chakrin and Wardell,
1974) .
There is evidence that in the presence of infection
the effects of S02 exposure, namely the increase in goblet
cells and proliferative changes, are not seen (Goldring
et al., 1967; Lightowler and Williams, 1969).
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CHLORINE: Exposure of rats to 40 ppm chlorine gas produces
goblet cell hyperlasia both in proximal and peripheral
airways (Elmes and Bell, 1963).
NITROGEN DIOXIDE: In the absence of disease, rats exposed
to 25 ppm of NO2 for 40 days exhibit respiratory goblet
cell hyperplasia (Freeman, 1964). Long term exposure to
lower doses of NO2 (15 ppm) also produces similar changes
(Freeman et al.. 1972).
Experimental Models of Respiratory Goblet Cell Hyperplasia
Using Tobacco Smoke: Mellors (1958) first reported an
increase in respiratory goblet cells in the rat following
exposure to tobacco smoke. Lamb and Reid in 1969 showed
that the increase in goblet cells was dose-dependent and
that at some doses there was a shift from neutral to acid
mucin production. Studies using lambs (Mawdesley-Thomas
and Healey, 1973) failed to demonstrate a statistically
significant increase in respiratory goblet cells after
exposure to tobacco smoke, but they did show a significant
and dose-related increase in gland size.
Expermental Models of Respiratory Goblet Cell Hyperplasia
Using Bacteria and Viruses: Cash et al. in 1979 reported a
rat model of chronic respiratory infection using
Pseudomonas aeruginosa, an organism persistently found in
the lungs of patients with cystic fibrosis. In the
infected rats they found increased epithelial goblet cells
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surrounding areas involved by the infecting organism.
Interestingly goblet cell numbers were increased in areas
where there are normally none, i.e. peripheral airways, as
well as in their usual sites in the proximal airways.
Conversely, in pigs suffering from enzootic pneumonia
caused by Mycoplasma hyorhinis, Jones et_al.(1975) reported
an increase in the height of the bronchial epithelium and a
depletion of epithelial goblet cells associated with a
marked reduction of both theca size and intracellular
glycoprotein.
The essential difference between these two models of
respiratory infection is that the former was a chronic
infection and the latter an acute infection. This may
account for the difference in the goblet cell response.
Experimental Models of Respiratory Goblet Cell Hyperplasia
Using Pharmacological Agents; As stated in the opening
paragraph of this section, both sympathetic and parasympa¬
thetic nerves have been observed within the sub-mucosal
bronchial glands of man, the rat and the cat and therefore
they may play a role in the control of the secretion of
mucus by the glands. However, epithelial goblet cell
secretion does not appear to respond to either
parasympathetic or sympathetic nerve stimulation and
neither type of nerve ending has been observed in close
proximity with epithelial goblet cells. The physiological
control over goblet cell activity is therefore unknown.
Whilst attempting to find a solution to this question a
number of experiments have been reported in which a variety
of pharmacological agents have been tested to see if any of
them are capable of influencing respiratory epithelial
goblet cells.
ISOPRENALINE: Isoprenaline, a ^-adrenoceptor agonist, was
first reported to induce an increase in respiratory epi¬
thelial goblet cells in rats by Sturgess and Reid in 1973.
They found that 6 and 12 daily injections of isoprenaline
sub-cutaneously, in doses of 10 and 25 mg, produced an
increase in both epithelial goblet cells and sub-mucosal
gland size. They also demonstrated that the newly formed
goblet cells were producing predominantly acid mucin and
less neutral mucin. Using organ culture techniques they
also studied the effects of isoprenaline in vitro on human
bronchial explants; isoprenaline administration was
combined with ^H-glucose administration and the secretion
of mucin macro-molecules was followed. They found
isoprenalne in vitro had no effect on the secretory index
of sub-mucosal bronchial glands or on epithelial goblet
cells (Sturgess and Reid, 1972).
In a similar study, this time in pigs, Baskerville
(1975) reported an increase in gland size and epithelial
goblet cell numbers following 6 daily injections of 75 mg
to pigs weighing between 32-40 lbs. The new goblet cells
were shown to produce acid sialomucin. The increase
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reached significant levels 24 hours after the last
injection and persisted for 16 days and then gradually
declined, taking as long as 84 days to reach control values
once more. Baskerville concluded that, as there were no
hyperplastic changes within the epithelium and the mitotic
acitivity showed no change, the drug was altering cellular
differentiation in order to produce the increase in goblet
cells.
In a later study, Jones and Reid (1979a) studied the
regression in goblet cell numbers in more detail following
systemic administration of isoprenaline in rats. Rats were
given cumulative daily doses of isoprenalne (10 mg/100 g
body weight) for up to 6 days. Rats were killed at
different times during the injection schedule; at 24 hours
following a single injection they found a 3-fold increase
in goblet cells, and this increased to a 4-fold increase
following 2 daily injections. This was a maximum increase
since following 6 daily injections the increase was still
4-fold. After withdrawal of the drug they found that the
goblet cell number fell at different rates in different
sites in the lung, e.g. proximal trachea took one week to
regain control values, the main bronchus, 8 weeks and the
peripheral airways were still slightly above control values
at 12 weeks.
SALBUTAMOL: This is a selective ^-adrenoceptor agonist
used to reverse broncho-constriction in asthma and chronic
bronchitis. In 1979, Reid and Jones briefly reported a
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study in which they compared salbutamol with isoprenaline
on the goblet cell population in rat lung. They found that
there were regional differences between the two drugs on
goblet cell numbers although both drugs altered the type of
mucin produced by the same amount to acid mucin. The
results, they suggested, indicated differences in and
^-adrenoceptor distribution. Further details of this
study were reported later in the year (Jones and Reid,
1979b). The doses of the drugs used were 10 mg/100 g body
weight sub-cutaneously as 6 daily injections. Isoprenaline
increased goblet cells in proximal and distal tracheal
epithelium but not in the central portion, and increased
goblet cells in allzones of the bronchial epithelium in
the lung. Salbutamol, however, only produced significant
increases in goblet cells in proximal tracheal epithelium
and in proximal bronchial epithelium and had no effect in
other zones. Isoprenaline had a much greater effect than
salbutamol despite the fact that salbutamol has a longer
half-life and therefore persists longer in the body once
injected.
PILOCARPINE: Pilocarpine is a para-sympathetic agonist
acting on muscarinic receptors. In 1973, Sturgess and Reid
reported increases in respiratory epithelial goblet cells
in the rat following 10 mg pilocarpine sub-cutaneously for
6 and 12 days. Pilocarpine, unlike isoprenaline, induced
an increase in both neutral-mucin-producing and acid-mucin-
producing goblet cells. In vitro studies by Sturgess and
Reid (1972) failed to show any influence on epithelial
goblet cells by pilocarpine but they did find that para¬
sympathomimetic drugs, among them pilocarpine, increased
sub-mucosal gland secretory index and that para¬
sympatholytic drugs, e.g. atropine, decreased gland
secretory index - evidence which supports the para¬
sympathetic nervous control of glands in the bronchial
epithelium.
METHACHOLINE: Methacholine is a para-sympathetic agonist
and its effects on epithelial goblet cells and bronchial
glands in the cat were reported by Kleinerman in 1976. 3
mg/kg in 3 doses given daily over a period of 90 days
produced both goblet cell 'metaplasia* and bronchial gland
hypertrophy. The descriptions were brief however; the
glycoprotein of the gland was unchanged and mainly neutral,
whilst the goblet cells showed a loss of acid groups.
SUMMARY: A pharmacological model of goblet cell hyper¬
plasia is the first not to be complicated by inflammation
and infection, and therefore it is easier to study the
goblet cell response after the drug has been administered.
Until now the drugs have been administered in multiple
doses over a period of days; however, should it be
possible to establish a single dose model of goblet cell
hyperplasia then detailed studies of the goblet cell using
cell kinetics and autoradiography will be possible. Also
the administration of the drugs is much easier and more
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reproducible than the inhalation and inoculation techniques
previously required and this means that comprehensive
studies using large numbers of animals become feasible.
1:35 The Origin of Goblet Cells
Cell turnover in the rat lung is very low: less than
1% of the total epithelium population being labelled one
hour after injection with ^H-thymidine (Hackett, 1979).
Consequently the question of whether goblet cells in the
respiratory tract arise directly from the stem cell
population or via some other indirect route is a vexed one,
and many conflicting theories have been proposed.
Donnelly et al. (1980) concluded that in the rat
tracheal epithelium, all cell types with the exception of
ciliated cells were proliferative and that the intermediate
cell was the precursor cell for the ciliated cell.
Conversely, also in the rat, Bindreiter et al. (1968)
concluded that ciliated and goblet cells were not pro¬
liferative and that the basal cells were the stem cell
population with one basal cell division giving rise to one
basal cell and one differentiating cell, the latter having
one subsequent division giving rise to differentiated
functional cells, e.g. ciliated and goblet cells. Another
theory has been proposed by Boren and Paradise (1978) in
which they put forward a model scheme consisting of three
kinetic compartments in which self-maintaining basal cells
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pre-goblet or oligomucus cells. These proliferating
precursor cells occupy the lower half of the crypt and in
turn give rise to the differentiating non-proliferating
functional cells which occupy the top half of the crypt
(Cairnie, 1970; Merzel and Leblond, 1969). Additional
villus goblet cells also arise on the side of the villus by
transformation of undifferentiated columnar cells (Porcella
et al.. 1979).
This scheme for the development of villus goblet cells
has some similarities with the schemes for the development
of respiratory goblet cells outlined earlier. It is
possible therefore, that the pre-goblet or proliferative
oligomucus cell of the small intestine epithelium has a
counterpart in the respiratory epithelium which has yet to
be identified and which may play a role in the development
of respiratory goblet cells.
1:4 EXPERIMENTAL TECHNIQUES AVAILABLE FOR GOBLET CELL
STUDY
1:41 Animal Models of Goblet Cell Hyperplasia
For various reasons it is necessary to resort to whole
animal experiments in order to study the goblet cell in
detail. Firstly, human material is scarce and cannot
easily be obtained, and it is virtually impossible to
obtain 'normal' specimens. Secondly, attempts at organ
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culture using strips of tracheal or bronchial epithelium
are complicated by the fact that the respiratory epithelium
rapidly de-differentiates in_vi t r. o losing all its
specialised structures including goblet cells (Heckman
et al.. 1978).
An important consideration when choosing the species
of animal for use as a model is the similarity between the
animals respiratory mucosa structure and that of human
respiratory mucosa structure. For example, human chronic
bronchitis is characterised by increased sub-mucosal gland
size and secretory activity and increased numbers of
epithelial goblet cells. Since the hamster, mouse, rabbit,
and guinea pig have very few sub-mucosal glands they are
not as suitable for studies into the aetiology and patho¬
genesis of chronic bronchitis as animals which do contain
sub-mucosal glands such as the rat, pig, lamb and dog.
The majority of studies in this field have used the
rat as it provides a convenient model of hypersecretory
disease states particularly as groups can be fairly large.
In addition, due to its size, the whole of the left lung of
the rat can be mounted in cross section in such a way as to
reveal the entire length of the main airway and part or all
of its side branches (Figure 3). It is therefore possible
to ensure that the same anatomical area is used for
quantification of the goblet cells in each rat used for the
study. When larger animals are used, such as pigs, then
the problem of sampling and orientation, which was
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discussed in section 1:33, becomes much greater and calls
for detailed dissection and careful handling of the tissue
to ensure that the results from each animal are truly
comparable.
1:42 Present Histological Techniques for Studies on
Goblet Cells in the Respiratory Tract
Many previous quantitative studies on the lung goblet
cell population have taken place using 5 ^im thick paraffin
sections stained with a mucin specific stain such as the
combined Alcian Blue/Periodic Acid Schiff (AB/PAS) stain.
The specificity of this stain precludes identification of
other cell types as only those containing mucin show up.
Application of counterstains is not helpful as they often
mask the mucin staining itself. Other disadvantages of
paraffin sections are the poor preservation of the lung
tissue, with shrinkage being a particular problem, and the
thickness of sections which often means that nuclei in the
field of view are in different planes and do not always
corresond to the layer of cells under study. Since in a
study such as this it is necessary to be able to identify
goblet cells quickly and reliably and to quantify them in a
linear epithelium, these are serious drawbacks.
With the advent of plastic embedding of tissue and the
resultant thinner sections, i.e. 1 - 1.5 pm thick, improved
histology is now possible. There are, however, special
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problems encountered with these techniques, particularly
when dealing with the lung, and their effects on this study
are discussed in detail later in the thesis (see Appendix
v) .
An automated counting system can be utilised to count
goblet cells (Mawdesly-Thomas and Healey, 1969a), but such
a technique was not available in this study. Accordingly
goblet cells could only be counted by manual methods using
the light microscope.
1:43 The Problem of Pulmonary Infection in Experimental
Animals
The use of animals in experiments necessitates the
implementation of careful controls in order to minimise the
variables inherent in such experiments. In pulmonary
studies one such variable is the presence of respiratory
infection in the animal stock.
In healthy rats the lungs contain very small amounts
of lymphoid tissue (Reid, 1970; Lamb, 1975). In the
presence of chronic respiratory infection the amount of
lymphoid tissue in the lungs increases and aggregates of
lymphocytes around major airways ('cuffing') with invasion
and destruction of the overlying epithelium in more severe
cases, can be observed (Lamb, 1975). At this stage of the
infective process the animals appear otherwise healthy and
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routine microbiological screening for mycoplasma and
Pasturella pneumotropica is usually negative.
A progressive clinically obvious decline in the colony
may take several more months to develop and the lung
pathology of animals from such a colony will show extension
of the lymphocytes to involve the tissue around small blood
vessels and airways in the periphery of the lung. This
peripheral involvement may progress to frank pneumonitis
and true inflammation of the alveolar portion of the lung
(Lamb, 1975). Such changes are often more severe in older
animals and the use of young animals in pulmonary studies
can reduce the incidence of lung pathology.
Due to the effect on the bronchial epithelium, namely
damage to the epithelium and the destruction of its normal
structure, animals with moderate or severe lymphocyte
cuffing around airways are unsuitable for a whole range of
investigations into the structure of the respiratory
epithelium.
Since histology is the most sensitive method of
identifying the early stages of chronic respiratory disease
in rats (Lindsey et al., 1971) every lung used for quanti¬
fication in this study was checked for lymphocyte cuffing
and any seriously affected animals were rejected from the
study. Nevertheless, problems were encountered with
respiratory infection during the course of this study and
these are reported in detail in section 1 of Chapter 3.
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1:5 INNERVATION OF THE RESPIRATORY EPITHELIUM
The innervation of the human lung consists of
preganglionic para-sympathetic nerves arising from the
vagus and post-ganglionic sympathetic nerves. The former
relay in ganglia close to the tissue they innervate, whilst
the latter synapse in the second, third, and fourth
thoracic sympathetic ganglia. Sensory nerves which
initiate most if not all respiratory reflexes travel in the
vagus nerve (Spencer, 1977).
Jeffrey in 1973 demonstrated that both myelinated and
non-myelinated sub-epithelial nerves were commonly found in
the lamina propria of both the extra- and the intra-
pulmonary airways in the rat. At no site did they cross
the basement membrane and enter the epithelium. He did
however find a mixed population of intra-epithelial axons;
these were confined to extra-pulmonary airways and none
were found in intra-pulmonary airways. These axons were
associated with all epithelial cell types particularly
basal cells. Approximately 33% of axons were efferent
terminal motor adrenergic endings, 17% of axons were
efferent cholinergic endings and 50% of axons were afferent
sensory nerve endings. There are three main afferent
pathways: from the pulmonary stretch receptors situated in
airway smooth muscle; from lung irritant receptors
situated in the mucosa of cartilagenous airways in
particular the trachea; and from type-J receptors which
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lie close to pulmonary capillaries in the interstitium of
the inter-alveolar septa (Breeze and Wheeldon, 1977).
Substance P-like immunoreactive nerves have also been
demonstrated in mammalian lung (Wharton et al.. 1979) .
They were found in all parts of the lungs of guinea pigs,
rats, mice and pigs, but none were found to be in the
epithelium of airways. It is thought that they may form
part of a complex system of regulation of lung function.
Parasympathetic nerves have been shown to enter sub¬
mucosal glands (Widdicombe, 1978; Bensch et al.. 1965).
The role of sympathetic nerves in the control of gland
secretion is not yet understood although Meyrick et al.
(1970) reported axons containing dense cored vesicles in
human bronchial sub-mucosal glands. Both parasympathetic
and sympathetic nerve stimulation cause an increase in
mucin production in vivo in dogs and cats (Ueki et al..
1980; Peatfield et al.. 1980; Gallagher et al.. 1975;
Davis et al.. 1979). Intra-epithelial goblet cells have,
however, been shown not to respond to either parasympa¬
thetic or sympathetic nerve stimulation (Gallagher et al..
1975; Last et al.. 1980).
1:6 THE PHARMACOLOGY OF ISOPRENALINE
Isoprenaline is the most active of the sympathomimetic
amines that act almost exclusively on ^-adrenoceptors by
virtue of their N-alkyl substitution (Innes, 1970).
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Figure 5. Isoprenaline Structure
1s61 The Structure of Isoprenaline
The asterisk denotes an asymmetric carbon atom, and
because of this, like nor-adrenaline and adrenaline, iso¬
prenaline has two optically active isomers. These were
first resolved and investigated by Kerschbaum and Benedikt
in 1952, and Beccari et al. in 1953. In dogs the levo-
rotatory form of isoprenaline known as the (-) isomer has
been shown to be approximately 90 times more potent as a
^-adrenoceptor agonist decreasing arterial blood pressure
than the (+) isomer (dextro-rotatory), and approximately
twice as active as the racemic mixture (Beccari et al..
1953). In man, the difference in potency of the (-) isomer
and (+) isomer is 50 times. This difference is probably
due to different rates of racemisation in body fluids after
administration. Virtually all pharmacological studies are
performed using the racemic mixture, the • usw\i
* form of the drug. It is both costly and
difficult to isolate the pure forms of the two isomers and
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as they are subject to spontaneous racemization they
are only rarely used.
1:62 The Metabolism and Duration of Action of
Isoorenaline
The duration of action and the mode of metabolism is
very similar to that of adrenaline. In rats, isoprenaline
given intravenously is rapidly O-methylated by
catechol-O-methyl transferase (COMT) and removed from
the blood stream by the liver where further conjugations
may occur (Nilsson, 1974). In the liver, glucoronyl
transferase acts on 3-O-methyl isoprenaline to produce
isoprenaline glucoronide. Isoprenaline can also be
conjugated with sulphate by various sulphatases,
particularly in the gut wall and therefore it is largely
inactive when given orally. Excretion occurs in the urine,
- - — - ' 1 - "i -! i_ _ - — a-!—-*. J /n man K Q i n rf n nn -i n rr n n /-I
COMT is not stereoselective with respect to the (-) and (+)
isomers of isoprenaline (Garg et al.. 1971; Guldberg and
Marsden, 1975).
1:63 The Direct Pharmacological Actions of
Isoprenaline
Isoprenaline has a powerful action on p-adrenoceptors
and almost no action on c<-adrenoceptors. Its main
actions, therefore, are on the heart, the smooth muscles of
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bronchi, skeletal muscle vasculature, and the alimentary
tract.
Cardiovascular Effects of Isoprenaline: Intravenous in¬
fusion of isoprenaline in man lowers peripheral vascular
resistance and diastolic pressure falls. It raises cardiac
output by positive inotropic and chronotropic effects; in
conventional doses the increase in cardiac output is
sufficient to maintain or raise systolic pressure, but in
higher doses its administration is followed by a striking
fall in blood pressure.
Effects of Isoprenaline on Smooth Muscle; Isoprenaline
relaxes almost all varieties of smooth muscle. When the
resting tone is high this action is most pronounced on
bronchial and gastrointestinal smooth muscle causing marked
bronchodilation and decreased tone and motility of
intestine musculature. On some muscles it has an
additional oc-adrenoceptor activity seen only with high
doses, and it causes blanching of the skin when injected
intradermally in man.
Effects of Isoprenaline on Metabolism and the Central
Nervous System: Isoprenaline causes hyperglycaemia in man;
this is not as pronounced as that which follows adrenaline
and results from the stimulation of glycogenolysis.
Isoprenaline also stimulates lipolysis and this results in
increased levels of circulating free fatty acids. Like
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adrenaline it can cause central excitation, but this has
not been extensively studied.
1:64 The Indirect Actions of Isoprenaline
Reed (1978) discusses the physiology and pharmacology
of ^2~a^rener<3ic agents and lists all the known events
occurring after either or ^2"~adrenoceptor stimulation
(see Table 2).
^-adrenoceptor stimulation is followed by a large
number of wide ranging effects, biochemical, metabolic and
mitotic. Those of particular interest to this project are
the stimulation of mitosis, the increase in protein content
of saliva, the increase in intra-cellular adenosine 3',5' —
cyclic monophosphate and the calorigenic actions.
Isoprenaline has been shown to stimulate both hyper¬
plasia and hypertrophy in salivary glands of rats (Barka,
1968; Selye et al., 1961) and mice (Baserga, 1966). This
is a two-fold effect as in addition to stimulating mitosis
in salivary glands it also increases the protein content of
their secretions by altering the synthesis. An increase in
cell proliferation has also been demonstrated in the mouse
kidney by Malamud and Malt (1971) and in the rat lung by
Bolduc and Reid (1978). In the lung, Bolduc and Reid
showed that isoprenaline increased the mitotic index of the
respiratory epithelium, they also found a smaller increase
following pilocarpine administration. The subsequent
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increase in goblet cells was due, they felt, to increased
cell division with a change in the pattern of
differentiation rather than increase in secretory activity
leading to an increase in cell division. The main reason
for this conclusion is the evidence of Sturgess and Reid
(1972) where they demonstrated that isoprenaline has no




2:1 MATERIALS USED IN THE STUDY
2:11 Animals
All the animals used were supplied by Imperial
Chemical Industries P.L.C. and were Alderley Park Strain I
rats, weight range 200 - 250 g. They were bred in strict
SPF conditions and were free from overt respiratory
disease. The animals were kept in a 12 hour light and dark
cycle and fed ad libitum with standard rat diet and water.
Experiments were carried out both in Edinburgh and at
Alderley Park, the exact location being indicated in the
experimental design section. Batches of rats were trans¬
ported up to Edinburgh by road, the journey taking roughly
5-6 hours; they were then housed in the animal house and
allowed one full week to acclimatise to their new
surroundings before being used in an experiment.
2:12 Precautions Taken to Prevent Cross-Infection of
Experimental Animals
The room in which the animals were housed was sprayed
with disinfectant twice between each batch of animals, once
immediately after the room was emptied and once immediately
prior to reoccupation with a new batch of animals. Gowns
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and masks were kept in the room and laboratory coats worn
elsewhere in the building were removed outside the room and
a gown and mask put on immediately upon entering the room.
The animals were housed in plastic cages in which the
sawdust bedding was changed daily to keep soiling to a
minimum. During the acclimitisation period the rats were
inspected daily and checked for signs of respiratory
disease such as coughing, sneezing and nasal discharge.
The number of people allowed to enter the room was strictly
limited and the animals were taken from the room only for
post-mortem purposes or for exposure to sulphur dioxide
gas. Animals which had been dosed with drugs or exposed to
sulphur dioxide gas were housed in racks separated from the
control rat.s and those yet to be dosed. Surgical gloves
were worn whenever it was necessary to handle the animals.
Food and water were dispensed from a bin and taps in the
room itself and not brought in daily from the animal house
store.
2:13 Drugs Used in the Study
dl-isoprenaline sulphate (rac emic). Sigma, London.
Levo (-) - isoprenaline d-bitartate. Aldrich Chemicals,
Dorset.
Dextro (+) - isoprenaline d-bitartate. Aldrich Chemicals,
Dorset.
Salbutamol sulphate. Glaxo, Herts.




Nicotine alkaloid. Sigma, London.
Terbutaline. Astra.
Clenbuterol. ICI, Cheshire.
Carbachol. Koch Light, Bucks.
Propranolol. ICI, Cheshire
SC>2 cylinders. BDH.
basfrtone.. May and Baker, Dagenham.
2:14 Fixatives and Reagents Used in the Study
All reagents used were of analar quality.
(a) Fixation for Light Microscopy
37 - 40% Formaldehyde (Tech. grade)
Sodium dihydrogenorthophosphate
Sodium hydroxide





2:15 Embedding Media and Reagents












2:2 METHODS - EXPERIMENTAL TECHNIQUES EMPLOYED IN
THE STUDY
2:21 Isoprenaline Formulation
In all cases, with the exception of the intratracheal
and nebuliser routes of administration (see section 2:24),
the isoprenaline rac emate and isomers were administered
intraperitoneally (IP) in 0.5 ml sterile physiological
saline. The drug solutions were prepared immediately prior
to use and consequently did not require the addition of
preservatives or anti-oxidants. Control animals in each
case received 0.5 ml sterile physiological saline IP.
2:22 Other Drug Formulations
Salbutamol, terbutaline, methoxamine, phenylephrine,
pilocarpine, carbachol, nicotine, and propranolol were all
administered IP in 0.5 ml sterile physiological saline.
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Clenbuterol was administered IP in 0.5 ml of polyethylene
glycol 400 (PEG400) diluted 3:1 with distilled water.
Where necessary solutions were warmed under the hot tap to
facilitate solution of the compound.
2:23 Technique Employed for the Exposure of Groups of Rats
to Sulphur Dioxide Gas
The technique employed was the same as that first
described by Reid in 1963. The apparatus used was in fact
similar to that which had been used by Reid (1963), Lamb
and Reid (1968) and Lamb (1968) at St George's Hospital.
The apparatus consisted of three perspex chambers into
which a mixture of sulphur dioxide gas and air was pumped.
The chambers were vented to the outside, the used air and
gas mixture being first scrubbed through a water column to
dissolve out most of the sulphur dioxide gas. A vacuum
cleaner working in reverse was used to supply the flow of
air and the sulphur dioxide gas was added to this at the
rate of 15 to 20 cc/min. This flow rate of sulphur dioxide
was sufficient to give a concentration of the gas of
approximately 400 - 500 ppm. During an exposure run the
concentration in each chamber was checked at hourly
intervals using Dreger tubes and the flow of sulphur
dioxide gas was altered whenever necessary to maintain the
concentration at 500 ppm. Up to 5 rats could be housed in
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each chamber and thus a total of 15 adult rats could be
exposed to sulphur dioxide simultaneously.
2:24 Nebulised and Intratracheal Routes
Intratracheal administration of drugs was done under
anaesthesia. The animal was placed on its back with the
neck extended over a support, the tongue was held up away
from the back of the mouth and a long curved wide-bore
blunt needle was inserted into the trachea. A change in
the breathing pattern usually accompanied entrance into the
trachea. The needle was sufficiently long to travel down
as far as the carina. The dose administered was calculated
thus:
Volume administered was 0.4 pl/g body weight, and
therefore a 250 g rat received 100 ul of drug solution
containing a total of 20 mg of drug. Once injected the
animals sometimes coughed or gasped and were then placed on
their left side to recover from the anaesthetic. The
anaesthetic used was Sagatal (sodium phenobarbitrate,
60 mg/ml), this was diluted 1:10 in 10% ethanol and
administered IP in a dose of 0.75 ml/100 g body weight.
For the nebulised route of administration, the aerosol
was produced using a Wright's Nebuliser and generated by
saturated compressed air flowing at 6 1/min. The aerosol
mist so produced passed directly into a perspex chamber at
a rate of 10.5 1/min. Rats were held in position along the
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sides of the chamber (5 at a time), by means of perspex
cylinders which screwed into holes in the chamber. The
head of each animal was thus forced through a thin rubber
seal and in this way snout only exposure was achieved. The
apparatus used was set up at the ICI Central Toxicology
Laboratories at Alderley Park and had been in constant use
for some time and was therefore a tried and tested system.
The atmosphere generated in the chamber was sampled in
two ways whilst each drug solution was being tested. The
first method of sampling was the total atmosphere sampler
(TAS); this consisted of a holder containing a single
preweighed Metricel 1.2 jum pore 25 mm diameter filter
connected to a vacuum pump which drew air from the chamber
through the filter at a constant rate of 2 1/min for up to
15 mins. The wet weight of the filter was quickly recorded
and the filter was then dried in a dessicator under a
slight vacuum overnight and reweighed. The amount of solid
deposited on the filter could then be calculated and by
extrapolation it was possible to obtain an indication of
amount of drug present in the chamber at any one time.
The second method of sampling was rather more
sophisticated and gave a more reliable indication of how
much respirable compound was being generated. The Anderson
4 stage impactor was made of aluminium and consisted of 4
impactor plates with pores of known size and a single
Metricel 2.5 jim pore 25 mm diameter filter. The aluminium
plates were designed to allow particles of <6 |im in
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diameter through into the sampler. Plate 1 trapped
particles >5.5 jam diameter, plate 2 trapped particles 5.5 -
3.5 jim diameter, plate 3 trapped, particles 3.5 - 2 jim
diameter, plate 4 trapped particles 2 - 0.3 Jim diameter and
finally the filter trapped particles less than 0.3 jam. The
atmosphere was sampled at the rate of 1.4 1/min.
The deposition characteristics of aerodynamic
particles is very complex and has only been roughly worked
out; however, it is generally believed that, for particles
>5 Jim diameter, 50% is deposited in the nose and the rest
in the upper respiratory tract, i.e. trachea, pharynx and
larynx. For particles <5 jam diameter approximately 20% is
deposited in the nose, up to 50% in the upper respiratory
tract and the remaining 30% in the lower respiratory tract
- bronchi and bronchioles. The maximum deposition in the
lung possible appears to be about 70% and occurs with
particles about 0.5 jam diameter. By weighing the various
plates before and after exposure it was possible to
calculate approximately the amount of drug administered to
the animals in respirable form and the most likely site of
maximum deposition.
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2:3 METHODS - HISTOLOGICAL TECHNIQUES EMPLOYED IN THE
STUDY
2:31 Fixation for Light Microscopy Using Glvcol-
methacrylate (GMA)
Millonig's phosphate buffered formaldehyde (modified
by Carson et al., 1972) was used and this was made up as
follows:
40 ml 37.40% technical grade formaldehyde
360 ml distilled water
7.44 g NaH2P04
1.65 g NaOH
The NaOH and NaH2P04 were dissolved in the water and
the solution allowed to cool. The formaldehyde was then
added and the fixative stored in an airtight container
until required. A fresh batch was made up for each
experiment.
2:32 Fixation for Light and Electron Microscopy Using
Araldite
The materials and fixative used were exactly the same
as those used for GMA. However, once the material had been
fixed for a minimum period of 24 hours it was post-fixed in
osmium tetroxide as follows:
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Processing: Solution composition.
Cacodylate Buffer 0.2M pH 7.4
42.8 g sodium cacodylate
6.9 ml N HC1
993.1 ml distilled water
0.5% Osmium Tetroxide
0.25 g OSO4
25 ml distilled water
25 ml 0.2M cacodylate buffer
Method:
i) Place trimmed, fixed tissue in 0.2M cacodylate
buffer and leave for 1 hour at 4°C.
ii) Replace the cacodylate buffer with 0.5% OsO^ and
leave for 3 hours at 4°C.
iii) Wash tissue twice in 10% alcohol, each time for
30 mins at 4°C, the tissue is then ready for
processing through graded alcohols.
2:33 Technique for Inflation Fixation of Intact Lungs
The apparatus used is shown overleaf. This was
adapted from that used by Fawell and Lewis (1971). The
apparatus was designed to deliver the fixative at a
constant pressure to the lungs at all times. It did this
by maintaining a constant head of fixative 20 cms above the
lungs. As soon as the Spencer wells were removed fixative
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FIGURE 6
Apparatus used for the inflation-fixation of rat lungs
(Adapted from Fawell and Lewis, 1971).
flowed down into the lungs from the syringe, simultaneously
fixative flowed from the reservoir at the same rate thus
maintaining a constant 20 cm level in the syringe. When
the lungs were fully inflated back pressure stopped the
flow of fixative and the Spencer wells were replaced. The
trachea was then tied securely to prevent leakage and the
lungs removed and placed in a histology jar filled with
fresh fixative. The use of this apparatus meant that each
time it was possible to reproduce the same conditions for
inflation fixation and prevented the lungs from being over-
inflated. It also speeded up the dissection time by
allowing the experimentor to start on the next animal
whilst the previous lungs were being inflated.
2:34 Technique Employed to Trim Blocks of Luna Ready for
Embedding in Plastic
The left lung was used for the assessment of goblet
cells using the light microscope in all but a few
experiments. The left lung was separated from the trachea
at the carina and placed on a board with the ventral
surface uppermost. The tissue had previously been fixed
for a minimum period of 24 hours. Using a dermatome knife
the top 2-3 mm of the lung tissue were sliced off using a
single horizontal stroke of the knife. With practice it
was possible to judge the depth of this cut such that the
top surface of the main airway and its branches can just be
seen in the lung. A sawing action of the blade was avoided
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as this leads to the cut surface being uneven and which in
turn leads to problems when trimming the block ready for
section cutting. Care was taken not to cut too deeply
because the further in the tissue is trimmed at this stage,
the less material is available for trimming-in and
orientation of the block when cutting the section.
The technique employed for trimming the tissue for
both glycolmethacrylate and araldite embedding was
basically the same. However, lungs destined for araldite
were trimmed to give a narrow block of tissue consisting of
the entire length of the main airway and just the start of
each of its side branches. Blocks destined for glycol¬
methacrylate consisted of the entire width of the lung and
thus incorporated the main airway and all of its side
branches right out to the periphery of the lung. To
facilitate penetration of the resin the pleural surface on
the dorsal surface of the lung was also sliced off. The
trimmed block was then placed in a perforated metal
cassette along with its label ready for processing in
graded alcohols.
2:35 Processing of Fixed Tissue for Light Microscopic
Studies in Glvcolmethacrylate and Araldite
The fixed, trimmed material was dehydrated in graded
alcohols over a period of 24 hours at room temperature.
The sequence of changes was 2 x 10% alcohol, 2 x 30%
alcohol, 2 x 50% alcohol, 1 x 70% alcohol, 2 x 90% alcohol
and 2 x absolute alcohol. This procedure was followed for
material destined for either glycolmethacrylate or araldite
embedding.
2:36 Impregnation and Embedding of Tissue in Resin
(a) Methodology for GMA Embedded Tissue - Adapted
from Sims (1974)
Impregnation and embedding: solution composition.
GMA solution A (infiltrating solution)
80 ml 2-hydroxyethyl methacrylate (monomers)
8 ml 2-butoxyethanol
0.5 g benzoyl peroxide
(Prepare just before use)
GMA solution B (promotor solution)
8 ml polyethylene glycol 400
1 ml N.N. dimethylaniline
(Prepare just before use)
GMA working solution (polymerising solution)
42 parts solution A
1 part solution B
(Mix thoroughly and use immediately)
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Impregnation: method.
i) Remove tissue from last change of absolute
alcohol. Place in the first change of GMA
solution A. No link reagent required. Leave for
24 hours at room temperature under 27 ins Hg
vacuum.
ii) Replace tissue in fresh GMA solution A. Leave
for 12 hours at room temperature under vacuum,
then change GMA solution A once more and leave
for a further 12 hours under vacuum.
iii) Before carrying out polymerisation make test
working solution, i.e. 43 ml and check that poly¬
merisation occurs controllably.
iv) Make up sufficient polymerisation solution for
whole batch to be processed.
v) Place tissue in polymerisation solution and
agitate thoroughly using a roller-mix. Usually
10 - 15 mins is possible before the solution
starts to thicken.
vi) Immediately the polymerising solution shows signs
of thickening transfer the tissue blocks, cutting
face down, to fresh polymerising solution in
disposable flat bottomed moulds.
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vii) Once the reaction is under way and heat is being
generated place the moulds on ice to dissipate
the heat and prevent gas bubbles forming in the
blocks.
viii) Once blocks are hard, remove from the moulds.
Trim away any excess soft resin and place any
soft blocks in an incubator at 60°C to harden.
ix) Trim blocks to a convenient size for cutting
using a hacksaw and a surform plane.
(b) Methodology for Araldite Embedded Material
Impregnation and' embedding: solution composition.
Araldite Solution A
200 ml resin (CY212)
200 ml hardener (DDA)
(Mix well and store at 4°C)
Araldite Solution B
20 ml ditutyl phthalate (plasticizer)
1 ml accelerator (HY960)
(Mix well and store at 4°C)
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Araldite Working Solution
19 ml Solution A
1 ml Solution B
(Mix well and store at 4°C)
Impregnation: method.
i) Remove tissue from last change of absolute
alcohol and place in epoxypropane. Leave for 1
hour at room temperature (epoxypropane is used as
a link reagent between the alcohol and araldite).
ii) Place tissue in 10 - 15 ml of araldite working
solution, taking care not to desiccAte. 1 the
tissue. Put under 27 ins Hg vacuum for 24 hours
at room temperature.
iii) Change the resin and leave under 27 ins Hg vacuum
for a further 6-12 hours.
iv) Put 7 - 10 ml of fresh araldite working solution
in the bottom of a rigid ice cube mould tray and
place the tissue, cutting face down, in the
araldite.
v) Cure blocks at 60°C for one week or until hard.
During this time the blocks can be sliced to a
convenient size and shape (approximately 3 days)
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whilst they are still soft, otherwise they
require sawing.
2:37 Technique Employed for Cutting Large. Thin, Plastic
Sections of Lung
All the blocks, i.e. both araldite and glycolmeth-
acrylate were trimmed-in and orientated using a Reichart-
Jung Autocut Microtome. The knife used for this had a
tungsten-carbide coated cutting edge and was capable of
trimming both araldite and glycolmethacrylate blocks at
15 - 20 pm thickness. Once the block had been faced-up and
the airway began to appear in the sections the knife was
changed. For glycolmethacrylate blocks a standard sharp D-
profile steel knife was used and 1.5 pm sections were
obtained in which the entire left lung of the rat was
present. For araldite blocks a glass knife was used. This
had a blade width of 12.5 mm and was therefore capable of
cutting blocks up to a maximum width of 10 mm, hence the
additional trimming required prior to processing and
embedding the tissue. Using this knife the autocut was
capable of cutting 1.5 pm araldite sections approximately
1 cm wide and 1.5 cm long. The quality of sections thus
obtained was poor and of very limited use. Hence the use
of glycolmethacrylate as the embedding resin for the light
microscopic assessment of goblet cells throughout the
study.
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2:38 Staining Methods for Glycolmethacrvlate and Araldite
Sections for Light Microscopy
(a) Staining Methods for GMA Sections
i) Alcian Blue/Periodic Acid Schiff (AB/PAS)
1% alcian blue in 3.0% acetic acid, pH 2.5
1% periodic acid Schiff reagent prepared using
"Lillie Cold Method" (Lillie, 1965),
prepared as follows:
For 500 mis:
5 g aldehyde fuchsin
9.5 g sodium metabisulphite
500 ml 0.15 N HC1
(Shake solution thoroughly until straw
coloured; can be left overnight. Filter
through activated charcoal until
decolourised. Store at 4°C or freeze until
required)
Procedure:
Stain sections with Alcian Blue for 15 - 20
mins at room temperature. Rinse and dry in air.
Treat sections for 5 mins with 1% periodic acid.
Rinse in tap water, then distilled water. Dry in
air. Place sections in Schiff reagent for 20 -
25 mins at room temperature. Wash sections for
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5 mins in running tap water to bring up staining.
Dry sections in air.
Solochromecyanin/Eosin (Hogg and Simpson, 1975).
90 ml of distilled water containing 10 ml 4%
ammonium ferric sulphate
0.5 ml concentrated sulphuric acid
0.2 g solochrome cyanine R.S.
Dissolve the dye in the concentrated
sulphuric acid, add the distilled water and then
the ferric ammonium sulphate. Mix thoroughly
then filter, store at room temperature.
The eosin is made up in distilled water as a
1% solution to which is added:
1 ml of 2.5% calcium chloride
1 ml of 2% phloxine
The fluid volume is approximately 500 ml.
Filter and store at room temperature.
Stain sections with solochromecyanin for 3 -
4 mins at room temperature. Rinse quickly in tap
water and differentiate briefly in 1% acid
alcohol put sections into Scott's tap water for
30 - 60 sees: (1 litre of tap water containing
20 g MgSO^, 3.5 g Na^CCC^) and 1 crystal of
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thymol). Counterstain sections in eosin for 20 -
30 sees. Rinse briefly in water and dehydrate
sections through graded alcohols to xylene prior
to mounting.
iii) Bullard's Haematoxylin and Eosin.
Bullard's haematoxylin:
8 g haematoxylin
16 ml glacial acetic acid
144 ml 50% ethanol
20 g aluminium ammonium sulphate
250 ml distilled water
8 g red mercuric oxide
275 ml 95% ethanol
330 ml glycerol
18 ml glacial acetic acid
40 g aluminium ammonium sulphate
Preparation:
Dissolve haematoxylin in 144 ml 50%
ethanol. Add 16 ml glacial acetic acid. Add to
this a heated solution of 20 g ammonia alum
dissolved in 250 ml 1^0. Heat mixture to boiling
and add slowly (to prevent frothing) 8 g red
mercuric oxide. Cool rapidly and filter. Add
275 ml of 95% ethanol, 330 ml of glycerol, 18 ml
glacial acetic acid, and finally 40 g of ammonia
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alum. Mix thoroughly and store at room
temperature.
Method:
Stain sections in Bullard's haematoxylin at
room temperature for 5 mins. Wash briefly in
water. Differentiate sections in 1% acid alcohol
and blue in Scott's tap water (see solochrome
cyanin method) for 30 - 60 sees. Counterstain
sections in 1% eosin for 20 - 30 sees (see also
solochromecyanin method). Rinse briefly in water
and dehydrate sections through graded alcohols to
cylene prior to mounting.
(b) Staining Methods for Araldite Sections
i) Toluidine Blue.
1% solution in 1% Borax or 1% solution in 1%
Na2CO-j. Staining carried out at 60°C for 30 - 60
sees on the slide using a hot plate or 2 - 3 mins
in a water bath at 60°C.
2:39 Mounting Stained Sections
(a) GMA sections.
All GMA slides were mounted in DePeX.
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(b) Araldite sections.
All Araldite setions were mounted in Harleco
coverbond, (xylene based).
2:4 QUANTITATION OF GOBLET CELLS
2:41 Criteria for Identification and Quantitation
It has been stated previously that the distribution of
goblet cells in the lung varies continuously from proximal
to peripheral airways. In addition increased numbers of
goblet cells occur at the points of bifurcations of
airways. It is therefore essential in any quantitative
study on respiratory epithelial goblet eels that the same
area is selected for assessment each time in every rat
included in the study. In order to do this histological
sections must encompass the whole of the longitudinal
section of the main airway and part or all of the side
branches arising from it. The side branches enable one to
divide the different regions of the main airway into zones
(Figure 3). In addition to this requirement it is
essential that the goblet cells stand out from the rest of
the epithelial cells, and therefore, the sections have to
be stained selectively for mucin glycoproteins with stains
such as AB/PAS.
Examples of different staining methods on rat
resiratory epithelium are shown in Figures 7, 8 and 9. In
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FIGURE 7
1.5 ^im sections of rat lung embedded in GMA. AB/PAS
staining. x25 magnification. a) Control lung,
b) after 40 mg/kg isoprenaline showing an increase in
PAS positive intra-epithelial goblet cells.
FIGURE 7-
FIGURE 8
As for Figure 7 but stain used was PAS/TB and
magnification = x40. a) shows goblet cell staining,
note high background staining due to the GMA taking up
the Toluidine Blue, b) shows the effect on the
epithelium of sub-epithelial lymphocytes: loss of




As for Figure 7 but stain used was Solochrome cyanin/
eosin. This was the stain routinely used to screen
the lung pathology checking for evidence of
respiratory infection.
FIGURE 9-
sections stained with AB/PAS goblet cells are easily
distinguished by their prominent AB/PAS positive theca.
Occasionally small clusters of PAS-positive granules
were observed at the apex of cells. These were not
included as goblet cells in this study, neither were cells
with a few supranuclear PAS-positive granules as they may
have contained glycogen or may have been lysozomes. Thus,
only obvious mucous filled cells were counted as goblet
cells and no attempt was made to distinguish immature
sparsely filled goblet cells at the light microscope level.
2:42 Methodology for Counting Goblet Cells in the Luna
As the respiratory epithelium of the rat appears as a
linear single layer of cells in 1.5 ^im sections, goblet
cells can be quantified as the mean number of goblet cells
per unit length of epithelium which for convenience is
generally one Higher Power Field (HPF) using a x40
objective. In this study this was equivalent to 0.35 mm of
epithelium, and all the results are expressed as the mean
number of goblet cells per 0.35 mm epithelium. As a
general rule 10 consecutive HPF's were counted on each side
of the airway in approximately the same position in zones 1
and 2.
The two results for each slide expressed as the number
of goblet cells per HPF were then averaged to give a
single result. This was then used to calculate the group
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mean number of goblet cells per HPF. Thus the results
obtained looked like this:-




Rat 1 40 44 4.0 ± 4,4 = 4>2 4.2 + 4.0-K..4.1
10
(no in group)
Rat 2 38 42 3.8 jt 4.2 — 4.Q
2
Rat 10 36 46
As stated previously there are pronounced clusters of
goblet cells at the points of bifurcation and in order to
keep the two sides of the epithelium as comparable as
possible counting on the branched side of the airway
omitted the extreme points of bifurcation. Sections in
which the epithelium in question had been cut tangentially
were also excluded from the results. In any study such as
this it is important to eliminate observer bias from the
results as much as is possible. It was therefore necessary
to randomise all the slides before counting and not break
the code until counting had been completed. In this way it
was not known to which treatment group any slide belonged
to until counting was complete, and thus observer bias was
eliminated from the results.
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2:43 Assessment of Reproducibility
Having chosen the criteria for identifying goblet
cells it was necessary to test them and see if they could
be applied consistently enough to give reproducible results
using 1.5 urn GMA sections stained with AB/PAS.
Ten slides were selected at random for counting from a
batch that had previously been randomised and counted; it
was not therefore known to which groups the slides
belonged, i.e. treated or control. Each slide was counted
5 times on separate occasions with either 2 or 3 days
between each counting session. The results of the previous
counts were put away and not referred to again until all 5
counts had been made, thus previous results were not
allowed to influence the count in progress at any time.
The results are shown in Chapter 3 section 2.
2:5 METHODS - STATISTICAL
In most experiments, group means were calculated
together with standard deviations and errors. Occasionally
the groups were so small that only a mean was obtained. In
larger experiments, e.g. 5 or more animals to a group, it
was possible to apply statisical analysis in order to test
the significance of the results obtained. In these cases
the Student's t-test was applied to find out whether the
difference between the treated group and the control group
was real or apparent. Only those results giving a P value
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of less than 0.05 were considered significantly different
from controls. All results which were significant are
marked with an asterisk on the graph and the relevant P
value is written alongside or given in the legend. Further
details of the statisical methods employed are given in the




3:1 QUALITY CONTROL OF ANIMALS
When the present study started the lungs from the ICI
rats on gross examination were disease-free. On histo¬
logical section this was confirmed by the lack of
lymphocytic nodules, and very consistent control goblet
cell numbers from one batch of rats to the next (Table 3).
However, during the mid-part of the second year of the
study there was an outbreak of Sendei virus within the
colony at Alderley Park. This is a respiratory virus which
can prove fatal and causes chronic inflammatory changes in
the lungs of affected rats. The most noticeable change is
a marked increase in both the size and numbers of lympho¬
cyte aggregates many of which surround the airway to form a
cuff of lymphocytes. In fact, the incidence of lymphocyte
cuffing is a particularly good pointer towards the presence
of a viral infection in the lung (Lamb, 1975).
It was at this time that the first investigation into
the timing of the response (experiment 3, section 4:3) was
carried out. The marked increase in control goblet cell
numbers in this batch of rats was pointed out to ICI and
shortly after this Sendei was confirmed in the colony and
the breeding unit was shut down for six months. As a
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result, no ICI rats were available for experiments.
Enquiries to other animal suppliers revealed that Sendei
was endemic in nearly all their colonies, and the few
examples looked at were rejected on the grounds of too high
an incidence of lymphocyte cuffing.
After this experience a check was made on control
goblet cell numbers in all the batches of animals used and
prior to goblet cell quantitation in the left lung H and E
sections were screened and any diseased rats rejected from
the study. Animals were considered to be diseased if more
than 10% of the main airways was involved with lymphocyte
infiltration. In addition, the presence of lymphocyte
cuffing in zones 1 and 2, the areas to be counted, was also
considered grounds for rejection even if the total area
involved constituted less than 10% of the main airway.
Another sign of possible infection was unusually large
numbers of free macrophages within the alveolar spaces;
whenever this occurred the animal was also rejected from
the study even though the proximal airway epithelium
appeared to be normal. Finally, increased numbers of
intraepithelial globule leucocytes and sub-epithelial mast
cells were considered to be indicative of abnormality and
animals showing this were also rejected from the study.
It was essential to look at all the lungs in each
experiment, otherwise isolated phenomena were missed.
Occasionally, it was necessary to reject one whole cage of
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animals, although usually it was only necessary to reject
one or two out of approximately 100 animals.
As stated earlier in section 1:43, the presence of
lymphocyte cuffing has a profound effect on the structure
of the overlying respiratory epithelium. The cells become
cuboidal in shape and there is a loss of ciliated and
goblet cells. In areas of epithelium adjacent to these
thus affected, there is often a marked increase in the
number of goblet cells. Thus, not only is the area of
epithelium lying directly over a lymphocyte aggregate
affected but the area adjacent to it is also affected and
shows an abnormal structure. Obviously animals thus
affected cannot be used in a quantitative study such as
this and hence the criteria for rejection which were
applied.
Table 3 shows a series of observations made throughout
the study. Column one shows the date on which the batch of
animals was received. Column two gives the number of lungs
examined for the presence of lymphocyte cuffing. Column
three shows the degree of lymphocyte cuffing graded as
follows:- - = <10%, + = 10-20%, ++ = 20-30% and +++ =
>30%. Column four gives the mean number of control goblet
cells per 0.35 mm epithelium, and the mean number of goblet
eels per 0.35 mm epithelium observed 24 hours after a
single IP dose of 40 mg/kg isoprenaline. The final column
gives the percentage change from control induced by
40mg/kg isoprenaline IP. It can be seen that there are no
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obvious relationships between the incidence of lymphocyte
cuffing, the magnitude of the response to 40 mg/kg
isoprenaline nor the control goblet cell number. What is
striking, however, is the wide variation in all three
parameters in the period immediately after the Sendei
infection. It was not until a year later that the control
goblet cell numbers and the isoprenaline response resumed
their pre-Sendei values.
To summarise, the effects of respiratory infection on
the present study were as follows:-
a) Increased incidence of lymphocyte cuffing.
b) Increased control goblet cell numbers
c) Increased within-group variability as reflected
in larger standard errors.
d) Diminution of the isoprenaline response.
To overcome the increased within-group variability and
also to allow for what, at times, became a high rejection
rate of animals from the study, groups were kept large,
i.e. 10 treated and 20 controls, and thus some experiments
involved over 100 animals. The large numbers of rats and
the need to check each lung prior to quantification meant a
great deal of extra work and this prolonged the amount of
practical work required, particularly as the experiment
immediately prior to the Sendei outbreak had had to be
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repeated once the virus had been eliminated from the colony
at Alderley Park.
3:2 ASSESSMENT OF REPRODUCIBILITY OF GOBLET CELL COUNTING
The results of the reproducibility study described in
section 2:43 are shown overleaf in Table 4 and Figures 10
and 11. Table 4 shows the individual results of each count
with means, standard deviations and standard errors for
each slide. In all cases the mean of the five counts for
each slide had a standard error of less than 1 and only one
slide had a standard deviation of greater than 1. Thus, it
was possible to count the same slide 5 times and reach a
goblet cell count which generally varied by less than 1
goblet cell from the mean.
Figures 10 and 11 show the same results in a slightly
different way. Using the data generated the upper and
lower limits of the mean at the 95% confidence level were
calculated, thus in the graphs the horizontal bars through
the mean show the 95% upper and lower confidence limits.
Whereas the standard error of the mean indicates how good
an estimate of the mean of the whole population the
calculated mean actually is, the 95% confidence limits
indicate that there is a 95% certainty of the population
mean being within the range shown (Ridgman, 1975). Thus,
with one exception all the means assessed were within * one
goblet cell or less of the 95% confidence range. This is
very encouraging as it shows that within the area chosen to
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TABLE 4
RESULTS OF REPRODUCIBILITY COUNTS OF 10 GMA SLIDES
COUNTED 5 TIMES
Slide






88 2.5 0.25 0.11 4.6 0.27 0.12
12629 1.8 0.24 0.11 2.9 0.17 0.17
14314 1.2 0.37 0.17 2.1 0.20 0.09
22297 6.4 0.98 0.44 7.9 0.86 0.38
33058 4.1 0.34 0.15 3.4 0.46 0.21
36969 6.4
'
0.33 0.15 9.6 0.96 0.43
42162 3.8 0.75 0.34 7.7 0.47 0.47
52746 5.1 0.42 0.17 3.8 0.46 0.46
67790 9.6 0.71 0.32 6.0 1.78 0.79
95148 4.1 0.65 0.29 4.8 0.83 0.37
Fig 10 RESULTS OF REPRODUCIBILITY COUNTS OF
10 GMA SLIDES COUNTED 5 TIMES
(a) Straight
95% Confidence













Showing the results of counting goblet cells in zones
1 and 2 on the straight side of the main bronchus in
10 GMA slides on 5 separate occasions. The columns
give the mean of the 5 counts for each slide and the
horizontal bars show the upper and lower limits or the
95% level confidence limits.
Fig 11 RESULTS OF REPRODUCIBILITY COUNTS OF
10 GMA SLIDES COUNTED 5 TIMES
(b) Branched
10
I I 95% Confidence
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FIGURE 11
As for Figure 10 but showing the results for the
branched side of the main bronchus in zones 1 and 2.
be used for quantification of goblet cells the population
is relatively evenly distributed, and also that they can be
reliably and repeated recognised. In no case was it
possible to ensure that the same 10 HPF's were counted each
time, and the variations obtained in this study probably
reflect clusters of goblet cells in the different HPF's
used for counting. In the case of slide 9 with the high
standard deviation and large confidence limits there were
two noticeable clusters of goblet cells in zone 2. The
clusters were situated on the branched side of the airway
near to the junction with zone 3. As a result, their
inclusion in the counts depended on whether the count
started very high in zone 1 or slightly lower down. Never¬
theless, in 1.5 ^am thick GMA slides stained with AB/PAS it
is possible to select and identify goblet cells
consistently and reliably for quantitative studies.
70
CHAPTER 4
EXPERIMENTAL DESIGN AND RESULTS
4:1 EXPERIMENT 1
INVESTIGATION OF THE GOBLET CELL RESPONSE OVER
ELEVEN DAYS FOLLOWING A SINGLE EXPOSURE TO SULPHUR
DIOXIDE GAS
4:11 Objectives
The aims of this experiments were a) to establish
whether or not a single exposure to S02 induced goblet cell
hyperplasia in the rat lung, and b) to study the timing of
that response.
4:12 Experimental Details
A total of 15 male rats approximately 390 g body
weight were used. On day zero 12 rats were exposed to S02
gas simultaneously in 3 chambers for a total period of 4
hours 15 minutes. The concentration used was approximately
400 - 500 ppm. The atmosphere in the chambers was sampled
at hourly intervals throughout the exposure period using
Dreger tubes, and any appropriate adjustments were made to
the S02 flow-rate in order to maintain the above
concentration.
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At the end of the exposure period the treated rats
were rehoused in standard cages, returned to the stock room
and killed in groups of 2 on days 1, 2, 4, 6, 8 and 11
following the SO2 exposure. Four rats served as controls;
they were not exposed to SO2 and were kept separate from
the SC>2 exposure room at all times. They were killed in
groups of 2 on days 1 and 11.
4:13 Tissues, and Processing
The lungs were inflation fixed in Millonig's fixative





The single exposure to SO2 gas resulted in a
respiratory goblet cell hyperplasia in the rat (Figure 12).
The increase was first detected on day 2 after the exposure
and reached a maximum of 11.7 goblet cells/0.35 mm
epithelium on day 6, thereafter the goblet cell numbers
fell slightly and on day 11 at 9.5 goblet cells/0.35 mm
epithelium were still much greater than the control value
of 4 goblet cells/0.35 mm epithelium. These results
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Fig 12 GOBLET CELL RESPONSE IN THE LUNG FOLLOWING





































Showing the timing of the response of the goblet cell
population in zones 1 and 2 following a single 4 hour
exposure to 400 - 500 ppm sulphur dioxide gas. The
vertical bars show the range of results obtained from
2 animals with the average indicated at the mid-way
point. Other results are single observations.
contrast sharply with those obtained in experiments 3 and 4
for the isoprenaline timecourse.
4:2 EXPERIMENT 2
A COMPARISON OF 10 DAILY DOSES WITH A SINGLE DOSE OF
RACEMIC ISOPRENALINE OR ITS ISOMERS
4:21 Objectives
The aims of this experiment were a) to repeat the
earlier work of Sturgess and Reid using Alderley Park rats,
b) to determine which of the two isomers of isoprenaline
was more effective in inducing an increase in respiratory
goblet cell numbers, and c) to establish whether or not the
goblet cells of the lung responded to a single dose of
isoprenaline.
4:22 Experimental Details
Groups of 10 rats were used consisting of 5 males and
5 females. All the animals were killed 24 hours after the
last injection.
Group 1 received 3.7 mg/kg (-) isoprenaline every day
for 10 days.
Group 2 received 2.4 mg/kg (-) isoprenalne every day
for 10 days.
Group 3 received 2.4 mg/kg (+) isoprenaline every day
for 10 days.
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Group 4 received 0.5 ml saline every day for 10 days.
Group 5 received a single 3.7 mg/kg dose of (-) iso-
prenaline.
Group 6 received a single 2.4 mg/kg dose of (-) iso-
prenaline.
Group 7 received a single 2.4 mg/kg dose of ( + ) iso-
prenaline.
Group 8 received a single 0.5 ml dose of saline.
4:23 Tissues and Processing
The lungs were inflation fixed in Millonig's fixative
and the left lung embedded in paraffin wax. Goblet cells
were assessed in 5 pm paraffin sections stained with AB/PAS




Figure 13 shows the results obtained following both 10
daily injections and a single dose of either racemic
isoprenaline or each of its two isomers. Ten daily doses
of 3.7 mg/kg racemic isoprenaline resulted in an increase
in respiratory goblet cells from a control value of 2.3
goblets/HPF to 6.64 goblets/HPF. Similarly 10 daily doses
of 2.4 mg/kg (-) isoprenaline resulted in an increase of
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FIGURE 13
Comparing the results obtained after 10 daily doses of
racemic isoprenaline and its isomers with those
obtained after a single dose of the racemate and its
isomers. The columns show the mean obtained after
each treatment and the vertical bars show the standard
error of the mean.
Control n = 18
3.7 mg/kg x 10
3.7 mg/kg x 1
2.4 mg/kg x 10
2.4 mg/kg x 1
2.4 mg/kg x 10






isoprenaline n = 8
isoprenaline n = 9
isoprenaline n = 7
isoprenaline n = 10
isoprenaline n = 10
isoprenaline n = 8
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respiratory goblet cells from a control value of 2.3
goblets/HPF to 5.3 goblets/HPF. Both these results were
significantly different from the control with P = <0.0005.
A single 3.7 mg/kg dose of racemic isoprenaline induced a
much smaller increase in respiratory goblet cells to 3.33
goblets/HPF whilst a single 2.4 mg/kg dose of (-)
isoprenaline induced an increase to 3.75 goblets/HPF; both
these results were significantly different from the control
value of 2.3 goblets/HPF with P = <0.005. The ( + ) isomer
of isoprenaline failed to produce any effect on respiratory
goblet cells when administered as either 10 daily doses or
a single dose of 2.4 mg/kg. The use of the Student t-test
showed that in none of the groups were there any
significant differences between the responses of the two
sexes. Their results have therefore been pooled and each
column in Figure 13 represents their combined mean.
4:3 EXPERIMENT 3
INVESTIGATION OF THE ISOPRENALINE RESPONSE OVER
16 DAYS: TIMECOURSE 1. BEFORE SENDEI
4:31 Objectives
Having established that a single dose of isoprenaline
could induce goblet cell hyperplasia in the lung it was
important to know when that increase occurred and how long
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it lasted before attempting further study of the nature of
the response.
4:32 Expermental Details
Groups of 6 rats, all male, received 40 mg/kg racemic
isoprenaline on day 0 and were killed in groups on days 2,
4, 8 and 16. Saline controls in groups of 3 were injected
with 0.5 ml saline on day 0 and killed in groups on days 2,
4, 8 and 16.
4:33 Tissues and Processing
The lungs were inflation fixed in Millonig's fixative
and the left lung embedded in paraffin. Goblet cells were




The results obtained are shown in Figure 14. There
was a rapid increase in goblet cell numbers which in this
experiment reached a maximum level of 15.8 goblets/HPF on
day 2, the first day sampled. Thereafter there was a
gradual decrease in the goblet cell numbers up to day 8,
where the level reached was 9 goblets/HPF. Between days 8
and 16 the decrease levelled off and the final value
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FIGURE 14
Showing the timing of the response following a single
dose of isoprenaline. Control rats were killed in
groups of 3 on days 2, 4, 8 and 16. Their results
were combined to give a mean (the open circle) and the
hatching shows the range of the standard error of that
mean. The X's represent the mean result obtained on
the different days after isoprenaline treatment and
the vertical bars show the standard error of each
mean. All the isoprenaline results were significantly
different from control with P = <0.001, <0.005, <0.05,
and <0.05 on days 2, 4, 8 and 16 respectively.
Control n = 9
Isoprenaline day 2 n = 4
Isoprenaline day 4 n = 4
Isoprenaline day 8 n = 5
Isoprenaline day 16 n = 5
(This experiment was conducted just prior to the
Sendei virus outbreak)
RAT AIRWAY GOBLET CELLS AFTER A SINGLE 40mg/kg DOSE
OF RACEMIC ISOPRENALINE
FIGURE
obtained was 8 goblets/HPF on day 16. This was still
significantly above the combined control value of 5.8
goblets/HPF and in fact all the responses obtained were
significantly different from the control with P = <0.001 on
day 2 and P = <0.05 on day 16.
4:4 EXPERIMENT 4
INVESTIGATION OF THE ISQPRENALINE RESPONSE OVER
16 DAYS: TIMECOURSE 2. AFTER SENDEI
4:41 Objectives
These were two-fold, a) to confirm the results of the
previous timecourse in the absence of Sendei infection, and
b) to look at the pattern of response in more detail with
the aid of additional time-points.
4:41 Experimental Details
Groups of 5 male rats received 40 mg/kg racemic
isoprenaline on day 0 and were killed in groups on days 1,
2, 4, 6, 8, 10, 12, 14 and 16. Saline controls were
injected with 0.5 ml saline on day 0 and were killed in
groups of 5 on days 1, 2, 4, 6, 8, 10, 12, 14 and 16.
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4:43 Tissues and Processing
The lungs were inflation fixed with Millonig's
fixative and the left lung embedded in GMA. Goblet cells




The pattern of goblet cell increase and decline
following isoprenaline as seen in Figure 15 was very
similar to that obtained in experiment 3, thus confirming
the previous results. Once again the increase in goblet
cells rapidly reached maximum values of 8.8 goblets/HPF on
day 1 and 9.3 goblets/HPF on day 2; thereafter the goblet
cell numbes gradually fell reaching control values of 2.2
goblets/HPF by day 8. Significant results were only
obtained on days 1, 2 and 4, the response was therefore
both rapid and short-lived.
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FIGURE 15
As for Figure 14 but with additional time points. The
results marked with an asterisk are significantly
different from control with P = <0.0005 on days 1, 2
and 4, and P = <0.005 on day 6.
Control n = 16
Isoprenaline day 1 n = 4
Isoprenaline day 2 n = 4
Isoprenaline day 4 n = 5
Isoprenaline day 6 n = 5
Isoprenaline day 8 n = 5
Isoprenaline day 10 n = 2
Isoprenaline day 12 n = 3
Isoprenaline day 14 n = 4
Isoprenaline day 16 n = 5
(This experiment was conducted once the Sendei virus
had been eradicated from the breeding colony)
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INVESTIGATION OF THE ISOPRENALINE RESPONSE OVER THE
FIRST 21 HOURS AFTER ISQPRENALINE
4:51 Objectives
The previous timecourse studies, experiments 3 and 4,
showed that the first 24 hours after the administration of
isoprenaline was the period of maximum change within the
respiratory epithelium. This experiment was designed to
look at this important period in detail.
4:52 Experimental Details
Groups of 6 male rats received 40 mg/kg racemic
isoprenaline at time 0 and were killed in groups 6, 9, 12,
15, 18 and 21 hours later. Control animals received 0.5 ml
saline at time 0 and were killed in groups of six 9, 15 and
21 hours later.
4:53 Tissues and Processing
The lungs were inflation fixed in Millonig's fixative
and the left lung embedded in GMA for goblet cell asses¬






Figure 16 shows the pattern of the early response
obtained in the lung following isoprenaline. At 6 hours
there was a slight drop in goblet cell numbers; this was
just significant. At 12 hours there was a small increase
in goblet cell numbers, likewise at 15 hours; these
increases were not significant. At 18 hours, however, a
significant increase in goblet cells was found (P =
<0.0025), the numbers being 5.11 goblets/HPF for the
treated group and 2.2 goblets/HPF for the control group. A
further increase was found at 21 hours to a value of 5.7
goblets/HPF and in this instance P = <0.005. These results
complement those obtained in experiment 4 and thus it is
possible to surmise that goblet cell numbers steadily
increase during the first 24 hours afterisoprenaline, reach
a maximum between 24 and 48 hours and thereafter steadily
decline, regaining control values between days 8 and 16.
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FIGURE 16
As for Figure 14 but showing the response during the
first 24 hours after the isoprenaline administration.
The results marked with an asterisk are significantly
different from control with P = <0.01 at 6 hours,
P = <0.0025 at 18 hours, and P = <0.005 at 21 hours.
Control n = 11
Isoprenaline 6 hours n = 5
Isoprenaline 9 hours n = 5
Isoprenaline 12 hours n = 6
Isoprenaline 15 hours n = 6
Isoprenaline 18 hours n = 5










40 mg/Kg ISOPRENALINE IP
COMBINED CONTROL
RAT AIRWAY GOBLET CELLS AFTER A SINGLE 40mg/Kg
DOSE OF RACEMIC ISOPRENALINE
FIGURE 16.
4:6 EXPERIMENT 6
INFLUENCE OF CIRCADIAN RHYTHM ON THE GOBLET CELL
RESPONSE TO ISOPRENALINE IN THE LUNG
4:61 Objectives
Schering et al. (1972) demonstrated that in mice the
time of injection of isoprenaline and the subsequent time
of death alters the effect seen on mitotic activity in the
small intestine. Thus at times there are significant
decreases in mitotic activity following isoprenaline and at
other times the results following isoprenaline are the same
as the controls. In this experiment, the influence of the
time of death on the isoprenaline response in the lung was
investigted, and with the aid of the "control animals any
circadian variation was looked for in the goblet cell
population at this site.
4:62 Experimental Details
A total of 90 male rats were used, 12 of which were
controls. The animals were injected in various groups with
either 40 mg/kg isoprenaline or saline at 4 hourly
intervals from 8 pm to 4 pm the following day. Groups of 3
treated and 2 controls were then killed at various times
later according to the time of injection of the isoprena¬
line (see Table 5). As the schedules for killing and
injections overlapped during the first night it was decided
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TABLE 5
SCHEDULE FOR INJECTIONS AND TIME OF DEATH FOR EXPERIMENT 6
No. killed and hours after injection
Time of
injection No.. injected 12hr 22hr 30hr 38hr 50hr 96hr
8 pn 18 + 2 controls 3 3 3 3 3 3 + 2 controls
12 midnight 12 + 2 controls - 3 - 3 3 3 + 2 controls
4 am 12 + 2 controls - 3 - 3 3 3 + 2 controls
8 am 12 + 2 controls - 3 - 3 3 3 + 2 controls
12 mid-day 12 + 2 controls - 3 - 3 3 3 + 2 controls




the animals throughout the
method of CO2 gas overdose
experiment by the
instead of using
4:63 Tissues and Processing
The lungs were inflation fixed in Millonig's





In the lung there was a very slight variation in
control goblet cells over a 24 hour period (Table 6). Both
groups at 4pm and 8 am had very small variations within the
group and were both in the region of 0.5 goblets/HPF -
0.01, whilst at 8 pm and 12 midnight (12 pm) the numbers
were higher and the within-group variation was much
greater, ranging from 1 to 3 goblets/HPF. In the absence
of larger groups it is not possible to say whether these
differences are significant. When the mean of all the
control values was taken an overall control value of 1.2 -
0.26 goblets/HPF was obtained and this is used in Figures
17 and 18 which show the timecourse and responses obtained
\





VARIATION IN CONTROL AIRWAY GOBLET CELLS IN THE RAT IN A
SINGLE 24 HOUR PERIOD
Time of Death Goblets/HPF Mean Goblets/HPF Group Mean
Goblets/HPF














0.67 1.2 SD = 1.0 SE = 0.26





12 noon Rat 1 2.0
Rat 2 not counted
2.0
FIGURE 17
Showing the timing of the response following a single
40 mg/kg dose of isoprenaline at 8 pm. The control is
represented as explained in Figure 14. The treated
results are shown as the individual responses (the
closed circles) and the mean is indicated by an X.
The figures given below each mean are the total in
each treated group.
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timecourse was obtained from rats all injected at 8 pm and
killed at 12, 22, 30, 50 and 96 hours later in groups of 3.
In Figure 17 the individual results for each group have
been shown as solid black circles and the group mean as a
cross. As in experiment 5, a detectable increase was
observed as early as 12 hours after the isoprenaline
injection, and by 48 hours there was a threefold increase
in goblet cells to 6.1 goblets/HPF. Unlike experiment 4
the number of goblet cells had not fallen by day 4 (96
hours) but had increased slightly to 6.8 goblets/HPF.
Because of the staggered injections it was possible to
investigate whether or not the time of death had any effect
on the goblet cell response in the lung. Figure 18 shows
the goblet cell response to isoprenaline in the lung
throughout two 24-hour periods, the first 22 hours after
injection and the second 38 hours after injection. It can
be seen that in both instances, regardless of the time of
death, all the lungs exhibited an increase in goblet cells
after the administration of isoprenaline. The increase at
38 hours was slightly larger than that at 22 hours, thus
the overall group mean for 38 hours was 7.5 goblets/HPF and
that for 22 hours was 5.4 goblets/HPF; these were signifi¬
cantly different.
The time of death had no significant effect on any of
the results obtained in this experiment. Control goblet
cells were consistently low throughout a single 24-hour
period and the response to a single dose of isoprenaline
Showing the results obtained during two 24 hour
periods, a) 22 hours and b) 38 hours after a single
40 mg/kg dose of isoprenaline. The control is as for
Figure 17. The treated results are the mean of a
number of observations as indicated next to each
point.
AIRWAY GOBLET CELL NUMBERS (a) 22hours
AND (D) 38hours AFTER A SINGLE INJECTION
OF ISOPRENALINE
COMBINED CONTROL
—i i i 1 i
6pm 10pm 2am 6am 10am 2pm
Time of Death
COMBINED CONTROL
I I I I I 1
10am 2pm 6pm 10pm 2am 6am
Time of Death
was also consistent throughout 2 separate 24-hour periods.
The isoprenaline resonse is therefore uninfluenced by any
circadian rhythm effect in the lung.
4:7 EXPERIMENT 7
DOSE-RESPONSE INVESTIGATION USING RACEMIC
ISOPRENALINE. DOSE-RESPONSE CURVE 1: PILOT STUDY
USING FEMALE RATS
4:71 Objectives
Experiment 2 suggested that there appears to be a
relationship between the dose of isoprenaline and the
degree of goblet cell hyperplasia in the lung. In this
experiment a series of IP doses of isoprenaline were tried
and, in an attempt to see if higher doses had a longer
lasting effect, rats were killed 22 hours, 41 hours and 6
days after receiving the different doses of isoprenaline.
4:72 Experimental Details
Animals in groups of 4 were dosed with either 0.5 ml
saline or the following doses of isoprenaline: 600 ug/kg
and 1.25, 2.5, 5, 10, 20, 40, 80 and 120 mg/kg
isoprenaline. Owing to limited availability of rats from





4:74 Tissues and Processing
The lungs were inflation fixed with Millonig's
fixative and the left lungs embedded in GMA for goblet cell
assessment.
4:75 Results
The response to isoprenaline was dose-dependent
(Figure 19). Shallow dose-response curves were obtained at
22 hours (a) and 41 hours (b) after the isoprenaline
injections but at 6 days (c) the results were less
conclusive and no clear-cut dose-response relationship was
obtained. At 22 hours and 41 hours maximum responses were
found after 40 mg/kg with lesser increases to 20, 10 and 5
mg/kg the responses to 80 and 120 mg/kg at both times were
sub-maximal.
The dose-response curve obtained at 41 hours after the
injection of the isoprenaline showed an overall higher
response than the curve obtained at 22 hours at all dose-
levels tested. The responses at 22 hours were therefore




Showing a series of dose-response curves obtained in
female rats, a) 22 hours, b) 41 hours and c) 6 days
after the administration of the isoprenaline. The
vertical bars represent the standard errors of the
mean. The control in each graph is a combined control
from groups killed at 22 hours and 6 days, n = 8, in
the treated groups n = 3-4.
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The maximum response obtained at 6 days was to 120
mg/kg with lesser increases obtained with 40, 20 and 10
mg/kg. There was a suggestion, therefore, that higher
doses had a longer lasting effect on goblet cells in the
lung.
4:8 EXPERIMENT 8
DOSE-RESPONSE INVESTIGATION USING RACEMTC
ISOPRENALINE■ DOSE-RESPONSE CURVE 2: DETAILED STUDY
USING MALE RATS
4:81 Objectives
The results of the female dose-response curves
indicated that there was a very shallow dose-response
relationship. This experiment was designed to look at this
relationship in greater detail using larger groups of male
rats and additional dose-levels. In addition two extra
groups of rats were included in a preliminary study to see
if the isoprenaline response could be antagonised pharma¬
cologically using a jB-adrenoceptor antagonist.
4:82 Experimental Details
Groups of 10 male rats were given isoprenaline in
doses of 5, 10, 20, 30, 40, 60 and 80 mg/kg IP; an
additional 20 rats received 0.5 ml saline and these were
\
the controls. Also included in this experiment were 2
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extra groups of 10 rats, one group receiving 50 mg/kg
propranolol IP alone whereas the other received 50 mg/kg
propranolol IP 35 minutes before receiving 40 mg/kg
isoprenaline IP. All the animals were killed 24 hours
after treatment.
4:83 Tissues and Processing
The lungs were inflation fixed wih Millonig's fixative





As in the previous experiment a shallow dose-response
relationship was found to exist between the degree of
goblet cell hyperplasia and the dose of isoprenaline
employed (Figure 20). The saline controls gave a mean of
2.5 goblets/HPF, after 5 mg/kg isoprenaline respiratory
goblet cells had increased to a mean of 4.1 goblets/HPF.
This was further increased to 5.1 goblets/HPF after
10 mg/kg, the response then levelled off between 6.5 and
7.5 goblets/HPF following doses of 20, 30, 40, 60 and
80 mg/kg. Unlike experiment 7 a decrease in response at
the higher doses was not seen.
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FIGURE 20
Showing a dose-response curve obtained in male rats 24
hours after the administration of the isoprenaline.
The vertical bars represent the standard error of the
mean. All doses of isoprenaline produced significant
increases in goblet cells with P = <0.01 for 5 mg/kg
and P = <0.0005 for all other doses. The reduced
response to 40 mg/kg isoprenaline in the presence of
propranolol (propranolol blockade), was significantly
different to the response obtained with 40 mg/kg
isoprenaline alone p = <0.0025 and was also
significantly different to the saline control,
P = <0.025.
Saline control n = 19
Propranolol control n = 9
Propranolol Blockade n s 10
Isoprenaline 5 mg/kg n a 10
Isoprenaline 10 mg/kg n = 9
Isoprenaline 20 mg/kg n = 9
Isoprenaline 30 mg/kg n = 8
Isoprenaline 40 mg/kg n = 10
Isoprenaline 60 mg/kg n = 9
Isoprenaline 80 mg/kg n = 7

















Propranolol (50 mg/kg) on its own gave a mean of 2.5
goblets/HPF the solid square in Figure 20, identical to
that of the saline controls. It therefore has no effect on
respiratory goblet cells.
The results of the group of rats pretreated with 50
mg/kg propranolol 35 minutes before receiving 40 mg/kg
isoprenaline are shown in Figure 20 as an open square. The
mean number of goblet cells obtained was 3.99 goblets/HPF;
this response is 54.4% smaller than the response of 7.4
goblets/HPF obtained when 40 mg/kg isoprenaline was given
on its own. Propranolol has partially antagonised the
isoprenaline response in the lung.
4:9 EXPERIMENT 9
DOSE-RESPONSE INVESTIGATION USING RACEMIC ISOPRENALINE.
DOSE-RESPONSE CURVE 3: ANTAGONISM OF THE ISOPRENALINE
RESPONSE BY PROPRANOLOL
4:91 Objectives
To study in detail the pharmacological antagonism of
the isoprenaline response by propranolol. Two isoprenaline
dose-response curves were carried out, one with
isoprenaline alone and the other in the presence of
propranolol. By using sub-maximal doses of isoprenaline it
was hoped to see if propranolol was capable of inducing a
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shift to the right of the isoprenaline dose-response
curve.
4:92 Experiment Design
Ten groups of male rats each consisting of 8 animals
were made up as follows:-
1 rat received saline 0.5 ml IP
1 rat received 5 mg/kg isoprenaline IP
1 rat received 10 mg/kg isoprenaline IP
1 rat received 20 mg/kg isoprenaline IP
1 rat received 50 mg/kg propranolol IP
1 rat received 50 mg/kg propranolol 35 mins before
receiving 5 mg/kg isoprenaline
1 rat received 50 mg/kg propranolol 35 mins before
receiving 10 mg/kg isoprenaline
1 rat received 50 mg/kg propranolol 35 mins before
receiving 20 mg/kg isoprenaline
Thus, every group consisted of one rat from each of
the 8 different treatment groups. All the animals were
killed 24 hours after treatment.
4:93 Tissues and Processing
The lungs were inflation fixed using Millonig's






The doses of 5, 10 and 20 mg/kg isoprenaline, when
administered alone, produced a series of dose-related
responses (Figure 21).
Thus, after 5 mg/kg isoprenaline there were 5.3
goblets/HPF, after 10 mg/kg there were 6.5 goblets/HPF and
after 20 mg/kg there were 8.0 goblets/HPF. These results
are all significantly different (P =<0.0025) from the
saline control value of 2.2 goblets/HPF.
50 mg/kg propranolol alone resulted in a mean number
of goblet cells of 2.0 goblets/HPF and this compares
favourably with that obtained for the saline controls. As
in the previous experiment propranolol has had no effect on
respiratory goblet cells. In the presence of 50 mg/kg
propranolol the three doses of isoprenaline tested (5, 10
and 20 mg/kg) failed to produce an increase in respiratory
goblet cells. Propranolol therefore antagonised the




Showing the effect of propranolol (50 mg/kg) on the
isoprenaline dose-response curve. The vertical bars
represent the standard error of the mean. The open
circles show the responses obtained to 5, 10 and
20 mg/kg isoprenaline. They are all significantly
different from control, with P = <0.0005 for 5 and
20 mg/kg and P = <0.0025 for 10 mg/kg. The closed
circles show the responses obtained with 5, 10 and
20 mg/kg isoprenaline in rats pretreated with 50 mg/kg
propranolol, of these the results obtained with 10 and
20 mg/kg isoprenaline are significantly different from
the corresponding results obtained in the absence of
propranolol with P = <0.025 and P = <0.0005
respectively. The saline control is indicated by X
and the propranolol control by a closed square.
Saline n = 10
Propranolol n = 9
Isoprenaline 5 mg/kg n = 4
Isoprenaline 10 mg/kg n = 7
Isoprenaline 20 mg/kg n = 7
Propranolol + 5 mg/kg isoprenaline n = 9
Propranolol + 10 mg/kg isoprenaline n = 9
Propranolol + 20 mg/kg isoprenaline n = 8
PROPRANOLOL ANTAGONISM OF
ISOPRENALINE DOSE-RESPONSE CURVE





THE EFFECT OF VARIOUS ADRENERGIC AND CHOLINERGIC
DRUGS ON RAT AIRWAY EPITHELIUM
4:10.1 Objectives
Isoprenaline is a powerful jB-adrenoceptor agonist and
it is tempting to think that its effect on respiratory
goblet cells is related to its chief pharmacological
actions. So far the only evidence obtained in support of
that assumption is the very shallow dose-response curves
and the propranolol antagonism of the isoprenaline
response. Further evidence in support of this hypothesis
may be obtained by examining the effects of other drugs of
known pharmacological properties. This experiment was
designed to test several drugs with known pharmacological
properties for an effect on respiratory goblet cells.
4:10.2 Exoermental Details
Groups of 5 male rats were given the following drugs
and doses:-
Receptor
Salbutamol (IP) 40 mg/kg and 4 mg/kg <p2>
Terbutaline (IP) 40 mg/kg and 4 mg/kg tp2)
Isoprenaline (IP) 40 mg/kg and 4 mg/kg (pi and
Methoxamine (IP) 20 mg/kg and 2 mg/kg (<x )




Pilocarpine (IP) 40 mg/kg and 4 mg/kg (Muscarinic)
(IP) 60 pg/kg and 6 pg/kg (Muscarinic)
(IP) 62 pg/kg and 6.2 pg/kg (Nicotinic)
Ten additional rats were given 0.5 ml saline IP and
these served as controls. All the animals were killed 24
hours after treatment.
4:10.3 Tissues and Processing
The lungs were inflation fixed with Millonig's





Of the drugs tested only the sympathomimetic drugs
were found to be capable of producing an increase in
respiratory goblet cells (Figures 22 and 23). Control
goblet cell numbers for this experiment were 3.84
goblet/HPF; 40 mg/kg racemic isoprenaline increased goblet
cell numbers to 8.49 goblets/HPF, 40 mg/kg salbutamol
induced a rise to 6.5 goblets/HPF and 20 mg/kg methoxamine
induced a rise to 7.8 goblets/HPF. All these increases
were significantly different from the control with P =
<0.0005, <0.025 and <0.005 respectively. None of the other
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FIGURE 22
Showing the responses obtained to a variety of
sympathomimetic drugs. The columns represent the
means obtained for each drug and the vertical bars
indicate the standard errors. The responses marked
with an asterisk were significantly different from the
controls, P = <0.0005, P = <0.005 and P = <0.025 for
the isoprenaline, methoxamine and salbutamol
respectively.
Saline n = 8
Isoprenaline 40 mg/kg n = 5
Salbutamol 40 mg/kg n = 4
Terbutaline 40 mg/kg n = 4
Methoxamine 20 mg/kg n = 4
Phenylephrine 20 mg/kg n = 2
FIGURE 22.
FIGURE 23
As for Figure 22 but with parasympathomimetic drugs.
The response to 4 mg/kg pilocarpine was significantly
different from control, P = <0.05.
Saline n = 8
Isoprenaline 40 mg/kg n = 5
Pilocarpine 40 mg/kg n = 5
Pilocarpine 4 mg/kg n = 5
Carbachol 60 pg/kg n = 5
Carbachol 6 pg/kg n = 5
Nicotine 61.7 pg/kg n = 3
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drugs or doses produced significant effects on respiratory
goblet cells with the exception of 4 mg/kg pilocarpine
which induced a reduction in goblet cell numbers to 2.19
goblets/HPF and this was just significant with P = <0.05.
However, 40 mg/kg pilocarpine produced a slight but not
significant rise in goblet cells. The significance of
these conflicting results is not known.
No clear-cut receptor type has emerged as being
involved in the goblet cell response in this experiment.
Of the drugs inducing goblet cell hyperplasia, isoprenaline
acts equaly on p^ and p2~a<3r enoceptor s, salbutamol is p2~
adrenoceptor selective, and methoxamine is ©^-adrenoceptor
selective.
4:11 EXPERIMENT 11
NEBULISER ADMINISTRATION: EFFECT OF ISOPRENALINE
AEROSOL ON RESPIRATORY GOBLET CELLS
4:11.1 Objectives
All the previous experiments involved the systemic
administration of a single high dose of isoprenaline. This
experiment was carried out to see if, by applying the
isoprenaline directly to the respiratory epithelium, it was
possible a) to eliminate non-specific systemic effects and




Three groups of 5 male rats were exposed to either
Nebulised isoprenaline solution (100 mg/ml or 10 mg/ml) or
saline for 45 minutes. The aerosol was produced using a
Wright's Nebuliser as described in the methods section
2:2.4. All the animals received a 5 minute acclimatisation
period with saline aerosol before being exposed to the
different drug solutions. The isoprenaline solution
contained approximately 10~^M ascorbic acid as antioxidant
because it was felt that the continual agitation and mixing
with air under pressure would almost certainly lead to
breakdown of the isoprenaline. 10 M ascorbic acid was
also added to the saline solution. During each exposure
period the atmosphere in the chamber was sampled twice
using a total atmosphere sampler and once with an Anderson
4-stage impaction sampler.. Each sample took place over 15
minutes and therefore the atmosphere was monitored
continuously throughout the run.
At the end of the exposure period the rats were
removed from the chamber, rehoused in standard cages and
killed 24 hours later using an overdose of CC>2 gas.
4:11.3 Tissues and Processing
The lungs were inflation fixed with Millonig's






An increase in respiratory goblet cells was observed
following aerosol administration of isoprenaline (Figure
24). The increases observed, however, were small.
100 mg/ml isoprenaline solution increased goblet cells from
the control level of 3.82 goblets/HPF to 5.72 goblets/HPF,
just significantly different from the control with
P = <0.05. The smaller dose of 10 mg/ml resulted in an
increased level of goblet cells of 5.8 goblets/HPF, this
was also just significantly different from the control with
P = <0.05. Thus, the ten-fold difference in drug solutions
(100 mg/ml and 10 mg/ml) was not reflected in the response.
Calculations of the atmosphere generated in the
chamber and the approximate dose to the rats were made from
the data obtained by the various sampling techniques. The
calculations are shown in detail in Appendix iii. A
summary of the results is given overleaf:-
Solution Dose by TAS Dose by Majority % Absorbed
Anderson Particle size in lung
100 mg/ml 658.3 pg/rat 2.15 mg/rat < 3 urn 20 - 50%
in 45 mins in 45 mins '
10 mg/ml 162.4 pg/rat 516 ug/rat < 3 pn 20 - 50%
in 45 mins in 45 mins
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FIGURE 24
As for Figure 22 but showing the responses obtained to
saline and two solutions of isoprenaline (100 mg/ml
and 10 mg/ml) when administered as an aerosol mist for
45 minutes. Both the solutions of isoprenaline tested
produced significant increases in goblet cells when
compared to the saline control, P = <0.05.
Saline n = 5
100 mg/ml isoprenaline n = 3
10 mg/ml isoprenaline n = 2
7-i
































































There is a big discrepancy in the doses calculated
using the two methods, with the TAS (total atmosphere
sampler) giving a lower reading than the Anderson sampler.
It is therefore not possible to say precisely the eventual
dose received by each rat in either run, however, it does
appear that a goblet cell increase was induced using much
lower doses of isoprenaline than had been used
systemically.
4:12 EXPERIMENT 12
RAT AIRWAY GOBLET CELLS FOLLOWING INTRATRACHEAL
ISOPRENALINE: DOSE-RESPONSE INVESTIGATION I
4:12.1 Objectives
This particular technique has the advantage over
aerosol administration in that the actual dose of drug is
known. It is, however, time-consuming to carry out. This
experiment was designed to investigate the dose-resonse
curve obtainable using this route of administration.
4:12.2 Experimental Details
Groups of 8 male rats were anaesthetised with Sagatal,
as described in section 2:2.4. Because of the time factor
each group was divided in half and two separate lots of
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four were dosed on different days. The doses of iso-
prenaline employed were:-
10 mg/rat IT = 40 mg/kg IP
4 mg/rat IT = 16 mg/kg IP
1.25 mg/rat IT = 6 mg/kg IP
0.625 mg/rat IT = 2.5 mg/kg IP
0.25 mg/rat IT = 0.1 mg/kg IP
0.1 ml saline was injected intratracheally into 8
control rats. All the animals were killed 24 hours later
using an overdose of CC>2 gas.
4:12.3 Tissues and Processing
The lungs were inflation fixed with





A very clear dose-response relationship was observed
between the degree of goblet cell hyperplasia and the dose
of isoprenaline administered (Figure 25). The range of
doses used was lower than those used in the systemic dose-





Showing the dose-response curve obtained with 0.25,
0.625, 1.25, 4 and 10 mg/rat isoprenaline administered
as an intratracheal injection. The vertical bars
represent the standard errors of the means.
Saline n = 7
0.25 mg isoprenaline n = 5
0.625 mg isoprenaline n = 8
1.25 mg isoprenaline n = 7
4 mg isoprenaline n = 8
10 mg isoprenaline n = 7

















maximum plateau response was not observed. The maximum
dose of 10 mg/rat intratracheally increased respiratory
goblet cells from a control value of 2.9 goblets/HPF to 7.9
goblets/HPF, a 192% increase. In experiment 8 the nearest
equivalent IP dose to this IT dose which was 40 mg/kg IP
gave a 196% increase in respiratory goblet cells.
Therefore, isoprenaline given intratracheally induces
increased numbers of respiratory goblet cells, the increase
so produced being of the same order of magnitude and
occurring after similar dose-levels to those which were
used to produce the systemic dose-response curve.
The use of the Student's t-test showed that in none of
the groups was there any significant difference between the
two halves operated on separate days. Figure 25 therefore
shows the overall mean for each group calculated using the
results of two halves.
4:13 EXPERMENT 13
CONFIRMATION OF THE STEREOSPECIFICITY OF THE
RESPONSE FOR THE (-) ISOMER OF ISOPRENALINE
4:13.1 Objectives
In experiment 2 it was observed that the goblet cell
response was stereospecific for the (-) isomer of
isoprenaline. However, very low doses were used in this
experiment. Since the bulk of the work in this study has
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involved single large doses of the isoprenaline racemate,
the following experiments were designed to reconfirm the
stereospecificity of the response using comparable large
doses of the isomers.
4:13.2 Experimental Details
Experiment A:
Groups of 5 male rats received 40 mg/kg IP of either
racemic isoprenaline, (-) isoprenaline, (+) isoprenaline or
0.5 ml saline. The isomers used in this experiment were,
the same as those used in Experiment 2.
Experiment B:
Groups of 10 male rats received 40 mg/kg IP of either
racemic isoprenaline, (-) isoprenaline, (+) isoprenaline or
0.5 ml saline. The isomers used in this experiment were
bought immediately prior to use and their optical rotations
were checked by Aldrich and found to be correct.
All the animals were killed 24 hours after dosing.
4:13.3 Tissues and Processing
The lungs were inflation fixed with Millonig's






As for Figure 22 but showing the results of two
separate experiments comparing the two isomers of
isoprenaline with the racemate. The isomers used in
experiment A were the same as those used in experiment
2; the isomers used in experiment B were purchased
immediately before the experiment and their optical
rotations were checked by the manufacturers, Aldrich
Chemicals. In both experiments all 3 drugs produced
significant increases in goblet cells with
P = <0.0005.
Experiment A Experiment B
Saline n = 8
(-) isoprenaline n = 5
{-) isoprenaline n = 4
(+) isoprenaline n = 5
Saline n = 19
(-) isoprenaline n = 10
(-) isoprenaline n = 8
(+) isoprenaline n = 10
EFFECTS OF THE ISOMERS OF ISOPRENALINE
ON RESPIRATORY GOBLET CELLS


















































Both isomers at the dose of 40 mg/kg induced the same
degree of goblet cell hyperplasia as 40 mg/kg of the
racemate (Figure 26A). There was no significant difference
between the increases induced by the three drugs.
Experiment B:
Very similar results were found with the recently
purchased isomers (Figure 26B). Thus, at 40 mg/kg there
was no significant difference between the responses to the
two isomers and the response to the racemate.
In conclusion therefore, at 40 mg/kg the goblet cell
response was not stereospecific for either isomer of iso-
prenaline.
4:14 SUMMARY OF THE EXPERIMENTAL RESULTS
1) A single IP dose of 40 mg/kg isoprenaline racemate was
shown to induce a consistent and reproducible three-fold
increase in respiratory goblet cells in the rat.
2) Using this single dose model it has been possible to
demonstrate a shallow dose-response relationship between
the dose of isoprenaline and the degree of goblet cell
hyperplasia induced.
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3) The single dose model has also been used to study the
time-course of the goblet cell response. The earliest
detectable increase occurs at 12 hours after the iso-
prenaline administration and the increase first reaches
statistical significance at 18 hours.
4) The maximum increase in goblet cells occurs between 24
and 48 hours after the isoprenaline administration.
5) The isoprenaline induced goblet cell hyperplasia
lasted between 8 and 16 days after the administration of a
single 40 mg/kg dose of the drug.
6) It was found that the goblet cell response was unaf¬
fected by either the time of injection or the time of
death.
7) Study of control goblet cell numbers in the rat lung
showed that during a 24 hour period there was no circadian
fluctuation in the goblet cell population.
8) It was possible to inhibit the isoprenaline-induced
goblet cell hyperplasia pharmacologicaly with a p-
adrenoceptor antagonist. Thus, in the presence of
propranolol the isoprenaline dose-response curve was
abolished.
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9) It was also possible to mimic the isoprenaline effect
on respiratory goblet cells with other systemic sympatho¬
mimetic drugs. The p2~a^renocePt;or agonist salbutamol, and
the cx-adrenoceptor agonist methoxamine were both shown to
induce statistically significant increases in respiratory
goblet cells when given as a single large dose.
10) Ten small daily doses of isoprenaline (3.7 mg/kg IP)
were found to induce a larger increase in respiratory
goblet cells than a single 3.7 mg/kg IP dose.
11) The response to ten daily 3.7 mg/kg doses of iso¬
prenaline IP was comparable to that which followed a single
40 mg/kg IP dose of isoprenaline.
12) At lower doses (2.4 mg/kg IP for 10 days, or as a
single dose) the goblet cell response was found to be
stereospecific for the (-) isomer of isoprenaline.
13) This stereospecificity was lost at higher doses, e.g.
both isomers produced similar responses at 40 mg/kg IP
(single dose), as a single dose of 40 mg/kg racemic
isoprenaline IP.
14) Isoprenaline was capable of inducing goblet cell
hyperplasia in the lung when applied directly to the
respiratory epithelium as an aerosol mist.
15) Isoprenaline was also capable of inducing goblet cell
hyperplasia in the lung when administered as a single
intratracheal injection.
16) Isoprenaline applied intratracheally had a dose-
dependent effect on respiratory goblet cells.
17) The goblet cell increase induced by intratracheal
isoprenaline was the same size as that induced by the
comparable systemic dose of isoprenaline.
18) There was no difference between the goblet cell
responses of male and female rats.
19) There was a tendency for goblet cells to increase with
age/body weight in control rats.
20) A single exposure to a high concentration of SO2 gas
induced goblet cell hyperplasia in the rat lung.
21) The timecourse of the SO2 gas single dose model was
different to the timecourse observed after isoprenaline.
22) Salivary gland and heart weights were recorded at
autopsy in most of the isoprenaline experiments. A single
IP 40 mg/kg dose of isoprenaline had no effect on the
salivary gland or heart weight. However, in experiment 2
the groups receiving multiple doses of isoprenaline or its





This study has shown that a single intraperitoneal
dose of 40 mg/kg of racaemic isoprenaline produces a
reproducible three-fold increase in epithelial goblet cells
in the proximal respiratory epithelium of the rat. The
timing of the response has been investigated and it was
found that a slight increase in goblet cells can be
detected as early as 12 hours after the isoprenaline
administration. A maximum increase occurs between 24 and
48 hours after the isoprenaline administration and there¬
after the increase gradually declines taking up to 8 - 16
days to regain control goblet cell numbers. The dose
dependency of the response was studied in some detail and a
shallow dose-response curve was found. Various sympatho¬
mimetic and parasympathomimetic drugs were tested to see if
any were capable of mimicking the isoprenaline induced
goblet cell hyperplasia. Of the -drugs tested only
salbutamol, a yB 2 - s e 1 e c t i v e adrenoceptor agonist and
methoxamine, an ^-selective adrenoceptor agonist, were
able to induce significant increases in epithelial goblet
cells in the proximal respiratory epithelium of the rat.
Attempts were made to antagonise the isoprenaline response
pharmacologically using propranolol, a p-adrenoceptor
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antagonist. It was found that propranolol, when given 30
minutes prior to the isoprenal ine, was capable of
abolishing the isoprenaline dose-response curve. All the
above findings were made using the systemic administration
of the isoprenaline; however, further experiments were
carried out to see if differing routes of administration
had any effect on the respiratory goblet cell response.
Pilot studies were carried out using intratracheal
injections of the isoprenaline and also the aerosol admini¬
stration of the isoprenaline generated by a Wright's
nebuliser. Both routes of administration resulted in an
isoprenaline-induced increase in the goblet cell population
of the proximal respiratory 'epithelium. The intratracheal
route was further investigated and the dose-dependency of
the goblet cell response was studied using this route of
administration. A dose-reponse curve was obtained, the
range of which was similar to that obtained using systemic
injections. Thus, direct application of the isoprenaline
to the respiratory epithelium did not result in a reduction
in the dose of isoprenaline needed to induced goblet cell
hyperplasia. Furthermore, the magnitude of the response
thus obtained was very similar to that obtained using the
systemic route. In many experiments the heart and salivary
gland weights were recorded at autopsy. Multiple
injections of isoprenaline were found to increase the
weight of both organs, however, a single 40 mg/kg dose of
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isoprenaline failed to produce a change in either organ
weight 24 hours later.
To conclude, this study has established a reproducible
single-dose pharmacological animal model of goblet cell
hyperplasia in the respiratory epithelium which is free
from infection and inflammation. This, therefore, has
great potential as a tool for studies on the goblet cell
hitherto not possible, such as cell kinetics studies to
find their origin within the respiratory epithelium.
5:12 AIMS OF THE DISCUSSION
1) To relate the new findings of this study with previous
work. With special reference to:
(a) Isoprenaline multiple injection studies in both
rats and pigs.
(b) Sulphur dioxide multiple and single exposure
studies.
(c) Tobacco smoke and nicotine exposure.
2) To discuss the problems encountered during the course
of the study. These will be divided into three
sections:
(a) Histological problems particularly with araldite
embedding and cutting techniques.
(b) Development of a novel, faster screening
technique.
(c) Animal health and rat lung pathology.
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3) To discuss the mechanism by which the isoprenaline
induces an increase in goblet cells. This will be
divided into two sections:
(a) Evidence for a direct pharmacological effect.
(b) Evidence for an indirect biochemical, metabolic
or humoral effect.
4) To outline the possible origins of the isoprenaline-
induced new goblet cells. There are five possible
mechanisms which will be dealt with in turn:
(a) Isoprenaline increases mitosis within the
respiratory epithelium leading either to
increased overall cellularity or selectively
increased goblet cells.
(b) Isoprenaline induces altered differentiation in a
multipotential precursor cell population such
that they 'switch on' mucin synthesis.
(c) Isoprenaline stimulates a quiescent population of
pre-goblet cells into mucin synthesis.
(d) Isoprenaline induces the transformation of a
differentiated mature cell into goblet cells by
causing mucin synthesis to occur - 'metaplasia'.
(e) Isoprenaline blocks mucin secretion with or
without increasing mucin synthesis. This would
lead to an increase in full goblet cells and a
subsequent decrease in empty goblet cells,
therefore more would be seen.
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This will be followed by a concluding statement on the
origin of the new goblet cells.
5) To discuss the clinical implications of the findings.
In the next chapter, Chapter 6, a series of brief
statements will be made about the main conclusions of the
study. This will be followed, in Chapter 7, by proposals
for further work arising from the study.
5:2 COMPARISON OF THE RESULTS OF THIS STUDY WITH THOSE
OF PREVIOUS STUDIES ON THE GOBLET CELL
5:21 Studies using Sympathomimetic Drugs in the Rat
In this study a single intraperitoneal dose of
40 mg/kg racemic isoprenaline produced a reproducible 3 to
4-fold increase in goblet cell numbers in the proximal
respiratory epithelium of the rat. This compares very
favourably with the results of Sturgess and Reid (1973),
Bolduc and Reid (1978), and Jones and Reid (1979a and
1979b), all of whom used much higher doses (100 mg/kg
subcutaneously) administered daily for either 6 or 12 days.
Thus, a 4-fold increase in goblets is the maximum response
obtained following isoprenaline administration.
In this study the increase in goblet cells following a
single 40 mg/kg dose of isoprenaline was found to persist
for up to 8 to 16 days after the isoprenaline
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administration. Jones and Reid (1979a) found that in the
trachea goblet cells took one week to return to control
values, 8 weeks in the main bronchus, and more than 12
weeks in the peripheral airways following 6 daily
injections of 100 mg/kg isoprenaline. It therefore appears
that the longer the isoprenaline stimulus, the longer the
goblet cell response persists, and also that goblet cells
in different areas of the respiratory tract return to
control values at different rates.
The finding in this study that salbutamol, a
selective adrenoceptor agonist was less potent than
isoprenaline as an inducer of goblet cell hyperplasia
confirms work carried out by Jones and Reid (1979b). In
the present study, the dose used was 40 mg/kg as a single
intraperitoneal injection; Jones and Reid gave 100 mg/kg
Salbutamol daily for 6 days subcutaneously. They found
that isoprenaline at the same dose level had a much greater
effect on goblet cell numbers than did Salbutamol. They
also found regional differences between the responses to
the two drugs. Whereas isoprenaline induced an increase in
goblet cells in zones 1 and 3 of the trachea and all zones
IV - VII in the lung, salbutamol only increased goblet
cells in zones I and V (upper trachea and proximal intra-
pulmonary airways). However, both drugs were found to
produce the same change in the type of mucin synthesised
to predominantly acid glycoprotein. The significances of
these differences are not known.
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5:22 Studies using Pilocarpine in the Rat
Pilocarpine, a parasympathomimetic drug, did not
produce an increase in respiratory goblets in the proximal
airways of the rat in this study. The doses administered
were 4 mg/kg and 40 mg/kg as a single intraperitoneal
injection. However, other workers have found an increase
in respiratory goblet cells following pilocarpine
administration. Sturgess and Reid (1973) administered 40
mg/kg daily for 6 and 12 days and found an increase in the
trachea from 40 goblet cells per 6 mm epithelium to 60
after 6 injections and a further increase to 160 goblet
cells per 6 mm epithelium after 12 injections. They also
stated that an increase occurred in the bronchial
epithelium but gave no details. Bolduc' and Reid (1978) on
the other hand found that after 40 mg/kg pilocarpine daily
for 12 days, a significant increase in goblet cells
occurred in the upper trachea only; there was a slight,
but not significant, rise in the proximal airway
epithelium. The evidence for a cholinergic element in the
control of goblet cell numbes is therefore slender and an
increase in tracheal goblet cells has only been detected
after prolonged administration of high doses of
pilocarpine.
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5:23 Other Studies on the Goblet Cell Population of the
Lung
Baskerville (1975) studied the effect of isoprenaline
on respiratory goblet cells in the pig. He showed that
after 6 daily injections of 75 mg isoprenaline there was a
significant increase in goblet cells in the bronchial
epithelium. The increase occurred within 24 hours of the
last injection and was maintained for 16 days, thereafter
there was a gradual decline in goblet cell numbers until
they regained control values 84 days after the last
injection of isoprenaline. Although the increase in goblet
cells occurring in the rat after a single dose of
isoprenaline does not last as long as it does in the pig
after multiple doses of isoprenaline, there are important
similarities between the responses of the two species. The
fact that the response is not limited to the rat implies
that, whatever the mechanism is by which goblet cell
hyperplasia is induced, it occurs in more than one species
of animal and may also occur in man, particularly as the
pig respiratory epithelium is very similar to that of man.
Much work has been carried out looking into the
effects of tobacco smoke on the cell populations of the
bronchial epithelium. Lamb and Reid (1969) demonstrated
that cigarette and cigar smoke produced a dose-dependent
increase in goblet cells throughout the lung. The effect
was, however, greatest in the proximal airways. Tobacco
smoke contains a mixture of elements and it is impossible
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to say which of its constituents is responsible for the
goblet cell hyperplasia. However, Wang et al. (1979) have
shown that in the guinea pig exposure to 1% nicotine
aerosol twice a day, 5 days a week for 3 weeks produces a
goblet cell and Clara cell hyperplasia in the large
airways. In the present study a single systemic dose of
nicotine intraperitoneally (6.2 |ig/kg and 62 jjg/kg) failed
to have any effect on the goblet cell population of the
proximal airways of the rat. This may be because the
effect is only seen after prolonged exposure directly to
the respiratory epithelium, or alternatively, the doses
given systemically may have been sufficiently high to be
toxic and thus masked any effect.
5:24 Studies using Sulphur Dioxide Gas
One experiment using sulphur dioxide gas was performed
in this study. Rats were exposed to approximately 500 ppm
sulphur dioxide gas for a single 4 hour period. They were
then killed at various times later. Following exposure to
the gas, goblet cells in the proximal airways of the rat
steadily increased over a matter of days reaching a maximum
value 6 days after the SO2 exposure. Thereafter there was
a very gradual decline in numbes such that at 11 days after
the SO2 exposure numbers were still much greater than the
control. A single dose of isoprenaline on the other hand
produces a rapid increase in goblet cells which reaches a
maximum between 24 and 48 hours after the injection,
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thereafter goblet cell numbers gradually decline regaining
control values between 8 and 16 days after the
administration of the isoprenaline. The timing of the two
responses are therefore very different. In addition, the
response to sulphur dioxide is much greater, particularly
when administered over a prolonged period of time (Lamb and
Reid, 1968). Sulphur dioxide gas is an irritant and can
cause severe inflammatory reactions within the respiratory
epithelium. The delay in the increase in goblet cells is,
in fact, due to desquamation of the surface epithelium
which is followed by regeneration and an increase in goblet
cells (Lamb and Reid, 1968). Thus, sulphur dioxide brings
about an increase in goblet eels by means of an
inflammatory action whilst isoprenaline does so by some
unknown pharmacological, biochemical or humoral effect.
5:25 Summary
Although much of the work of this thesis is new and
has not been reported before, it compares very favourably
with the limited amount of similar work previously
reported, namely, the size and duration of the response.
It has been possible to produce an increase in goblet cells
of the proximal airways of the rat, using a single 40 mg/kg
dose of isoprenaline, equal to that previously produced
using 12 and 6 daily injections of 100 mg/kg isoprenaline.
This increase has been shown to be reproducible and occurs
equally in both male and female rats. The response was not
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confined to a single species of animal or a particular
strain of rat and as such represents a very useful tool for
the study of the goblet cell.
5:3 PROBLEMS ENCOUNTERED DURING THE COURSE OF THE STUDY
5:31 Problems with Histological Techniques
Many previous quantitative studies on the lung goblet
cell population have taken place using 5 urn thick paraffin
sections stained with a mucin specific stain, such as the
combined Alcian Blue/Periodic Acid Schiff (AB/PAS) stain.
The specificity of this stain precludes identification of
other cell types as only those containing mucus show up.
Application of counter stains is not helpful as they mask
the mucin staining itself. Other disadvantages of paraffin
sections are the poor preservation of the lung tissue, with
shrinkage being a particular problem, and the thickness of
sections which often means that nuclei in the field of view-
are in different planes and do not always correspond to the
layer of cells under study.
Ideally what is required for a study such as this one
are large araldite sections, 1 Jim thick, of post-osmicated
material. These would allow the same area to be studied at
both the light and electron microscope level. In practice
this was found to be impossible and a compromise was worked
out (see Appendix v) : The left lung was embedded in GMA
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and large 1.5 }im sections cut and then stained with AB/PAS.
These were used for the light microscopic assessment of
goblet cell numbers. Meanwhile, selected right lungs were
post-osmicated and embedded in araldite awaiting
development of the technique for using larger glass knives.
All the difficulties encountered in the study serve to
emphasise the need for a new embedding medium suitable for
both the light and electron microscopic study of histo¬
logical material. This would ideally be a resin which is
water soluble in the unpolymerised state thus facilitating
easier staining with a wide range of stains; all the
reagents necessary should be less toxic than those
presently in use; and v/hilst permitting easy handling of
large thin sections the polymerised resin should be 'soft'
enough to cut easily, thus eliminating the use of glass or
diamond knives as required for epoxy resins. It would be
advantageous if the new material were somewhat cheaper than
those at present in use which work out at considerable cost
for each block processed and cut.
With regard to cutting technique, the Reichart-Jung
autocut was found to be excellent for dealing with large
blocks of GMA. The tungsten carbide knives recommended for
use with large araldite blocks were hopelessly inadequate
and they have been relegated to extremely expensive
trimming-in knives. The quality of epoxy resin sections
cut using larger glass knives still falls short of the
conventional EM 'thick* section, primarily because it is
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almost impossible to flatten the sections once cut
sufficiently for study at higher powers of magnification.
In our hands, at least, this particular technique still
requires a lot of work.
5:32 Development of a Fast-Screening Technique for the
Quantitation of Tracheal Goblet Cells
Details of this technique along with the various
methods of quantitation employed can be found in
Appendix i. The actual methodology of the technique is
very simple and fast, it being possible to have slides
ready for counting the same day as the animals were killed.
When compared to the 3-5 weeks delay for GMA embedded
material, this is an obvious advantage. However, there
exists some doubt as to whether the technique is capable of
detecting all of the available goblet cells, particularly
from the areas between the cartilage rings. When examined
under the microscope the impressions obtained showed
numerous discrete, highly PAS positive dots interspersed by
occasional mucus strands and sheets of epithelial cells
(see Figure 29). Proof is still required that these
actually are goblet cells. In addition, more work is
required on the method of quantitation and its
reproducibility.
The preliminary nature of the work carried out using
\
this technique makes it difficult to accurately assess the
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technique as a whole. However, when an independent
observer counted several slides and their results were
compared with mine, there was close agreement between the
two sets of results on several occasions. Bearing in mind
that this was the first time that they had attempted to
count goblet cells using this type of preparation this was
very encouraging. It therefore seems likely that the
technique has great potential for the fast quantification
of tracheal goblet cells and it certainly merits further
investigation.
5:33 Problems Encountered with Animal Health
Section 3:1 describes in some detail the effects that
an outbreak of Sendei virus had on the project. This is a
respiratory infection which has profound effects on the
lung pathology of infected animals. Nevertheless, because
it is of viral origin, commercial animal breeding units can
still qualify for 4-star Specific Pathogen Free
accreditation even when it is endemic in their breeding
colonies. Lung disease has also been demonstrated in the
lungs of rats reared (apparently successfully) under germ-
free conditions (Lamb, 1975). It therefore appears that
the onus for ensuring that animals used in lung research
are free from respiratory disease lies with the purchaser
and not with the supplier - a far from satisfactory state.
Histology is accepted as the most sensitive method of
identifying early changes of chronic respiratory disease in
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rats (Lindsey et al., 1971) and this was demonstrated in
this project by the rise in control goblet cells which
preceeded the clinical manifestation of Sendei virus
infection at the Alderley Park breeding unit. It would be
helpful if histological examination of longitudinal
sections of airways always formed part of routine quality
control in commercial animal breeding units, as this would
detect early changes in lung pathology long before the
animals became clinically ill. It would then be easier to
obtain rats for lung research with reliably 'clean* lungs,
thus eliminating one important source of variability.
5:4 POSSIBLE MECHANISM FOR THE ISOPRENALINE REPONSE
There are two distinct possible ways in which
isoprenaline may induce respiratory goblet cell
hyperplasia. These are firstly, that the effect is a
straight forward pharmacological one; that is, it is
linked to the drugs activity as a jB-adrenoceptor agonist
and its interaction with p-adrenergic receptors located in
the airway. Secondly, the effect may be due to some
indirect, metabolic, biochemical or humoral effect which
need not necessarily be instigated within the airway
epithelium itself.
The work carried out in this thesis has supplied
evidence both for and against the response having a direct
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pharmacological basis. This evidence has been summarised
below and is followed by a discussion of each item.
Evidence for a pharmacological basis;
(i) The response exhibits dose-dependency
(ii) The response can be antagonised pharmacologically
(iii) The response was limited to sympathomimetic drugs
(iv) The response shows stereo-specificity at low
doses
(v) Preliminary studies suggest the response is not
limited to goblets cells in the lung
Evidence against a pharmacological basis;
(i) The systemic dose required is very high
(ii) Likewise the dose of p-antagonist required to
inhibit the response is very high
(iii) No clear cut receptor type has emerged from
studies with other sympathomimetics
(iv) The dose of isoprenaline required to increase
respiratory goblet cells was not decreased by
applying it directly to the respiratory
epithelium
(v) The stereo-specificity of the response was lost
at high dose levels
5:41 Discussion of Evidence for a Pharmacological Basis
Dose-Response Relationship: For the goblet cell response
to have a pharmacological basis it must involve a drug-
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receptor interaction. In this instance, this is an
interaction between isoprenaline and p-adrenoceptors
(adrenergic receptors). Such interactions obey (in
simplistic terms) the law of mass action (Fingl and
Woodbury, 1970). Thus, the higher the concentration of a
drug at the receptor site the more numerous the inter¬
actions and the greater the reponse is likely to be. A
study of the dose-reponse relationship for the isoprenaline
induced goblet cell hyperplasia revealed that there was
indeed a shallow dose-response relationship. This was
demonstrated using both the systemic, i.e. intra¬
peritoneal, and the inhalation, i.e. intratracheal routes
of administration. The range of doses being from 5 mg/kg -
40 mg/kg by the intraperitoneal route and 1.25 mg - 10 mg
by the intratracheal route. Doses higher than 40 mg/kg
intraperitoneally resulted in either a response of similar
magnitude obtained with 40 mg/kg or in a smaller response,
there was therefore a maximal effect. The doses involved
are very high when compared with those required to elicit
changes in heart rate and blood pressure in vivo in the
rate, namely 10 ^g/kg - 100 ^ig/kg. However, other drugs
have been shown to have different pharmacological effects
at different dose-levels, e.g. aspirin at relatively low
dose levels effectively relieves the pain of headache while
at much higher dose levels it can relieve arthritic pain.
As stated earlier the dose-reponse curve for the
goblet cell hyperplasia is shallow and doses above 40 mg/kg
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resulted in a reduced response. These two characteristics
probably reflect the toxic nature of such high doses of
isoprenaline. It is likely, therefore, that the
isoprenaline may no longer be acting as a selective p-
adrenoceptor agonist and the existance of a dose-reponse
relationship should only be taken as tenuous support for a
pharmacological basis to the goblet cell response.
Pharmacological antagonism of the response bv propranolol:
Propranolol is a competitive ^-adrenoceptor antagonist and
as such competes directly with the isoprenaline for the
same ^-adrenergic receptors. If the isoprenaline is acting
through ^-adrenoceptors to induce goblet cell hyperplasia
then propranolol should, in a sufficient dose, be capable
of antagonising the response. This it has been shown to do
on two occasions. Firstly 50 mg/kg propranolol given 30
minutes prior to the administration of 40 mg/kg
isoprenaline resulted in a goblet cell response which was
50% smaller than that obtained with 40 mg/kg isoprenaline
on its own. Secondly, propranolol (50 mg/kg) was shown to
abolish the isoprenaline/goblet cell dose-response curve
obtained using 5, 10 and 20 mg/kg isoprenaline. As with
the dose-reponse evidence, care must be exercised in inter¬
preting these results as evidence in support of a pharma¬
cological basis for the response.
The dose of propranolol used was, with hindsight, too large
and further work is required using smaller doses to see if
isoprenaline can indeed overcome the propranolol, i.e.
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successfully compete with the propranolol for the p-
adrenoceptors thus confirming the competitive nature of the
blockade.
The Effect of Other Sympathomimetic Drugs on Respiratory
Goblet Cells: Isoprenaline belongs to a family of drugs
classed as sympathomimetic because their actions in vivo
mimic that of adrenergic nerve stimulation (the sympathetic
nervous system). The drugs can be sub-divided according
to the type of adrenergic receptor they are selective for
into <x - and p-adrenoceptor agonists. The p-adrenoceptor
agonists can be further divided into an<^ f2~
adrenoceptor agonists; isoprenaline is a p-adrenoceptor
agonist acting equally on both p-j_- and p2~-adrenoceptors.
This classification is based on the selectivity of the
drugs for a particular receptor type. None of them
however, can be said to have specificity for a single
receptor type. Thus, although at lower doses they are
capable of selectively activating <=*-, f>\~ or ^2"
adrenoceptors, at higher doses this selectivity may be lost
and they may act on any of the three types of
adrenoceptors. Attempts were made in this study to mimic
the effect of isoprenaline on respiratory goblet cells
using a number of sympathomimetic and parasympathomimetic
drugs. Methoxamine, a selective cx-adrenoceptor agonist,
and salbutamol, a selective ^2~adrenocePtor agonist, were
found to be capable of producing significant increases in
respiratory goblet cells 24 hours after a single dose of 20
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and 40 mg/kg respectively. None of the parasympathomimetic
drugs tested produced an increase in resiratory goblet
cells following a single intraperitoneal dose. Thus,
although the response was limited to sympathomimetic drugs
no single adrenergic receptor type has emerged. In fact,
drugs acting on all three receptor types have been found to
be capable of inducing goblet cell hyperplasia in the
respiratory epithelium of the rat. Since ^-adrenoceptors
are found in bronchial smooth muscle and when stimulated
give rise to bronchodilatation, and ^-adrenoceptors are
found in pulmonary vasculature and when stimulated give
rise to vasoconstriction and finally, ^"adrenoceptors
occur almost exclusively in cardiac smooth muscle and give
rise to positive inotropic and chronotropic effects when
stimulated, there is no common site or action associated
with the three receptor types so far shown to be involved
in goblet cell hyperplasia. This fact along with the
failure by terbutaline, another p2_adrenocePtor agonist, to
induce goblet cell hyperplasia lends very little support
for the direct involvement of adrenoceptors in the goblet
cell response.
The Effect of the Optical Isomers of Isoprenaline on Goblet
Cells; Isoprenaline in common with many of the sympatho¬
mimetic drugs has within its molecular structure an
asymmetric carbon atom. The molecule can therefore be
resolved into two optically active isomers, a levo-rotatory
isomer and a dextro-rotatory isomer. The levo-rotatory
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isomer is the pharmacologically active isomer being
approximately 90 times more potent than the dextro-rotatory
isomer in reducing blood pressure in the dog (Becarri
et al.. 1953). Their relative potencies vary from species
to species due to differences in the rate of racemisation
in body fluids. Nevertheless, in all species the levo-
isomer is the pharmacologically more active and is generaly
more potent than the racemate. When the two isomers of the
drug were tested in this study the goblet cell response was
found to be stereo-specific for the levo-isomer at lower
doses of the drugs but not at higher doses. The stereo-
specificity of the response at low doses lends support to
the theory of a pharmacological basis to the goblet cell
response. The lack of stereo-specificity at higher doses
on the other hand raises serious doubts about this and will
be discussed in the next section.
The Effect of Isoprenaline on Goblet Cells Elsewhere in the
Body.: Goblet cells do not occur exclusively in the
respiratory epithelium. They can be found in all mucosal
surfaces where mucus is required. Thus, goblet cells can
be found throughout the length of the alimentary tract and
in the small intestine they occur along the sides of the
villi, and as stated in the introduction, much of the work
carried out to elucidate the origin of goblet cells using
cell kinetics has been performed using the small intestine.
The response to isoprenaline by goblet cells may not,
therefore, be limited to the lung. Should it occur at
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other goblet cell sites around the body then the mechanism
of the isoprenaline action may be involved in the normal
physiological control mechanism governing the goblet cell
population as a whole, and not just in the respiratory
epithelium. This is an important area for future study.
5:42 Discussion of the Evidence Against a Pharmacological
basis
Dosages required: As pointed out in the previous section
the dosages involved are very high. It is therefore
impossible to be absolutely certain that the isoprenaline
is acting purely as a ^-adrenoceptor agonist. In man, high
doses of isoprenaline have been shown to cause increased
salivation and this has been attributed to oc-adrenoceptor
stimulation by the isoprenaline. It can also cause
blanching of the skin when injected intradermally; this,
too, has been attributed to ^-adrenoceptor stimulation
(Innes and Nickerson, 1970). It is worth remembering that
isoprenaline is the most active of the sympathomimetic
drugs acting exclusively on ^-adrenoceptors, and as such
normally requires very low doses to achieve a pharmaco¬
logical ^-adrenergic effect.
However, the high doses required may simply reflect the need
for the presence of the isoprenaline over a set length of
time before the goblet cell response is seen. To confirm
this an experiment is needed in which a low dose of
isoprenaline is given as a slow infusion over a number of
hours.
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High Dosage Levels of ^-antagonist Employed: The previous
section mentioned the fact that propranolol has in addition
to its ^-adrenoceptor antagonist activity the ability to
cause membrane stabilisation (membrane stabilisation
activity - MSA). MSA is in fact a direct local anaesthetic
action on cell membranes leading to an increase in
electrical threshold. It is prominent only with doses
larger than those required to produce significant fi-
receptor blockade (Nickerson, 1970). In this study the
single dose of 50 mg/kg propranolol intraperitoneally was
found to inhibit the isoprenaline induced goblet cell
hyperplasia. However, observation of the animals receiving
the propranolol revealed that there were within the group,
two distinct groups of animals. The majority of the rats
receiving the propranolol became very depressed and showed
loss of muscle co-ordination and in some cases appeared to
exhibit a form of catatonia. The rest of the rats,
however, appeared to be unaffected by the dose of
propranolol and behaved normally.
It was thought probable that the severely depressed
rats were exhibiting signs of MSA caused by the high dose
of propranolol. If this was indeed the case then those
animals would be unreceptive to most pharmacological
stimuli by virtue of the raised electrical theshold and
local anaesthetic effect on the cell membranes. In other
words, the propranolol was no longer acting as a p-
adrenoceptor antagonist but as a highly potent local
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anaesthetic. To try to ascertain whether or not this was
the case a small numbers of rats were fitted with carotid
canulas at the I.C.I, laboratories at Alderley Park and
continuous monitoring of heart rate and blood pressure was
carried out following a variety of procedures, the details
of which are given in Appendix ii.
Of the two rats receiving propranolol, one showed
signs of MSA and this was confirmed by the severe drop in
resting heart rate 35 minutes after the administration of
the drug. The rats were then given 40 mg/kg isoprenaline
and a continuous recording of heart rate and blood pressure
was made. The rat without MSA on receiving the
isoprenaline showed a marked increase in heart rate and a
fall in blood pressure. The increase in heart rate was
smaller than that obtained in a rat receiving isoprenaline
alone; it was nevertheless considerably higher than the
control heart rate. The fall in the blood pressure
observed was, on the other hand, very similar to the fall
in blood pressure observed in the isoprenaline control.
The rat with signs of MSA also exhibited the same
decrease in blood pressure after isoprenaline as the rat
without MSA and the isoprenaline control. The effect on
heart rate was, however, different. Prior to receiving the
isoprenaline, the rat with signs of MSA had a markedly
reduced heart rate, almost half the normal resting value.
After the administration of the isoprenaline the heart rate
increased sharply to just below the control rate and then
127
dropped again. Unfortunately it was not possible to obtain
readings from this animal longer than 15 minutes after
receiving the isoprenaline. This experiment has shown that
50 mg/kg propranolol intraperitoneally may induce MSA in
the majority of the rats so dosed. Where MSA has occurred
the propranolol does inhibit the effect of isoprenaline on
heart rate to some extent but has no effect on the
reduction in blood pressure induced by the isoprenaline.
Where propranolol has failed to have any MSA effects
the dose of 50 mg/kg intraperitoneally has not antagonised
the cardiovascular effects of 40 mg/kg isoprenaline. Thus,
although propranolol abolished the isoprenaline dose-
response curve for the goblet cell hyperplasia, this might
not be due to pharmacological antagonism brought about by
competition for the ^-adrenoceptors, but may be brought
about by the powerful membrane stabilisation effect such a
high dose of propranolol has in the rat.
Receptor Type Involved in the Response: As stated earlier,
all three types of adrenoceptor have been implicated in the
response. In addition, Sturgess and Reid (1973) found a
significant increase in respiratory goblet cells following
6 and 12 daily doses of 10 mg pilocarpine. However, a
single 40 mg/kg dose of pilocarpine failed to have any
effect on respiratory goblet cell numbers in this study.
In section 5:51 it was pointed out that there was no
common site of action or effect associated with the
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selective adrenergic actions of the three drugs found to be
capable of increasing respiratory goblet cells. The
classification of adrenergic receptors as o<- (peripheral
excitatory), (peripheral inhibitory) and (cardiac
excitatory) apptie.s to the receptors for the
metabolic and the central nervous actions of the drugs
^ Wilier / 1980). In fact, many of the
metabolic and central nervous effects can readily be
classified as being due to a particular receptor type.
If one or more of these indirect metabolic or central
nervous effects were responsible for the goblet cell
response then this may account for the variety of sympatho¬
mimetic drugs which induced goblet cell hyperplasia. The
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J the order of potency of the various
adrenergic agonists enables the metabolic effects to be
divided into cx-associated and ^-associated effects, the
effects of adrenergic blocking agents on metabolic
processes in man and other species can also be divided into
c< — and ^-adrenoceptor associated effects (Weiner, 1980).
Since the goblet cell response requires large doses
of the various drugs, it is very probable that they are no
longer selective in their metabolic effects and that a
common alteration in metabolism is occurring which may be
responsible for triggering the goblet cell increase.
The same considerations apply to the central nervous
effects of the drugs, and it is not possible at this point
to say which of the varied effects, both metabolic and in
the brain, may be responsible for inducing a goblet cell
hyperplasia.
The Lack of Stereo-Specificity at High Dose Levels; When
the optical isomers of isoprenaline were administered as a
single intraperitoneal dose of 40 mg/kg both isomers
induced an increase in respiratory goblet cells. The
increase so induced was of the same order as that induced
by 40 mg/kg of the racemic mixture. Thus, all three drugs
proved equipotent at inducing goblet cell hyperplasia when
given as a single intraperitoneal dose of 40 mg/kg. One
One possible explanation for this may be that the (+) isomer
contained a small amount of the active (-) isomer which was
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present in sufficient quantity at 40 mg/kg to produce goblet
cell hyperplasia but not at 2.4 mg/kg.
Alternatively,
there may be a common metabolic or CNS (central nervous
system) effect which all three drugs have at 40 mg/kg and
which only the levo-isomer and racemic mixture produce at
lower doses because of their greater potency. The loss of
stereo-specificity at higher doses lends support to a non
pharmacological basis for the response.
Dosgge Required by the intratracheal Route; if the goblet
cell response is the result of interaction between
isoprenaline and ^-adrenoceptors located in or near the
respiratory epithelium, then it might be anticipated that
applying the isoprenaline directly to the respiratory
epithelium would lead to a reduction in the dose of
isoprenaline needed or an increase in the response.
Isoprenaline was found to have a direct effect on
respiratory goblet cells. In the event, however, it was
found that intratracheal injections of isoprenaline
resulted in the same size of goblet cell increase as did
systemic doses. The amount of isoprenaline administered by
the intratracheal route was in the range 1.25 mg - 10 mg
per rat; as the rats weighed 250 g the dose of 10 mg was
equivalent to 40 mg/kg. Thus, the intratracheal dose was
similar to the intraperitoneal dose. It has been shown
that there is little airway absorption of isoprenaline but
there is rapid absorption in alveolar regions; systemic
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effects such as tremor and tachycardia can be detected
30 sees after inhalation (Newhouse and Ruffin, 1978; Dashe
et al.f 1974). Drugs given by inhalation are therefore
rapidly absorbed and dispersed by the blood stream. The
high dose of intratracheal isoprenaline required to induce
goblet cell hyperplasia argues against a localised effect
within the respiratory epithelium and therefore does not
lend support to the theory of a pharmacological basis to
the response.
5:43 Summary
The findings of this study have not made it possible
to say definitely that the goblet cell response is directly
related to the pharmacological interaction between
isoprenaline and ^-adrenergic receptors. However, several
of the findings point towards some kind of sympathetic
control over the goblet cell population. The nature of
that control and its mediation are not known. It may be
biochemical, metabolic or humoral and need not necessarily
be initiated within the respiratory epithelium itself. The
fact that the response is not limited to isoprenaline, or
confined to rats, but can occur in other species of animals
and strains of rats shows that it is not an idiosyncratic
side effect of high doses of isoprenaline. As such it is a
useful tool for elucidating much that is not known about
goblet cells such as their origin and synthetic and
secretory control mechanisms.
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5:5 THE EFFECT OF ISOPRENALINE ON THE RESPIRATORY
EPITHELIUM WHICH LEADS TO INCREASED EPITHELIAL GOBLET
CELLS: THE ORIGIN OF THE NEW GOBLET CELLS
5:51 Introduction
There are several possible ways in which the new
goblet cells can arise. These are listed below with brief
details, each possibility is then discussed more fully in
the following four sections.
Possible Origins of the New Goblet Cells
(i) Isoprenaline stimulates mitosis within the
respiratory epithelium. This may either result
in an increase in the overall cellularity of the
respiratory epithelium, including goblet cells,
or the increased mitosis may only give rise to
new goblet cells.
(ii) Isoprenaline stimulates differentiation from
precursor undifferentiated or differentiating
cells into goblet eels by switching on the
synthesis of mucin.
(iii) There may a be quiescent population of goblet
cells, i.e. committed dormant goblet cells, which
are stimulated to synthesise mucin by
isoprenaline. Once they contain stored mucin the
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cells are identified as goblet cells using the
light microscope and mucin specific stains.
(iv) Isoprenaline stimulates the transformation of
existing functional differentiated cells into
goblet cells. Possibilities being Clara cells in
peripheral airways and ciliated cells in proximal
airways.
(v) Isoprenaline may block the secretion of mucin
with or without stimulation of synthesis. This
would result in greater numbers of full goblet
cells and very few empty goblet cells. The
numbers of goblet cells identified using the
light microscope and mucin specific stains would
subsequently increase.
5:52 The New Goblet Cells Arise From Isopenaline Stimulated
Mitosis
Isoprenaline has been shown to affect mitosis in a
variety of tissues and species. Schering et al. (1972)
found isoprenaline flattened the mitotic curve in the
gastro-intestinal tract of mice. Also in mice, Malamud and
Malt (1971) reported that isoprenaline stimulated mitosis
in the kidney. In the rat isoprenaline has been shown to
induce an increase in mitosis in the salivary gland,
resulting in an alteration in the pattern of secretion with
increased protein content and output of saliva (Seifert,
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1967). Bolduc and Reid (1978) have also reported an
increase in mitosis in the epithelium of the rat lung
following isoprenaline administration. Conversely,
Baskerville (1975) concluded that since the respiratory
epithelium was not hyperplastic and there was no change in
mitotic activity following isoprenaline administration in
pigs, the drug was inducing an alteration in
differentiation which was responsible for the increase in
epithelial goblet cells.
The fundamental biochemical action of isoprenaline
which immediately follows its interaction with Ji-
adrenoceptors is an increase in the intracellular levels of
adenosine S'^'-cyclic monophosphate (c-AMP). c-AMP has
been implicated in the regulation of cell growth through
its inhibitory action on DNA synthesis (Abell and Monahan,
1973). They have shown that increased levels of c-AMP can
inhibit cell division by reducing the synthesis of DNA;
this effect was greater on malignant cell growth than on
normal cell growth and occurred in vitro. Thus, increased
intracellular c-AMP has been associated with a decrease in
cell division and a shift towards increased cell
differentiation. In vivo, however, isoprenaline has been
shown to increase the synthesis of DNA in the parotid gland
of the mouse, and this stimulatory effect was dependent on
isoprenaline inducing increased c-AMP levels within the
cells (Guidotti et al., 1972). Isoprenaline has also been
shown to stimulate DNA synthesis in vitro in haemopoietic
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stem cells (Byron, 1972). This stimulatory effect was
dependent on an intracellular increase in c-AMP and was
inhibited by propranolol. These results are at variance
with those of Abell and Monahan (1973). The role of c-AMP
in cell division is therefore unclear and appears to vary
in different tissues and species.
The response of goblet cells to isoprenaline is very
fast, increased numbers can be detected 12 hours after the
isoprenaline administration and the increase reaches
significance by 18 hours and reaches a maximum between 24
and 48 hours. In the mouse kidney the stimulatory effect
on DNA synthesis reaches a peak at 34 hours and in the
parotid gland at 22 hours (Malamud and Malt, 1971), and in
mouse haemopoietic stem cells peak DNA synthesis occurs 28
hours after the isoprenaline administration (Byron, 1972).
Thus, the increase in goblet cells in the lung occurs
before the peak increase in DNA synthesis in other tissues.
Furthermore, the biochemical events, prior to mitosis,
which occur in murine or rat salivary glands after a single
injection of isoprenaline have been studied by Fujioka
et al. (1963). They showed that there were between 30 and
33 hours delay from the injection of isoprenaline and the
occurrance of mitosis. In the small intestine it has been
estimated that it takes 10 hours for the appearance of
immature goblet cells in the crypt, following stem cell
division, and 40 hours for 'mature' goblet cells to appear
at the base of the villus (Cairnie, 1970; Merzel and
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Leblond, 1969; Leblond and Messier, 1958). The small
intestine has a much faster cell turnover than the lung,
and in the small intestine the process from stem cell
division to fully mature goblet cell takes up to 40 hours.
It therefore seems unlikely that in the lung, with its much
slower cell turnover, that the process of stem cell
division to fully mature goblet cell would take as little
as 12 - 18 hours. Is 12 - 18 hours sufficient time for a
cell in the resting phase of the cell cycle to enter the
DNA synthesis phase, prepare for and then undergo mitosis,
mature and synthesise a theca full of stored mucin? It
seems unlikely. An example of goblet cell hyperplasia
induced by increased mitotic activity in the lung is that
caused by exposure to sulphur dioxide gas. The irritant
damages the respiratory epithelium, this leads to increased
mitotic activity and repair of the epithelium with a
subsequent increase in the number of goblet cells. This
increase reaches a maximum 6 days after the exposure to the
sulphur dioxide (experiment 1, chapter 4). In addition to
the difference in the timing of the response, there is
another important difference between the isoprenaline
induced goblet cell hyperplasia and the sulphur dioxide
induced hyperplasia, and that is the size of the response.
The response to sulphur dioxide is much greater than
that due to isoprenaline. The latter is therefore
stimulating a finite population of cells into becoming
goblet cells. Now, the effect of isoprenaline on
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intracellular c-AMP is dependent on the presence of a p-
adrenergic receptor on the exterior surface of the cell,
which in turn stimulates the synthesis of c-AMP. It is
possible that within the respiratory epithelium only a
limited number of cells have such a receptor and that these
cells are capable of undergoing mitosis to give rise to new
goblet cells. However, this action on c-AMP is a highly
selective property of p-adrenergic agonists and requires
low concentrations of the drug in vitro for its initiation
(Byron, 1972). As stated in the previous section, the
response of goblet cells to isoprenaline requires very
large doses and is not obviously related to its
pharmacological activity as a ^-adrenoceptor agonist. It
is therefore highly unlikely that the new goblet cells
detected after a single dose of isoprenaline arise through
its stimulatory effect on DNA synthesis and a subsequent
increase in cell proliferation leading to increased numbers
of goblet cells.
5:53 The New Goblet Cells Arise From Isoprenaline Induced
Altered Differentiation
In the summary of possibilities outlined at the
beginning of this sections, points (ii), (iii) and (iv) are
all related to alterations in differentiation. Points (ii)
and (iii) will be dealt with together in this section and
point (iv) will be dealt with separately in the next
section. The essential difference between points (ii) and
138
(iii) is that in (ii) the cells which may be stimulated by
the isoprenaline are multipotential and can become any cell
type whatsoever within the respiratory epithelium. In
(iii), however, the cells in question are already committed
to becoming goblet cells and isoprenaline has speeded up
the process.
In the larger airways the epithelium has a pseudo-
stratified appearance and this is due to the presence of
basally situated cells called basal cells. These cells act
in a similar way to the germinal layer of the epidermis and
represent the stem cell population for the tracheal and
large airway epithelium (Blenkinsopp, 1967; Breeze and
Wheeldon, 1977). As such, basal eels are multipotential
and each division gives rise to one new basal cell and one
new undifferentiated cell, the fate of the latter is at
present unknown. Section 1:35 of the Introduction gave an
outline of the various theories proposed for the origin of
respiratory epithelial goblet cells. Donnelly et al.
(1980) stated that all tracheal epithelial cells were
proliferative with the exception of ciliated cells.
Conversely, Bindreiter et al. (1968) concluded that
ciliated and goblet cells were non-proliferative and that
the proliferative basal cells feed into an undifferentiated
proliferative compartment of cells which in turn give rise
to differentiated functional cells. Finally, Boren and
Paradise (1978) proposed a scheme whereby basal cells feed
into a dividing mucus cell compartment from which
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functional ciliated cells arise. In the small intestine it
is now generally accepted that goblet cells do not undergo
mitosis but are derived from a precursor proliferative pre-
goblet or oligomucous cell situated in the lower half of
the crypt (Cairnie, 1970; Merzel and Leblond, 1969).
There have not, so far, been any descriptions of a cell
resembling the intestinal oligomucous cell within the
respiratory epithelium. However, two poorly differentiated
cell types have been described, the intermediate cell and
the transitional cell (Jeffrey, 1975; Rhodin and Dalhamn,
1956; Breeze and Wheeldon, 1977). The intermediate cell
is thought to be an undifferentiated cell capable of
proliferation and differentiation into either ciliated or
secretory cells. The transitional cell is a cell showing
morphological characteristics of more than one cell type,
i.e. mucin granules in the cytoplasm plus evidence of
ciliogenesis and basal bodies at the apex (Osada, 1964;
Harris et al., 1975; Breeze and Wheeldon, 1977).
It is possible that the intermediate cell, which is
multipotential and is capable of differentiating into
either goblet or ciliated cells, is being selectively
stimulated by isoprenaline to synthesise mucin and
differentiate into goblet cells. Jeffrey (1975) reported
that under the electron microscope intermediate cells con¬
tained either an electron dense cytoplasm or an electron
lucent cytoplasm, the former being destined to become
goblet cells and the latter ciliated cells. Futher studies
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using the electron microscope are required to ascertain
whether or not the electron dense intermediate cell
resembles the so-called oligomucous pre-goblet cell of the
small intestine. Until this has been done it is not
possible to clarify more fully whether or not isoprenaline
is stimulating a committed pre-goblet precursor cell or if
it is selectively altering the differentiation of a multi-
potential precursor cell towards mucin synthesis.
5:54 The New Goblet Cells Arise From Isoprenaline Induced
Transformation of Existing Functional Differentiated
Cells
As stated in the previous section a transitional cell
showing the morphological characteristics of more than one
cell type has been described in the respiratory epithelium.
Precisely what this means is not as yet understood. In the
small intestine observations of the villus cell populations
have revealed that not all the goblet cells found in the
villus epithelium arise within the crypt, some are derived
by transformation of undifferentiated columnar cells
situated on the villus (Porcella et al., 1979). A similar
situation may also arise in the respiratory epithelium
(Reid, 1977). Certainly studies of the terminal bronchiolar
epithelium have suggested that functional non-ciliated
secretory cells, Clara cells, are the progenitor cell for
this region (Evans et al., 1978; Lum et al.. 1978). Evans
et al. in a detailed study using the electron microscope
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and tritiated thymidine labelling, also suggested that
there was a heterogenous population of Clara cells
consisting of 3 types:- Type A cells containing no
secretory granules and with or without profiles of smooth
endoplasmic reticulum; Type B cells with secretory
granules but no smooth endoplasmic reticulum and a dense
cytoplasm, and finally functional Clara cells with dense
secretory granules and profiles of smooth endoplasmic
reticulum. They suggested that Type A cells were Clara
cells minus secretory granules and that these were the
proliferative form of the Clara cells, and that Type B
cells were a transitional cell between Type A and Clara
cells, which because of their dense cytoplasm could be
confused with the serous cell.
Until a universal systematic form of lung cell
nomenclature has been adopted it is impossible to
distinguish fully between serous, intermediate, Type A
Clara and Type B Clara cells. Likewise, it is not possible
to speculate at the present time precisely which of these
cells responds to the isoprenaline and differentiates into
mucin synthesising goblet cells. This work needs to be
carried out using the electron microscope as it is only at
the ultrastructural level that subtle differences between
cell types can be detected. In addition, autoradiographic
studies using labelled mucin precursors could give useful
information about alterations in the pattern of mucin
\
synthesis and whether or not mature functional cells, such
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as ciliated cells, are able to switch on mucin synthesis
following isoprenaline.
5:55 The New Goblet Cells Arise Through Interference bv the
Isoprenaline with the Synthetic and Secretory
Processes of the Goblet Cell
There is no evidence as yet that epithelial goblet
cell secretion is influenced by either nerve stimulation or
a wide variety of drugs. The sub-mucosal bronchial glands
have, however, been shown to be under nervous control (Ueki
et al.. 1980; Peatfield and Richards, 1980; Davis et_al.,
1979; Davis et al.. 1979a; Ueki et al.. 1979; Gallagher
£i_a!., 1975 ; Florey £ ., 1932). In addition, a
variety of adrenergic agonists and antagonists and
cholinergic agonists and antagonists have been shown to
influence bronchial gland secretion (Phipps et al.. 1980;
Borson and Nadel, 1979; Whimster and Reia, 1973).
Gallagher et al. (1975) showed that in the cat neither
parasympathomimetic drugs, parasympathetic nerve
stimulation, sympathomimetic drugs or sympathetic nerve
stimulation had any effect on epithelial goblet cell
secretion.
If isoprenaline was simply inducing an increase in
mucin synthesis which was faster than the baseline rate of
mucin secretion then the number of full goblet cells would
increase. Consequently, using the light microscope and
mucin specific stains the number of goblet cells detected
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•would increase. However, the evidence of this study does
not support this hypothesis. Firstly, isoprenaline induces
a rapid 4-fold increase in respiratory goblet cells. If it
is doing this by increasing the mucin synthesis then it
follows that at any one time the number of empty or resting
goblet cells is three times greater than the number of full
goblet cells. That represents a very large reserve
population even taking into account the fact that mucus
production is a first line of defence within the
respiratory tract. In fact, the increase in mucus
following irritation is immediate and is more likely to
come from the more numerous glands than the scattered
populations of goblet cells. Secondly, the timing of the
goblet cell response has shown that the maximum increase
occurs between 24 hours and 48 hours after the isoprenaline
administration and that the increased numbers persist for
upwards of 2 to 8 weeks after cessation of the isoprenaline
administration. It is highly unlikely that isoprenaline
would affect mucin synthesis for upwards of 8 weeks after
it was last administered. As it is, the delay of 24 hours
before the maximum increase implies that rather more than
just mucin synthesis has occurred, indeed Neutra and
Leblond (1966) have shown that it takes just 4 hours for
goblet cells in the colon of the rat to absorb ^H-glucose,
incorporate it into mucin granules within the Golgi complex
and secrete the labelled mucin from the apex of the cells.
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Further work is required using radioactive mucin
precursors and the electron microscope to clear up the
question of whether or not isoprenaline has any effect on
the synthesis of mucin in goblet cells.
5:56 Summary
Isoprenaline induces a reproducible 4-fold increase in
goblet cells in the respiratory epithelium of the rat. The
source of the new goblet cells is as yet not known.
However, the evidence gained from this study does not
support the involvement of increased mitosis or a direct
effect on goblet cell mucin synthesis with or without any
effect on mucin secretion. Taking into account the size of
the response, the timing of the response and the diversiy
of cell types within the respiratory epithelium, many of
which have no obvious function, it is probable that
isoprenaline is inducing an alteration in the
differentiation pattern of the respiratory epithelium
leading to increased goblet cells. Due to the lack of
ultrastructural studies it is not possible to say which
cell or cells are being induced to synthesise mucin and
become goblet cells. Possible candidates include serous,
intermediate, ciliated and Type A and Type B Clara cells.
5:6 THE CLINICAL IMPLICATIONS OF THE FINDINGS
The primary clinical use of isoprenaline is as a
bronchodilator to relieve bronchoconstriction in asthma.
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Dosage is generally by aerosol as the hydrochloride or
sulphate and the recommmended adult dose is 1 - 3
inhalations of 80 ^ig repeated if necessary after 30 minutes
up to a maximum of 8 inhalations in 24 hours. A stronger
aerosol is available giving 400 jig and this can be used in
a similar manner up to a maximum of 8 inhalations in 24
hours (Martindale, 1977).
Asthma is only rarely fatal in its own right.
However, on the few occasions when sudden death has
occurred from status asthmaticus it has been possible to
study the pathological changes in the lung, due to the
asthma, uncomplicated by a superimposed respiratory
infection. The microscopic changes observed were that the
small bronchi (diameters 0.2 - 1 cm) were filled with plugs
of mucus and the bronchial epithelium mostly shed into the
lumen. However, where the epithelium remained intact it
showed extensive mucous metaplasia, the ciliated epithelium
being replaced almost entirely by goblet cells. Mucous
glands were also increased in numbers and size and their
lumens filled with thick mucus. Similar findings have been
found in chronic asthma, where the bronchial epithelium has
been shown to undergo almost total mucous metaplasia and
the lumens filled with tenacious mucus plugs (Spencer,
1977a).
Martindale (1977) states that sudden death caused by
overdosage and indiscriminant use of aerosols has been
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reported and self administered doses of up to 100 mg daily
have been observed. These deaths have been ascribed to
cardiac failure.
Although the isoprenaline-induced goblet cell hyper¬
plasia in the rat lung requires a single large systemic
dose of isoprenaline, it has been shown in this study that
a much smaller dose, i.e. 3.7 mg/kg administered daily for
10 days can also induce goblet cell hyperplasia. In
addition the nebuliser study (Chapter 4, experiment 11) has
shown that isoprenaline aerosol can induce goblet cell
hyperplasia in the rat lung when given as a single dose
over 45 minutes. The various methods used to determine the
final dose administered to the rats in this experiment
yielded conflicting results, however all the doses
calculated were considerably less than the systemic dose
(the actual range calculated being 2.15 mg - 658 jig per rat
for the higher concentration of 100 mg/ml and 516 jig -
162.4 jig per rat for the lower concentration of 10 mg/ml).
These doses, if correct, are well within the dosage range
of the metered dose inhalers in routine clinical use. It
would be interesting to speculate what effect long term
isoprenaline aerosol inhalation has on the goblet cell
population in the lungs of asthmatics, particularly those
that regularly overdose themselves. A prospective study in
which the lung pathology of asthmatics dying in
status asthmaticus after the introduction of aerosol
\
therapy was compared with the lung pathology of asthmatics
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dying in status asthmaticus before the use of aerosols may
yield some interesting information. Likewise, the use of
isoprenaline aerosols to relive constriction in chronic
bronchitis raises questions as to what effect the drug has
on the goblet cell population in their lungs. It is
interesting to note that in both asthma and chronic
bronchitis despite relieving the bronchoconstriction,
isoprenaline does not increase the pC^,
Could it be that
excessive mucous production is to blame for this? These
are interesting questions raised by the results of this
study and they should be answered before further
synpathomimetic-type aerosols are developed for use in




(1) A reproducible non-inflammatory and non-infective
model of goblet cell hyperplasia in the proximal airways of
the rat has been established. The agent employed to induce
the model was a single intra-peritoneal dose of 40 mg/kg
isoprenaline. This is the first time that a single-dose
pharmacological model of goblet cell hyperplasia has been
reported. The model has been studied . and
characterised. Thus, an optimum systemic dose has been
established along with the time at which the maximum
increase occurs. It has been shown that the response is
the same in both male and female rats and that is is not
influenced by either the time of injection or the time of
death and that it can be antagonised by propranolol.
Finally, it has been possible to induce a similar increase
in respiratory goblet cells with systemic salbutamol and
methoxamine and also with isoprenaline applied directly to
the respiratory epithelium.
Since the goblet cell hyperplasia occurs after a
single dose of isoprenaline the model can be used in con¬
junction with cell kinetic studies to study the origin of
the new goblet cells. Such studies have hitherto been
impossible as the previous animal models of goblet cell
hyperplasia have all involved either multiple exposures to
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irritants such as sulphur dioxide or tobacco smoke, or
multiple doses of isoprenaline. The model can also be used
in conjunction with radioactive labelled mucin precursors,
administered in vivo, to study the pattern of mucin
synthesis and secretion in respiratory goblet cells.
(Z) The evidence gathered in the course of this study supports
both the involvement of a fundamental pharmacological
interaction with ^-adrenoceptors and also the involvement of
some non-specific, metabolic, biochemical or humoral effect.
Further work is required with ^3-and =»c - antagonists before a
more definite conclusion can be drawn.
(3) The origin of the new goblet cells is unknown;
however, the involvement of mitosis is unlikely due to the
rapidity of the response. It is probable that isoprenaline
is stimulating the differentiation of a precursor cell
population into goblet cells. Future studies, such as
differential cell counts using the electron microscope, and
autoradiographic studies with radioactively labelled mucin
precursors, which would also require the use of the
electron microscope, are needed before it can be
ascertained from which cell or cell types the new goblet
cells are derived.
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(4) The difficulties encountered with the histological
techniques available at the present moment have highlighted
the need for a new embedding medium which is compatible
with both light microscopic and electron microscopic
studies. One of the most serious drawbacks of the existing
embedding media was the length of time required to process
the tissue and the labour intensive nature of the section
cutting. As a consequence, an attempt was made to develop
a fast screening technique which would facilitate the quick
assessment of the tracheal goblet cell population. The
tracheal dab technique has shown potential for this,
however, it requires considerably more work to characterise
it more fully, in particular to minimise the inherent
variability of the preparation.
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CHAPTER 7
PROPOSALS FOR FUTURE WORK
(1) Further studies are required with a wider range of
sympathomimetic drugs to see which, if any, are also
capable of inducing goblet cell hyperplasia.
(2) As stated earlier, the fundamental biochemical event
which follows ^-adrenoceptor stimulation is an increase in
intracellular c-AMP levels. This is caused by the
stimulation of the enzyme adenyl cyclase which is
responsible for the synthesis of c-AMP. Intracellular c-
AMP can also be increased by the inhibition of phosphodi¬
esterase, the enzyme responsible for the breakdown of c-
AMP. It would be interesting to see what effect phosphodi¬
esterase inhibitors had on the goblet cell population and
also whether or not they had any effect on the
isoprenaline-induced goblet cell hyperplasia.
(3) Further inhalation studies using nebulised
isoprenaline are required. However, the system employed
will have to be very thoroughly characterised in advance in
order that the dose administered can be accurately guaged.
(4) Differential cell counts are required on the early
stages of the response during the period of maximum change
in the epithelial cell population. This would have to be
carried out using the electron microscope and may shed some
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light on the origin of the new goblet cells.
(5) The single dose model could be utilised for in vivo
cell kinetic studies, using ^H-thymidine, to find out what
role, if any, mitosis plays in the formation of the new
goblet cells.
(6) Likewise, the model could be exploited to study
in_viv£t with the aid of radioactive labelled mucin
precursors, the possible effect isoprenaline may have on
their pattern of uptake, incorporation and discharge from
goblet cells. It may be possible to see changes in uptake
using GMA and the light microscope, but use of the electron
microscope would yield more detailed information about
their incorporation and discharge.
(7) A small study in which radioactive labelled
isoprenaline was administered intraperitoneally followed by
autoradiography in GMA would show if any actually reaches
the respiratory epithelium following this route of
administration.
(8) Likewise, administration of labelled isoprenaline by
intratracheal injection, followed by autoradiography would
yield interesting data about its absorption and fate in the
respiratory tract. A similar study with labelled
isoprenaline aerosol would yield valuable information about
its pattern of deposition and fate in the respiratory
tract; however, such a study would require very stringent
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safety precautions because of the radioactive mist which
would be generated.
(9) Further work is required to develop the histological
techniques necessary for many of these future studies. In
particular, large, thin, araldite sections of an adequate
quality are still not possible using the Autocut and large
glass knives. Since in many of the proposed studies it
would be imperative to study the same area using first the
light microscope to count goblet cells, and then secondly
the electron microscope for differential cell counts, an
embedding medium compatible with both is required.
Araldite is the best that we have available at the moment
and this has been shown to have many disadvantages in this
study. However, intensive work using the Autocut and large
glass knives may yield a workable solution to the problem
of obtaining large thin sections.
Quantitative electron microscopic studies of the
respiratory epithelium would also require the adaptation of
existing techniques to overcome the problems of sampling
and orientation.
Finally, further work is required on the tracheal dab
technique so that the fast screening of a wide range of
drugs can be carried out.
(10) Goblet cells occur in almost all mucosal membranes and
are therefore widely distributed throughout the body. In
particular, large numbers are found in the alimentary
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canal. Further studies to see what effect isoprenaline has
on goblet cells elsewhere in the body would be particularly
interesting, since, if it can be shown that the
isoprenaline effect occurs in several goblet cell
populations, it would be indirect evidence that the
mechanism involved may be part of the overall physiological
control of the goblet cell population.
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APPENDICES
APPENDIX i
DEVELOPMENT OF A SCREENING TECHNIQUE FOR THE FAST
ASSESSMENT OF GOBLET CELL NUMBERS
The number of goblet cells in rat and human trachea
increases from the caudal to the distal end of the trachea
and in addition there are higher numbers of goblet cells
present on the anterior (cartilagenous) surface than on the
posterior surface with no cartilage. This fact makes
quantitation of the goblet cell population tedious although
the problem can be overcome by careful sampling. One
existing method for studying the distribution of goblet
cells is to embed the whole of the trachea opened and flat,
and to cut serial sections longitudinally from one side to
the other and count the cells. This is too time consuming
for a screening test. Another method is to cut the trachea
in the coronal plane at predetermined anatomical sites and
count the goblet cells occurring in a set number of
sections. Dr A. Adams of the Department of Ophthalmology,
Edinburgh University has developed a simple technique for
studying conjunctival mucus layer patterns and goblet cell
distribution by dabbing the conjunctival surface with a
Millipore filter (Adams, 1979). The tracheal dab technique
is an adaptation of his method.
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TRIAL PREPARATION A: EN FACE WHOLEMOUNT PREPARATION OF
LUNG BRONCHIAL TREE
Prior to discussions with Dr Adams, attempts were made
to develop a screening technique using the whole lung.
Preliminary work succeeded in clearing a lung tissue block
in which a 'gutter' comprising the bronchial tree, cut in
longitudinal section, had been stained using PAS. The lung
was fixed and sectioned longitudinally in such a way that
almost all the bronchial tree was exposed as a 'gutter'.
The epithelium was carefully painted first with periodic
acid and then with Schiff reagent with minimal spillage
over the rest of the lung tissue. Methyl salicylate was
used as a clearing agent. It was then possible to
visualise and count discrete PAS stained magenta dots
dispersed throughout the bronchial tree using a dissecting
microscope with a long working distance. However, this
method was not pursued further as the preparation did not
keep long before going completely dark and thus became
unusable.
Comment
This preparation has potential for studying goblet
cell numbers in the lung. However, it will not be possible
to count any other cell types, and numbers will have to be
large as the size of the goblet cells themselves will be
critical to the number detected, thus leading to increased
\
variability in small groups.
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TRIAL PREPARATION B: TRACHEAL DAB TECHNIQUE USING
MILLIPORE FILTERS
In essence, fresh tracheas were dissected into two
halves, a front half with the semi-circular cartilage
rings, and a back half consisting of muscle. The length
used was the entire distance between the ring immediately
below the larynx and the cartilage ring immediately above
the carina. A careful note was made of the top and bottom
of each half (very important when quantitation is
performed) and an imprint was made of the tracheal mucosa
from each half on separate pieces of Millipore filter
attached to microscope slides. The imprints were fixed in
Millonig's fixative for 2-3 minutes, dried thoroughly and
then stained wih PAS. Each imprint was trimmed, cleared in
xylene and mounted in xylene-based coverbond on a con¬
ventional microscope slide.
The initial results were very promising (Figure 29).
Impressions of the whole of the tracheal sections were
obtained in which it was easy to see the placing of the
cartilage rings. By varying the pressures used and
employing various pretreatments, it was possible to
demonstrate numerous discrete highly PAS positive dots
interspersed by occasional mucous strands and sheets of
epithelial cells. There is still some doubt as to whether
the technique is able to demonstrate part or all of the
available goblet cell population. Confirmation is also
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FiqgftS 29
Example of the tracheal dab technique. Stained with
PAS and x40 magnification. The PAS positive dots are
goblet cell thecae and just discernable are sheets of
epithelial cells which have not taken up the stain.
FIGURE 29-
required as to whether the PAS stained dots actually
represent the mucin-filled thecae of epithelial goblet
cells. There are three possible ways this can be tackled:
(a) By embedding the remains of the trachea after the
imprints have been taken. Sections taken
longitudinally down the length of the tracheas should
indicate how far the epithelium was penetrated. If
the epithelium is denuded of goblet cell mucous blebs
then the imprints almost certainly show goblet cells.
(b) Using large groups of animals it may be possible to
compare results obtained from tracheas sectioned in
the usual manner with those obtained from tracheal
dabs. In addition, if the groups of animals receive
different treatments beforehand, i.e. saline and
40 mg/kg isoprenaline, it may be possible to
demonstrate a similar percentage increase in tracheal
goblet cells using the two methods. This would lend
support to the idea that the tracheal dab technique is
capable of detecting changes in the goblet cell
population and the difference detected using the two
methods would give some idea as to the sensitivity of
the dab technique.
Alternatively, a comparison could be made between
tracheal goblet cell counts using dabs, with results
obtained for bronchial goblet cell counts from plastic
lung sections, following both saline and 40 mg/kg
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isoprenaline. If both methods were to detect an
increase in goblet cells then this would be
circumstantial evidence that the dab technique is
demonstrating tracheal goblet cells.
By comparing counts obtained using scanning electron
microscopy of the tracheal mucosa with those obtained
using the dab method. It was felt that this was not
worth following up as using the SEM it is only
possible to obtain an idea of the ratio of the areas
of non-ciliated cells to ciliated cells. It is not
yet possible to distinguish the different non-ciliated
cell types using the SEM, and therefore the two
techniques are not measuring the same thing.
However, specimens of normal trachea and tracheas
which had been used for dab preparation were examined
using a scanning electron microscope. The latter
showed areas of flattened and damaged epithelium
denuded of cilia and non-ciliated cells, and also
areas of relatively normal epithelium with cilia and
non-ciliated cells. It is therefore a rather patchy
preparation. However, it is not known whether or not
the non-ciliated cells which remained were goblet
cells or serous, Clara or intermediate cells. Figure
29 shows a fairly even distribution of goblet cells
with no large empty patches and it may be that the
Millipore filter removes the mucin-filled thecae
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without necessarily removing the rest of the tracheal
epithelium.
QUANTITATION OF TRACHEAL DABS
Using a graticule with a small square of known
dimensions it was possible to assess goblet cells per unit
area. However, this has the disadvantage of only covering
a very small area of the whole and so an investigation was
carried out to determine the minimum number of squares it
was necessary to count and the area from which they would
be taken in order to obtain a reliable and representative
number of goblet cells.
As the number of goblet cells varies over the surface
of the trachea; they tend to be in clusters and occur more
frequently over the cartilage rings in the anterior mucosal
surface than in the areas between the rings, and as a whole
their numbers increase from the larynx to the carina;
there are several different methods by which quantitation
could be performed. The results of several methods tried
so far are shown below, others are still being assessed.
Method (a) : An arbitrary area was marked on the slide at
the lower 3-4 mm of the trachea. It contained a minimum
of 4 cartilagenous rings and 4 areas between the cartilage
rings. Counting was carried out using a x40 objective and
a graticule containing a small square measuring 53.3 x
53.3 p. This was moved across the trachea in lines
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running parallel to the rings; thus the square travelled
from one side of the trachea to the other. Having
completed one line of counting, the stage was moved to a




In practice it proved very difficult to keep the areas
of cartilage and non-cartilage equal. The results can be
seen in Table 7.
Method (b): A similar arbitrary area was marked as in the
previous method. This time, however, the line of counting
travelled at right angles to the cartilage rings. The area
covered was as near as possible to the centre of the





The results can be seen in Table 7.
Results
Method (a) Mean goblet cells/square 2.48 SD 0.2 SE 0.047
Method (b) Mean goblet cells/square 2.18 SD 0.026 SE 0.0086
From Table 7 it can be seen that Method (b) gave a
reasonably consistent value for goblet cells once 90 - 100
squares had been counted. Method (a), however, gave more
variable values and still had not reached consistency after
counting 200 squares. Therefore, for consistency and
convenience Method (b) is the method of choice.
The two methods give reasonably comparable mean
values; however, method (a) gave a slightly higher value
than method (b). A combination of factors may account for

























COMPARISON OF COUNTING TECHNIQUES FOR THE
TRACHEAL DAB PREPARATION
Squares Average Number of Goblet Cells/Square









































keep the areas counted over cartilage rings and areas
between them equal. There was also the added problem of
the area to be counted extending to the rather ill-defined
edges of the preparation. Generally, it was observed that
the areas at the edge which corresponded with the cut end
of a cartilage ring were better defined and the resulting
dab more complete than corresponding areas obtained between
the rings. This is partly due to the fact that the trachea
is not flat, and the presence of the cartilage underneath
the mucosa makes it slightly raised, whilst the areas in
between are slightly depressed. The pressure of contact
between the filter and the mucosa is therefore probably
better over the cartilage rings than elsewhere. Similarly,
as the trachea is circular and the cartilage gives the
anterior surface a semi-circular shape, even contact over
the whole surface is difficult. The dabs were taken with
sufficient downward pressure of the filter to flatten the
trachea and in so doing the extreme edges become blurred
whilst the central areas give very good results. In method
(b) it was the better central area which was used for
counting, and since this gives nearly equal reproduction of
the mucosa both over the cartilage and in between, the
areas of each from which goblet cell numbers were
determined were more likely to be equal. The slightly
higher value obtained from method (a) can be explained by
taking into account all of the above factors, the main
reason probably being that since the mucosal reproduction
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was better and wider over the cartilage rings than over the
non-cartilage areas, more was counted from these areas. In
Table 7, the periodicity of goblet cell numbers as they
rise and fall, depending on whether the area counted was
overlying a cartilage ring or not, can be clearly seen.
Obviously, counting 200 squares using a x40 objective
is tedious and requires a lot of time. The primary
interest was to see if the preparation could be used as a
fast screening technique for goblet cell population
fluctuations and consequently further methods of
quantitation were investigated to see if a shorter method
could be found.
Since the imprints were obviously 'patchy' in their
effectiveness in lifting off goblet cells, a study was
carried out to investigate the result of only counting the
better areas and ignoring the poorer areas completely. The
best areas were always found in the centre of the cartilage
rings and these were used for quantification as follows:
Method (i) Using the x40 objective and the larger
square in the graticule counts were made
along the centre of each of the four lowest
cartilage rings.
Method (ii) Using the x40 objective and the smaller
square in the graticule counts were made
along the centre of each of the four lowest
cartilage rings.
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Method (iii) Using the x25 objective and the photographic
square in the photography graticule counts
were made along the centre of the rings in
the lower region of the trachea (i.e. the
four lowest cartilage rings.
Method (iv) Using the x25 objective and the photographic
square in the photography graticule counts
were made from the two 'best' squares
present in the lower region of the trachea
(i.e. the four lowest cartilage rings).
Methods (iv) and (v) were as in (i) and (ii) but using the
x6.5 objective.
Method (vi) An independent observer counted the same two
rings as myself using a x25 objective and
the photographic square. They also recorded
the best two squares from these rings.
The results for methods (i) and (ii) are shown in
Tables 8 and 9. It is evident that with a x40 objective
and the larger of two graticule squares the results a-re
highly variable. However, with the smaller square at the
same magnification the results for each ring reached
consistency once 10 - 15 squares had been counted.
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TABLE 8 RESULTS OF QUANTITATION METHOD (i)
Ring No. Number of Squares Average Number of Goblet Method
Counted Cells per Square (i)




























TABLE 9 RESULTS OF QUANTITATION METHOD (ii)
Ring No. Number of Squares Average Number of Goblet Method
Counted Cells per Square (ii)
























The results for method (iii) are shown in Table 10.
The results show fairly consistent numbers although this is
not as good as with method (ii).
Methods (iv) and (v) were totally unsatisfactory as
the magnification was too low. Method (iii) was preferred
to method (ii) as it was felt that the x25 objective gave a
more suitable magnification than did the x40 objective.
The latter, it was felt, was too high a magnification, and
the ease of picking out the goblet cells was greater with
the x25 objective. Accordingly reproducibility by an
independent observer was carried out at this power. The
results are shown in Table 11 [Method (vi) ]. It is evident
that in some instances we agreed very closely with each
other, in others we differed by so large an amount that it
cannot be ignored. Occasionally, this could be explained
by either one or other continuing to count areas which the
other had rejected as too poor. Also, included in Table 11
are the results of the 'best' two squares by the two
observers. None of these correspond very closely and it is
obvious that two squares are not sufficient. Further work
is required particularly in deciding the criteria for which
areas should and should not be counted.
In conclusion, therefore, the tracheal dab technique
provides a fairly quick and easy source of material for the
assessment of tracheal goblet cell populations.
Unfortuntely, owing to the patchy nature of the imprints
sometimes obtained, quantitation has to be carried out over
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TABLE 10 RESULTS OF QUANTITATION METHOD (iii)
Ring No. Number of Squares Average Number of Goblet Method
Counted Cells per Square (iii)






































REPRODUCIBILITY OF GOBLET CELL ASSESSMENT
BETWEEN TWO INDEPENDENT OBSERVERS
Mean Goblet Cells/Square Best 2 Squares
(Results of Best 2 Rings
Contained)
DL MB DL MB
37.7 39.1 59 and 46 121 and 126
54.3 54.4 69 and 64 95 and 83
26.6 26.7 92 and 62 72 and 100
35.3 18 67 and 83 85 and 77
16 24.5 43 and 25 51 and 51
32.9 55.7 42 and 31 52 and 69
37.9 22.3 70 and 70 86 and 83
47.1 70.5 65 and 61 83 and 67
56.6 66.5 76 and 67 74 and 99
36.6 18.7 46 and 44 41 and 28
47.6 53.8 59 and 59 72 and 73
20.5 19.4 23 and 27 20 and 25
29.4 23.9 64 and 67 57 and 45
a very wide area of the sample and this, of course, takes
time. It also necessitates large groups of animals to
combat the subsequent within-group variation. As a
technique, however, it definitely has potential,
particularly for obtaining information much more quickly
than by conventional histology. The problems of
quantitation require further study, and unfortunately it
has not been possible to do more in the course of this
study. The preparation has proved remarkably stable on
storage, and the material collected here is still usable
despite, in some instances, being two years old, and thus
is available for further study.
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APPENDIX ii
OBSERVATION OF HEART RATE AND BLOOD PRESSURE:
RESPONSES TO VARIOUS DRUGS IN CONSCIOUS CATHETERISED RATS
Objectives
Owing to the very high doses of isoprenaline employed
there was some doubt as to whether the dose of propranolol
which antagonised the goblet cell response was also capable
of antagonising the systemic pharmacological actions of
isoprenaline namely, increased heart rate and decreased
blood pressure. This experiment was designed to answer
this question using catheterised rats from which heart rate
and blood pressure could be continuously recorded.
Experimental details
Rats were fitted with carotid artery catheters, under
general anaesthesia using the method of Popovic and Popovic
(1960). The animals were allowed to recover from the
operation for two full days and were used for the
experiment in the third post-operative day.
To make recordings animals were restrained two at a
time in perspex tubes, the carotid cannula was then
connected to a pressure transducer using polythene tubing.
Once the catheter had been flushed out with heparinised
saline it was possible to obtain readings for the blood
pressure on a Devices 2-channel recorder linked to the
185
pressure transducer. The pulse thus detected was used to
trigger a rate-meter which then gave a reading for heart
rate. The animals were left in the tubes, undisturbed,
long enough to reach a 'steady' pulse and blood pressure,
this was taken as a control resting value. Those rats with
high resting heart rates, i.e. greater than 450 beats per
minute were not used for the experiment. Having obtained a
resting heart rate the animal was disconnected from the
pressure transducer and removed from the plastic tube. It
was then given one of several possible drugs
intraperitoneally and either replaced immediately in the
tube and reconnected to the pressure transducer or, as in
the case of propranolol, put in a cage for 35 minutes
before receiving isoprenaline intraperitoneally and then
immediately reconnected to the pressure transducer.
Animals remained in the tube and connected to the
pressure transducer throughout the first 30 minutes of
recording. They were then removed from the tube and placed
in a cage. For subsequent readings animals were taken from
the cage, placed in the tube and connected to the pressure
transducer and allowed 10 minutes to reacclimatise before
taking the next reading. In this way the animals were not
too distressed by being confined within a perspex tube for
too long a period of time.
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The drugs treatments tested were as follows:
Rat 1 40 mg/kg isoprenaline IP
Rat 2 40 mg/kg isoprenaline IP. This animal died.
Rat 3 40 mg/kg isoprenaline IP
Rat 4 40 mg/kg Clenbuterol IP
Rat 5 Saline 0.5 ml IP
Rat 6 Saline 0.5 ml IP
Rat 7 50 mg/kg propranolol IP followed by 40 mg/kg
isoprenaline IP 35 minutes later. This rat did
not show signs of being greatly depressed after
the propranolol and did not exhibit signs of MSA
as judged by a normal heart rate 35 minutes after
the propranolol had been administered.
Rat 8 50 mg/kg propranolol IP followed by 40 mg/kg
isoprenaline IP 35 minutes later. This rat was
extremely depressed following the propranolol.
It was catatonic and the heart rate was so low
that it was impossible to trigger a recording on
the Devices recorder even after the admini¬
stration of isoprenaline.
Rat 9 50 mg/kg propranolol IP followed by 40 mg/kg
isoprenaline 35 minutes later. This rat was also
catatonic following the propranolol and showed
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signs of MSA (membrane stabilisation activity) as
judged by a very low heart rat at 35 minutes.
However, it was possible to obtain a few readings
from this rat after it had received the
isoprenaline before the signal became too weak to




These are shown in Figures 27 and 28. The results for
the two rats receiving 40 mg/kg isoprenaline were pooled
together to give an average result for each reading as were
those of the two saline controls. Control heart rate
remained reasonably steady throughout the 6 hours of the
experiment, the range being from 350 - 450 beats per
minute. Likewise control blood pressure showed very little
variation, the range being from 100 - 130 mm Hg. 40 mg/kg
isoprenaline on its own induced a rapid increase in heart
rate from a resting level of 420 beats per minute to 545
beats per minute; during the following 6 hours heart rate
gradually fell to 455 beats per minute. Clenbuterol, a
selective p2_a^renocePtor agonist, also induced a rapid
increase in heart rate from a resting value of 380 beats
per minute to 505 beats per minute. However, unlike
isoprenaline which took 6 hours to regain control values,
Clenbuterol regained control heart rate by 50 minutes. 40
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FIGURE 27
Showing the effects of 40 mg/kg isoprenaline and 40
mg/kg clenbuterol and 0.5 ml saline on heart rate
in vivo in rats. Also shows are the effects in two
rats of 50 mg/kg propranolol on the changes in heart
rate produced by 40 mg/kg isoprenaline in vivo. In
the rat receiving propranolol and isoprenaline and
which did not exhibit symptoms of MSA (membrane
stabilising activity) propranolol has failed to
antagonise the isoprenaline induced increase in heart
rate: represented by a ▲ prop + isop (no MSA).
In the rat which did exhibit symptoms of MSA,
confirmed by the drop in heart rate 35 minutes after
receiving the propranolol (P35), propranolol was
partially inhibited the isoprenaline induced increase
in heart rate: represented by A prop + isop
(with MSA).
Saline n = 2
Isoprenaline 40 mg/kg n = 2
Clenbuterol 40 mg/kg n = 1
50 mg/kg propranolol + 40 mg/kg isoprenaline (- MSA)
n = 1
50 mg/kg propranolol + 40 mg/kg isoprenaline (+ MSA)
n = 1















mg/kg isoprenaline also produced a rapid decrease in blood
pressure, from a resting value of 112 mm Hg to 72 mm Hg,
thereafter during the following 6 hours the blood pressure
remained at the same low level and was still only 77 mm Hg
at 6 hours, well below the control value of 120 mm Hg.
Clenbuterol produced a slightly slower decrease in blood
pressure from 140 mm Hg to 75 mm Hg and at 50 minutes the
blood pressure was 75 mm Hg, well below the control level
of 110 mm Hg.
Of the two rats receiving 50 mg/kg propranolol prior
to receiving 40 mg/kg isoprenaline, from which successful
recordings were obtained, one had MSA and one did not. In
the rat without MSA propranolol reduced the resting heart
rate from 425 beats per minute to 355 beats per minute,
whilst in the rat with MSA it fell from 425 beats per
minute to 230 beats per minute. In neither rat did
propranolol effect the blood pressure. When isoprenaline
was administered to the rat without MSA it produced a rapid
increase in heart rate which was only slightly lower than
that of the isoprenaline controls. During the subsequent 6
hours the heart rate in this rat showed a very similar
pattern to that of the isoprenaline controls. The
propranolol in the absence of MSA had not therefore
antagonised the heart rate effect of the isoprenaline.
Similarly, in the rat without MSA, propranolol had no
effect on the blood pressure response to isoprenaline.
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FIGURE 28
As for Figure 27 but showing the corresponding effects
on blood pressure in the same rate. Propranolol wih
or without MSA has had no effect on the isoprenaline
induced decrease in blood pressure.
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However, in the rat with MSA isoprenaline appeared to
produce only a transient increase in heart rate from 210
beats per minute to 360 beats per minute and at 15 minutes
the heart rate had again fallen to 295 beats per minute, at
which point recording ceased. The propranolol in
conjunction with MSA had therefore inhibited the
isoprenaline heart rate response. However, propranolol
again had no effect on the blood pressure response to
isoprenaline even in the presence of MSA.
Conclusions
This experiment has shown that in some rats 50 mg/kg
propranolol IP can produce a marked degree of membrane
stabilisation. This means that in addition to its actions
as a p-adrenoceptor antagonist, it is acting as a powerful
local anaesthetic. It is therefore inhibiting a great deal
of the normal nerve impulse traffic and electrophysio¬
logical activity throughout the body. It is interesting
that in the presence of MSA propranolol appeared to inhibit
to some extent the effects of isoprenaline on heart rate
whilst not affecting its effects on blood pressure. The
former is due to ^-adrenoceptor stimulation in the heart
whilst the latter is due to ^2~a<3renoceptor stimulation in
the smooth muscle of the peripheral vasculature. The
positive chronotropic and inotropic effects on the heart,
of isoprenaline, are dependent on an efficient conducting
system within the myocardium; in particular the sinu-
190
atrial node, the Purkinje tissue, the bundle of His and the
atrioventricular node (Keele and Neil, 1971). All of these
specialised conducting tissues will have been subjected to
membrane stabilisation by the propranolol and this in turn
will prevent the isoprenaline from having any effect on
heart rate. However, ^"^renoceptor s are not innervated
and bring about relaxation of the muscle by means of
increased intracellular levels of c-AMP. Thus, the effect
of isoprenaline on blood pressure, not being dependent on
electrophysiological phenomena, is unaltered by the
existance of MSA.
The relationship between the presence of MSA and the
antagonism of the i soprenaline-induced goblet cell
hyperplasia is not known. Further work is required to
study the cardiovascular effects in greater detail and also
to see if in the absence of MSA propranolol is capable of
antagonising the goblet cell response. In all of the
experiments to date, animals exhibiting signs of MSA were
assigned to a group receiving isoprenaline whilst those not
exhibiting signs of MSA were used as propranolol controls.
The propanolol control group therefore generally consisted
of mainly depressed (MSA) rats with a few non-MSA rats,
whilst the propranolol versus isoprenaline groups generally
consisted of only those animals with MSA.
In the light of the evidence so far, it is probable
that the propranolol antagonism of the isoprenaline-induced
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goblet cell hyperplasia is due to its membrane
stabilisation activity and not just competition for the p-
adrenoceptors, since the studies on blood pressure have
shown that propranolol was unable to block the isoprenaline
induced fall in blood pressure.
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APPENDIX iii
CALCULATIONS FOR THE ATMOSPHERE CONCENTRATIONS DURING
THE NEBULISER STUDY DATED 1.5.80 CTL, ICI: EXPERIMENT II
1st Run
Five rats exposed to solution containing Saline and
10~^M ascorbic acid.
Flow rate of compressed air (saturated) was 6 1/min
Outflow with chamber was 10.5 1/min
Total atmosphere sample taken at 2 1/min for 15 mins
Total exposure time = 45 mins
Wet filter weight = 0.01891 g post dry wt. = 0.01445 g
Pre-dry weight = 0.01434 g pre-dry wt. = 0.01434 g
Gain net weight = 0.00457 g Gain in dry solid = 0.00011 g
2nd Run
Five rats exposed to solution containing 100 mg/ml
isoprenaline, 10~^M ascorbic acid in physiological saline.
Solution contained the following solids in 1 ml:
1.98 mg ascorbic acid
9.00 mg NaCl
100.00 mg isoprenaline
Total solids in 1 ml = 110.98 mg
% of total solids = isoprenaline = —4^— x 100 = 90 .1%* 100.98
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Flow rate of compressed air (saturated) was 6 1/min
Outflow into chamber was 10.5 1/min
Total atmosphere sample 1 taken at 2 1/min for 10 mins
Anderson sampler used at 1.41 1/min for 15 mins
Total atmosphere sample 2 taken at 2 1/min for 5 mins
Total exposure time = 45 mins
Solution used during exposure = 15 - 12.5 ml = 2.5 ml/45 mins
Calculations
(i) Total atmosphere sample 1 collected 0.0005 g total
solids (dry wt.)
.*. 0.5 mg were collected in 20 1 in 10 mins
.*. Total atmosphere conc. filter 1 = 0.025 mg/1
= 25 pg/1 solids
Now 90.1% solids = isoprenaline = 22.53 pg/1 iso-
prenaline conc.
Assuming rat minute volume = 500 ml/min
Then each rat received 11.26 pg/min/rat isoprenaline
.*. In 45 mins exposure each rat received 506.7 pg
isoprenaline.
(ii) Total atmosphere sample 2 collected 0.00045 g total
solids (dry wt.)
.*. 0.45 mg were collected in 10 1 in 5 mins
.*. Total atmosphere conc. filter 2 = 0.045 mg/1
= 45 pg/1 solids
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Now 90.1% solids = isoprenaline = 40.55 pg/1 iso-
prenaline
Assuming rat minute volume = 500 ml/min
Then each rat received 20.275 ^ag/rat/min isoprena¬
line
.*. In 45 mins exposure each rat received
912.4 jag/rat isoprenaline
If we average total atmosphere conc. from filters 1
and 2 we get the following dose:
Filter 1 TA concn. = 25 |ig/l
Filter 2 TA concn. = 45 pg/1
Average TA concn. = 35 jig/1 (90.1% isoprenaline)
.♦. per rat per min >55 x 50o = 15.775 ^ag/rat/min
isoprenaline
.*. In 45 mins exposure each rat received
709.8 rat isoprenaline
(iii) Anderson sampler. 1.4 1/min for 15 mins = 21 1.
plate 1 + 0.00011 g
plate 2 - 0.00009 g
plate 3 + 0.00065 g
plate 4 + 0.00059 g





^21^* = 0*^0524 mg/1 plate 1
0-^5- = 0 .03095 mg/1 plate 3
= 0.028095 mg/1 plate 4
= 0.04190 mg/1 plate 5
Total solids in 1 litre = 0.1619 mg
However, only 90.1% total solids = isoprenaline
.*. Isop. collected in 1 litre = 0.09568 mg/1
Assuming rat minute volume of 500 ml/min
Each rat received 0.04783 mg/isop/min/rat
In 45 mins exposure total dose of isoprenaline
received = 2.1523 mg isop/rat.
(iv) Weight loss from bottle
Solution used =2.5 ml/45 mins
= 3.333 ml/hr
Generation rate into box = 10.5 1/min
= 630 1/hr
Total solids in 1 ml solution = 110.98 mg
.*. In 3.333 ml solids = 3.69.89 mg
.*. Atmos. concn. = = 0 .5 871 mg/1
Now 90.1% solids = Isoprenaline
.*. Total concn. of isoprenaline in atmosphere
= 0.529 mg/1
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Assuming minute volume of rat = 500 ml/min
Then dose to rat = 0.2645 mg/min/rat
.*. In 45 mins total exposure dose received =
11.90 mg/rat/isop.
3rd Run
Five rats exposed to solution containing 10 mg/ml
isoprenaline, 10~^M ascorbic acid and physiological saline.
Solution contained following solids in 1 ml:
10 mg isoprenaline
1.98 mg ascorbic acid
9.0 mg NaCl
Total solids in 1 ml = 20.98 mg
% total solids = isoprenaline = .x 100 = 47 .61%
20.98
Flow rate of compressed air (saturated) = 6 1/min
Outflow into chamber was 10.5 1/min
Total atmosphere sample 4 taken at 2 1/min for 15 mins
Anderson sapler used at 1.4 1/min for 15 mins
Total atmosphere sample 5 taken at 2 1/min for 11 mins
Total exposure time = 45 mins
Solution used during exposure = 15 - 11.2 ml = 3.8 ml/45 mins
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Calculations
(i) Total atmosphere sample 4 collected 0.00046 g in
15 mins
0.46 mg were collected in 30 1 in 15 mins
.*. Total atmosphere concn. filter 4 = 15.33 jug/1
solids
Now 47.61% solids = isoprenaline = 7.298 Jjg/1 iso-
prenaline
Assuming rat minute volume = 500 ml/min
Then each rat received 3.649 ^ag/min isoprenaline
Therefore in 45 mins exposure each rat received
164.21 ^pg/rat isoprenaline
(ii) Total atmosphere sample 5 collected 0.00033 g in
11 min dry solids
.*. 0.33 mg were collected in 22 1 in 11 mins
.*. Total atmosphere conc. filter 5 = 0.015 mg/1
= 15 jug/1 solids
Now 47.6% solids = isoprenaline = 7.14 |ig/l
isoprenaline
Assuming rat minute volume = 500 ml/min
Then each rat received 3.57 ^jg/min isoprenaline
Therefore in 45 mins exposure each rat received
160.65 ug/rat isoprenaline
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If we average Total Atmosphere concn. from filters 4
and 5 we get the following dose:
Filter 1 TA concn. = 15.33 jig/1
Filter 2 TA concn. = 15.00 jig/1
Average TA concn. = 15.165/1 (47.6% isoprenaline)
.*. per rat per min 7^218 x 500 = 3.609 ^pg/min/rat
.*. In 45 mins exposure each rat received
162.42 yug/rat/isoprenaline
(iii) Anderson sampler. 1.4 1 for 15 mins = 21 1 total
volume.
plate 1 + 0.00024 g
plate 2 + 0.00012 g
plate 3 - 0.00001 g
plate 4 + 0.00019 g
Filter + 0.00037 g
wt. collated = atmos> concn. (mg/1)
Total volume
.-. £^1 _ 0.01143 mg/1 plate 1
= o.Ol mg/1 plate 2
= 0.009048 mg/1 plate 4
= 0 .01762 mg/1 plate 5
Total solids in 1 litre = 0.048095 mg
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However only 47.6% total slids = isoprenalne
Isoprenaline collected in 1 litre = 0.02289 mg/1
Assuming rat minute volume of 500 ml/min
Each rat received 0.01146 mg/min isoprenaline
.*. In 45 mins exposure total dose of isoprenaline
received = 0.5157 mg/rat isoprenaline
Weight loss from bottle
Solution used = 15 - 11.2 ml = 3.8 ml in 45 mins
= 5.066 ml/hr
Generation rate into box = 10.5 1/min
= 630 1/hr
Total solids in 1 ml solution = 20.98 mg
.*. In 5.066 ml solids = 106.285 mg
.*. Atmos. concn. = ^.0^285 = 0.1687 mg/1 solids
Now 47.6% solids = isoprenaline
.*. Concentration of isoprenaline in atmosphere =
0.0801 mg/1 isoprenaline
Assuming minute volume of rat = 500 ml/min
Then dose to rat = 0.040203 mg/min/rat
.*. In 45 mins exposure total dose received
1.809 mg/rat isoprenaline
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Total Atmos. Sample 1
Total Atmos. Sample 2
Average
Anderson Sampler
Weight loss from bottle
22.53 pg/l isop. =
40.55 pg/l isop. =
= 31.54 pg/l isop. =
95.68 pg/l isop. =
0.529 mg/1 isop. =
506.7 pg/rat/45 mins
912.4 pg/rat/45 mins




Total Atmos. Sample 1
Total Atmos. Sample 2
Average
Anderson Sampler
Weight loss from bottle
Atmos. concn.
7.298 pg/l isop. =
7.14 pg/l isop. =
= 7.218 pg/l isop. =









Characteristics of Anderson Impaction Sampler
Plate 1 traps particles > 5.5 pm
Plate 2 traps particles 5.5 - 3.5 pm
Plate 3 traps particles 3.5 - 2.0 pm
Plate 4 traps particles 2.0 - 0.3 pm
Filter 5 traps particles < 0.3 pm
Deposition characteristics of aerosol particles
For particles > 5 pm 50% deposits in nose, the rest in URT.
For particles < 5 pm < 20% deposits in nose, up to 50% in
the URT and the rest in LRT. Maximum deposition in LRT
possible is approximately 70% at about 0.5 pm (see graph
below).
Wright's Nebuliser produces particles nominally < 8 um.
% deposition
75-
0.5 5 7 10
AED (pm) (Aerodynamic equivalent diameter)
Figure 30. The Effect of Particle Size on the Percentage
Deposition in the Lower Respiratory Tract
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APPENDIX iv
COMPARISON OF VARIOUS FIXATIVES AND THEIR SUITABILITY
FOR THE STUDY
There are several fixatives recommended as being
compatible for studies at both the light and electron
microscope level (Carson et al., 1972). Some have the
disadvantage of being costly and difficult to make up on a
large scale, however, there remain several possibilities
which it was considered should be tried out to see which
was most suitable for this study.
EXPERIMENTAL DETAILS
Fixatives and Formulation
1) Glutaraldehyde in phosphate buffer
32 ml of 25% Glutaraldehyde (EM grade)
368 ml of Millonig's phosphate buffer (170 ml of
2.5% NaOH and 830 ml of 2.26% NaH2P04).
2) Millonig's phosphate buffered formaldehyde (Modified
by Carson et al.. 1973)
40 ml 37-40% Technical grade formaldehyde




3) 4CF-1G (4 parts formaldehyde : 1 part glutaraldehyde)
4.64 g NaH2P04
1.08 g NaOH
344 ml Distilled water
40 ml 37-40% formaldehyde (Technical Grade)
16 ml 25% glutaraldehyde (EM Grade)
4) Buffered 10% Formalin (Departmental routine fixative)
100 ml 37-40% Technical grade formaldehyde




Four rats were used for the study. They were killed
using an overdose of sagatal and the following tissues
taken for histology:
1 mm slices of liver
Short sections of ileum fixed in rings
Kidneys sliced in half
Intact heart
Intact spleen
Stomach opened and cleaned
Lung inflation fixed. Left lung for light microscopy,
right lung for electron microscopy
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A piece of each tissue was placed in each of the four
fixatives being tested. Initial fixation was carried out
at 4°C for 24 hours, after which time storage continued at
room temperature. Pieces of tissue were taken for
histology at 24 hours, 3 weeks and several months later.
For light microscopy the tissues were embedded in GMA, for
electron microscopy the tissues were post-fixed in 0.5%
osmium tetroxide (OsO^) in Millonig's phosphate buffer for
3 hours and then processed into araldite using the routine
procedure adopted in the EM Suite of the Department of
Pathology.
CONCLUSIONS
Of the four fixatives tested Millonig's phosphate
buffered formaldehyde was chosen for the following reasons:
it gave good results in most tissues at both the light
microscope and EM levels, particularly for the lung and
small intestine. Penetration was superior to that of
glutaraldehyde in the spleen and liver and the heart was
adequately fixed when left whole. It is very simple to
make up, stable for long periods of time and unlike
glutaraldehyde, it is reasonably cheap and relatively non¬
toxic .
Glutaraldehyde was excellent at the EM level and
produced very good EM results. However, penetration was
very poor in the liver, spleen and heart. An additional
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drawback is that during the fixation process,
glutaraldehyde releases a large number of free-aldehyde
groups within the tissue and this interferes with the
specificity of PAS staining making it very non-selective.
This, of course, masks to some extent the mucin staining
and makes it much harder to identify goblet cells.
The routine formaldehyde tested gave adequate fixation
for light microscopy but there was evidence of shrinkage
artefact in the small intestine, and relatively poor
fixation for EM study. The mixture of formaldehyde/
glutaraldehyde tested gave least penetration, and produced
poor results at both the light and EM levels.
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APPENDIX V
DEVELOPMENT OF NEW HISTOLOGICAL TECHNIQUES FOR THE
QUANTITATIVE ASSESSMENT OF THE GOBLET CELL AND OTHER
EPITHELIAL CELL TYPES IN THE RAT LUNG USING BOTH THE
LIGHT AND ELECTRON MICROSCOPE
Bearing in mind the original intentions of the project
as given in the synopsis at the beginning of the thesis,
the histological methods employed must, if they were to be
capable of demonstrating both goblet cells and other cell
types within the respiratory epithelium, at both the light
and electron microscope levels, satisfy the following
requirements:
(1) To be able to identify all the different cell types at
the light and electron microscope levels; ideally
using one technique, or it may be necessary to use a
combination of techniques.
(2) The embedding medium and the fixation technique
employed should be compatible with both the light and
the electron microscope.
(3) It must be possible to count individual goblet cells
quickly and unequivocally.
(4) In order to overcome the problems of sampling caused
by the uneven distribution of goblet cells in the
respiratory tract, the sections prepared for the light
microscope need to encompass the entire longitudinal
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section of the main airway in the rat lung and some of
its side branches. They therefore need to be quite
large, at least 1 x 1.5 cm and ideally 2x2 cm.
(5) It must be possible to stain nuclei and cytoplasmic
detail sufficiently to allow identification of
labelled cells in autoradiographs.
(6) The sections must be thin (1.5 - 2.0 ^im) if the nuclei
and cells are not to overlap cells underneath, that
is, sections must be less than one cell thick.
(7) In order to facilitate rapid assessment of new
compounds for goblet cell hyperplasia activity a fast
screening procedure needs to be developed: see the
tracheal dab technique Appendix i.
SELECTION OF A SUITABLE EMBEDDING MEDIUM
Ideally the embedding medium chosen had to be
compatible with both the light and electron microscopes.
There are a few resins available which satisfy this
requirement. These are the epoxy resins Araldite and Epon
812, Spurr resin, and a resin made up from a combination of
Epon 812 and Araldite.
Spurr resin was tested for suitability and quickly
rejected after preliminary work revealed that sections
stained for the light microscope rapidly faded to such an
extent that they were no longer usable. In addition most
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of the reagents for this resin are extremely toxic and
hazardous and it is therefore particularly unpleasant to
work with on a large scale.
Epon 812, like Araldite, is an epoxy resin and as such
has many characteristics in common with Araldite,
particularly with regards staining properties for the light
microscope. Since Araldite was in routine use in the
Department's EM suite and was therefore well tested for use
in routine EM work, it was decided to concentrate on
Araldite as an embedding medium. Likewise, the combination
of Epon 812 and Araldite was not pursued beyond the
preliminary stage as it exhibited the same staining
properties as Araldite when used alone.
PROCESSING LARGE BLOCKS OF TISSUE INTO ARALDITE
The ultimate aim of the histological techniques
employed was to achieve large, thin plastic sections of
tissue. It follows, therefore, that large blocks of
tissue, in this case lung, had to be processed and embedded
in Araldite, the chosen embedding medium. This presented a
number of problems. Firstly, the processing procedure,
i.e. dehydration from fixative to Araldite had to be
adapted to allow adequate penetration of the alcohols and
other reagents throughout the tissue block. A method was
worked out which was an adaptation of that used in the EM
suite for very small blocks of tissue and that used for
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routine paraffin embedding. This work was carried out with
the assistance of Mr J.K. Rae of the Departmental technical
staff and the method eventually developed is his
adaptation. Details of the processing and embedding
procedures for araldite are given in the histology methods
sections in Chapter 2, along with details of the poly¬
merisation procedure adopted, and the methods for the
trimming-in of blocks and the cutting of sections. Since
the cutting of large, thin sections of araldite embedded
material presented a number of problems not discussed
elsewhere in this thesis a brief outline of these
difficulties will be given here.
PROBLEMS ENCOUNTERED WHEN CUTTING LARGE. THIN SECTIONS
OF ARALDITE EMBEDDED MATERIAL
The sections obtained lacked definition, were of
uneven thickness, were poorly stained and very difficult to
focus adequately for study under higher powers on the light
microscope. The blame for this inadequacy was first
thought to be an inability to achieve crisp and definitive
staining of the sections. However, a wide range of stains,
'mordants' and promoters all failed to improve the staining
quality sufficiently (see next section).
At the time sections were cut using a tungsten carbide
edged knife fitted to a Reichert-Jung Autocut microtome, a
new machine which had been specifically developed by the
manufacturers to make it possible to cut large plastic
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embedded sections, of any thickness from 0.5 pm - 30 pim.
Because of the newness of the techniques involved, all
stages of microtomy, namely fixation, processing,
embedding, cutting, floating out, staining and mounting of
sections, had to be developed from the start. Having
established that staining was not the problem it was
necessary to see which of the preceding events was at
fault. The fixative was not thought to be the problem as
it produced adequate results both at the EM level and in
paraffin (see Appendix iv). The processing technique
evolved to cope with larger blocks of tissues was very
similar to that used routinely for EM preparation, however,
it was more protracted to allow adequate penetration of the
tissue by all reagents. In order to see if this had any
effect on the section quality, a large araldite block was
prepared using the new regime and then sawn up into 3 mm x
3 mm blocks, mounted on beam capsules and 1.5 pm sections
cut using a 6.25 mm glass knife on a conventional ultra-
microtome. The improvement in staining and histological
detail was very pronounced (see Figures 31 - 33). By
comparing Figure 31 and Figure 33, it can be seen that the
quality obtained was comparable to that achieved using
conventional EM techniques. The conclusion drawn from this
was that the fault lay with the cutting technique employed,
i.e. the tungsten carbide knife. This knife is not
exceptionally sharp like a conventional D-profile steel
knife or a glass knife and cuts blocks by virtue of the
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FIGURE 31
1 jam section of rat lung embedded in araldite. Post-
osmicated and stained with 1% Toluidine Blue in 1%
borax. Magnification = x40.
Section cut using Reichart-Jung Autocut fitted with a
tungsten carbide edged steel knife. Note the apparent
loss of cilia, the broken alveolar structure, variable
depth of staining and inability to focus the whole




As for Figure 31, except this section was cut with a
large glass knife (12.5 mm wide) fitted to the
Autocut. It is impossible to focus any part of the
section at x40 magnification. The light and dark
striations are caused by excessive judder in the block
causing 'chatter* at the knife edge and variable
thickness of the section along with severe wrinkling.
The block cut measured 1 cm wide by 1.5 cm long.
 
FIGURE 33
As for Figure 31, except this section was cut on a
conventional ultramicrotome using a 6.25 mm wide glass
knife. In fact the block used to obtain this section
was sawn out of the block used for Figure 31 and
mounted on a Beem capsule, it measured approximately
5mm x 5 mm. The cytological detail obtained is
excellent and compares very favourably with that
obtained using conventional EM techniques. It was
this section which provided the evidence that the
tungsten carbide knife was the cause of the poor
quality of sections obtained in the larger blocks.
FIGURE 33.
pressure exerted at the knife edge, rather than by shearing
off a slice of block as sharper knives do. In some way
this adversely affects the quality of the sections obtained
and also renders them less permeable to stains.
At this stage it became obvious that if large, thin
plastic sections of the quality desired were to be achieved
then either a large glass knife had to be fitted to the
Autocut or a new 'softer' resin had to be used as an
embedding medium.
Reichert-Jung at this time produced an adaptation of
the glass knife holder which allowed it to take 12.5 mm
thick glass knives. Using one of these it was hoped to be
able to cut post-osmicated araldite embedded blocks 1 cm x
1.5 cm large. By careful trimming of the lung prior to
embedding, and of the blocks once hardened, it was thought
that complete longitudinal sections of the main airway of
the left lung of the rat may be obtained. However, there
was a delay in the delivery of the glass knife holder and
during this time various different embedding media were
tried as alternatives.
One of them, glycolmethacrylate (GMA), a water soluble
methacrylate resin, proved to be suitable. It had several
advantages over araldite, not least being ease of staining.
It was also quicker to process, easier to cut requiring a
conventional D-profile steel knife only, and this allowed
the use of large blocks. Unfortunately, GMA is not
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suitable for the EM as it is not electron-stable, and also
in our experience it is not compatible with osmium
tetroxide and this limits contrast in the sections
obtained. Finally, background staining in autoradiographs
makes them difficult to study.
All this had taken several months to establish and as
time was pressing the decision was taken to embed the left
lungs in GMA for goblet cell assessment, post-osmicate
selected right lungs, embed them in araldite and cut
sections using a 12.5 mm glass knife as and when this
technique became available. At the time of writing the use
of the 12.5 mm glass knife still does not give sections of
an adequate quality (see Figure 32). This is mainly
because it has proved impossible to flatten the sections
sufficiently when mounted on the microscope slide to allow
for their study under the higher powers of magnification on
the light microscope.
STAINING METHODS APPLIED TO ARALDITE SECTIONS
The objectives were to achieve crisp, definitive
staining of all cell types in the respiratory epithelium
and also to be able to distinguish goblet cells
unequivocally for easy quantitation.
Toluidine Blue
1% solution in 1% borax or 1% solution in 1% Na2C03.
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Staining was carried out at 60°C for 30 - 60 sees on
the slide using a hot plate or for 2-3 mins in a water
bath set at 60°C.
Methylene Blue/Basic Fuchsin (Jones et al., 1977)
1% solution of methylene blue in 1% borax
0.5% solution of basic fuchsin in alcohol
Staining carried out at 60°C for 60 sees in methylene
blue using a hot plate followed by 15 - 20 sees at room
temperature in basic fuchsin.
Periodic Acid-Schiff (PAS) Toluidine Blue (Jones et al..
1977)
2.5% periodic acid
Schiff reagent, prepared using the 'Lillie Cold
Method* (Lillie, 1965)
Preheat slides for 1 hour in xylene at room
temperature. Dry sections at 60°C and rinse in water.
Treat with 2.5% periodic acid at 60°C for 15 mins. Wash
sections then dry. Place in Schiff reagent and leave in
the dark overnight. Wash sections and allow colour to
develop, approximately 5 mins. Dry sections and
counterstain with 1% Toluidine Blue in 1% borax at 60°C for
45 - 60 sees.
214
Tribasic Stain (Grimley et al. , 1965)
100 ml 30% ethanol containing 0.4 g Azure B; 1 g
malachite green; 1 g aniline; 1 g phenol crystals.
Filter and store at room temperature.
Prepare sections for staining using following
'mordant' procedure: 10 mins at room temperature in 0.5%
KMnC>4. Wash. 5 mins at room temperature in 1.0% oxalic
acid. Wash. 1 min at room temperature in 1.0% L^COj.
Wash. Cover sections with stain solution and leave for 1 -
2 mins at room temperature. Rinse and mount sections
having air dried them. Sections can be counterstained with
4% saturated solution of aqueous basic fuchsin in distilled
water: filter and warm basic fuchsin to 50°C, cover
section and leave for 1-5 mins, checking all the time for
depth of staining. Blot sections, rinse and dry in air.
Azure B (Grimley et al.. 1965)
100 ml 30% ethanol containing 0.4 g azure B; 1 ml
aniline, 1 g phenol crystals.
Filter and store, do not dilute.
Prepare sections using the same mordant procedure as
for the tribasic stain. Cover sections with the Azure B
solution and stain for 0.5 - 1 min at room temperature.
Rinse sections and air dry. Sections can be counterstained
with basic fuchsin as in the tribasic stain.
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Results
The only really satisfactory stain for araldite
sections was 1% Toluidine Blue in 1% borax. Definition and
cytoplasmic detail was particularly good in post-osmicated
material provided the sections were cut with a glass knife
(Figure 33). Staining of sections cut with the tungsten
carbide knife was patchy and the overall picture seen with
the light microscope was hazy (Figure 31).
The use of methylene blue/basic fuchsin gave very
little improvement over Toluidine Blue although it was
found that elastic laminae in blood vessels and airway
musculature showed up very well indeed.
The Tribasic stain gave interesting results in the
kidney and may be quite useful for sections of kidney,
however, it offered no improvement over Toluidine Blue in
the lung. Likewise for Azure B, which was more difficult
to produce than Toluidine Blue and was not as effective.
The PAS staining in araldite was extremely faint
despite the long drawn out staining method and it ws
considered inadequate for the reliable quantitation of
goblet cells using the light microscope.
Many people have claimed to get good results with a
variety of stains following de-aralditing procedures
(Donald Mayor et al., 1961; Yensen, 1968; Imai et al..
1968). These usually involve exposure of sections to
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alcoholic sodium methoxide or bromine gas, neither of which
are pleasant to work with. Sodium methoxide treatment was
tried on a number of slides; a large number of sections
became detached from the slides but those that remained and
which were subsequently stained with Toluidine Blue
revealed that, along with the araldite, a lot of the tissue
itself had disappeared. This was particularly true in the
lung, and this method too was abandoned.
To conclude, therefore, the only really satisfactory
stain for araldite embedded material is Toluidine Blue. It
was not possible to apply any mucin specific stains and
this would have made the quantification of goblet cells
difficult; particularly as, although human goblet cell
mucin readily displays metachromasia with Toluidine Blue in
the rat, it does so only rarely. The cytological detail in
the' sections used for quantification would have therefore
needed to be of a very high quality if goblet cells were to
be identified easily and accurately.
CONCLUSIONS
Araldite proved unsatisfactory for the purposes of
this project for the following reasons:
(1) It was incompatible with most histological stains and
it proved impossible to stain selectively for goblet
cell mucins.
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(2) It was very difficult to cut large, thin sections from
araldite blocks using both the tungsten carbide edged
knife and a large glass knife.
(3) It was impossible to achieve adequate flattening of
the sections when mounted on glass microscope slides.
This meant that the sections could not be studied
using the higher powers of magnification on the light
microscope.
(4) Processing and polymerisation took place over long
periods of time. This led to a prolonged period of
time between dosing the animals and acquiring the
sections for counting.
(5) All the techniques employed were highly labour
intensive and this also contributed to the time
factor.
(6) Autoradiographs proved very unreliable and the
techniques were not pursued beyond the very early
stages.
(7) Many of the reagents employed are highly toxic and
allergenic and this necessitates the use of a fume
cupboard throughout the embedding procedure.
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THE COMPROMISE SOLUTION EMPLOYED FOR THE REST OF THE
PROJECT
It had taken many months to find that the cause of the
poor histology lay with the cutting technique employed,
i.e. the tungsten carbide knife. At this point there were
three alternative paths which could be followed:
1) Search for a completely new embedding medium
compatible with the light and electron
microscopes.
2) Wait for the delivery of the new glass knife
holder and develop the techniques for cutting
large araldite blocks with this.
3) Change to an alternative plastic embedding medium
which was compatible with most stains, easily cut
with a conventional D-profile steel knife, but
could not be used for EM purposes, i.e.
glycolmethacrylate (GMA).
GMA has been in use for several years as an alterative
to paraffin and therefore a number of stains have been used
routinely on material embedded in it. The Autocut has now
made it possible to extend its use to the cutting of large,
thin (1 - 1.5 pm) sections of GMA embedded tissue. Since
there was already some experience within the department of
this resin it was decided to investigate its suitability
for the study of goblet cell numbers in the rat lung.
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It was very quickly found that GMA was amenable to
most of the routine histological stains and that large,
thin sections could easily be cut on the Autocut using a
conventional D-profile steel knife. The combined AB/PAS
stain proved easy to achieve and it was also consistent,
which meant that goblet cells could easily be identified
and quantified in the rat lung (see Figure 7). It was
therefore decided that goblet cell assessment would be
carried out in the left lung using 1.5 pm GMA sections and
that selected right lungs would be post-osmicated and
embedded in araldite to await future developments with the
glass knife.
As it was no longer possible to study the same area
using both the light and electron microscopes the proposed
differential cell count studies had to be abandoned.
Likewise the autoradiographic studies had to be postponed
until the technique had been developd using GMA. The
emphasis of the project was therefore changed at this
point from a concentrated study of the goblet cell to a
detailed investigation of the isoprenaline response
designed to identify the mechanism whereby isoprenaline




The following statistical formulae have been applied
to the results obtained in the course of this study.
Mean (x) =
n
where x = individual result
n = total number in group
Standard Deviation (SD) = /< (x - x)^
V n - 1
Standard Error (SE) = ^5.
Yn
Significance of the results was tested using the Student's
t-test where
_ (m^. - iAQ) / ^t^c
SD v nt + nc
nt = total number in treated group
nc = total number in control group
mt = treated mean
mc = control mean
Confidence Limits (95% level) = t x SE
where t is taken at the 5% level for (n - 1) degrees
of freedom.
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